Compound Adverse Effects of COVID-19 mRNA Vaccination and Coronavirus Infection A Convergence of Extensive Spike Protein Harms to the Human Body    REPORT   ARCHIVE

1. The "Hybrid Harms Hypothesis"

• Core Premise: The hypothesis states that "repeated spike antigenic exposure via mRNA vaccination may interact with either a previous or subsequent coronavirus infection due to the long-term persistence of spike protein in the body. This interaction results in an amplification of 'spikeopathy,' manifesting as chronic immunotoxicity, hyper and persistent inflammation, immune dysregulation, and diverse pathological sequelae."

• Misattribution of Causality: The temporal association between diverse health problems and SARS-CoV-2 infection in vaccinated individuals has led to "systematic misclassification, attributing causality solely to the viral infection rather than considering the potential background noise of spike protein generated by previous mRNA vaccinations."

• Five Fundamental Features:COVID-19 mRNA product's three-pronged toxic payload: Consists of spike protein, inflammatory lipid nanoparticles (LNPs), and process-related DNA impurities.

• Whole-body biodistribution: mRNA and spike protein can distribute to nearly all organs, including ovaries, adrenal glands, brain, eyes, heart, testes, uterus, pituitary gland, spinal cord, thymus, and bone marrow.

• Multiple mRNA injections: Repeated doses lead to cumulative toxic impacts and immune system disruption.

• Prolonged exposure to the mRNA product’s payload: Spike protein and vaccine-derived mRNA can persist for "2-3 years at a minimum" and potentially up to 3.2 years for mRNA, creating a "window of vulnerability" (WOV).

• Infection with SARS-CoV-2 or Omicron variants: Occurring before or many months after vaccination, symptoms are often "misattributed to the viral infection and its 'Long Covid' sequelae."

2. Doubts on Vaccine Efficacy and Safety

• Waning Immunity and "Vaccine Failure": The initial 95% efficacy reported in trials for preventing symptomatic infection was "short-lived." Protection against symptomatic Omicron infection dropped to "about 10-20% by 6 months" post-second dose, with faster declines in vulnerable populations. The term "breakthrough infections" (BTIs) is critiqued as inaccurate; "vaccine failure" is suggested as more appropriate, as fully vaccinated individuals can still contract and develop COVID-19.

• Negative Efficacy: Later studies showed "repeated or successive doses of the modified mRNA products would lead to a further disruption of immune system functioning, resulting in a wide range of serious disease outcomes." Negative efficacy means vaccinated individuals are more likely to contract the targeted disease. Examples cited include:

• Cleveland Clinic study: Risk of infection "actually rose with successive doses, with concurrent increases of 107%, 150%, 210%, and 253% for 1, 2, 3, and >3 doses, respectively, compared to unvaccinated individuals."

• Japanese study: Elevated infection risk among vaccinated (adjusted OR, 1.85), with a dose-dependent trend (63% higher risk for 1-2 doses, 104% for 3-4 doses, and 121% for 5-7 doses).

• Global Bayesian causal analysis (Beattie): COVID-19 vaccinations "significantly increased global COVID-19 cases by up to 291%... and COVID-19 deaths by up to 205.25%." These increases correlated positively with the number of vaccine doses.

• Serious Adverse Events (SAEs):Re-analysis of Pfizer trial data by Fraiman et al. found a "significant 36% risk... of serious AEs in the mRNA-injected group compared to the placebo group." This equates to "one out of every 800 doses... resulted in a serious AE," far exceeding the historical threshold of "one serious AE per 100,000 injections."

• Confidential Pfizer documents (obtained via legal action) revealed "about 1.6 million AEs were linked to the mRNA injections by August 2022, with roughly one-third involving serious injuries to cardiovascular, neurological, thrombotic, immunological, and reproductive systems, alongside a notable rise in cancers."

• Underreporting: The commonality of certain AEs (e.g., ischemic stroke, myocardial infarction) makes clinicians "less likely that clinicians will attribute the more commonly seen conditions to the COVID-19 mRNA products," leading to underreporting in public health statistics.

• Overlapping Risks: Common chronic diseases (diabetes, obesity, hypertension, cardiovascular disease) are associated with increased risks of both severe COVID-19 and SAEs from mRNA vaccinations, suggesting a "preexisting chronic inflammatory state."

3. "Spikeopathy" and Immunological Dysregulation

• Spike Protein Toxicity: The spike protein itself, whether from infection or vaccination, "exhibits toxic and pathogenic potential." Its effects ("spikeopathy") involve "oxidative stress, inflammation, thrombogenesis, endotheliitis-related tissue damage, and prion-related dysregulation."

• Lipid Nanoparticles (LNPs): The LNP delivery system is "intrinsically immunotoxic," causing "prolonged inflammation" and potentially suppressing adaptive immunity. Pre-existing inflammation can "amplify the inflammatory impacts of the mRNA vaccine’s LNPs."

• DNA Impurities: Pfizer's Comirnaty product contains plasmid DNA fragments, sometimes "over 500-fold" exceeding acceptable limits. These DNA fragments can integrate into the human genome, potentially "disrupt[ing] immune function, possibly leading to autoimmune conditions... and (potentially) oncogenesis." The higher DNA contamination in Pfizer products is suggested as a reason for its "38% greater risk of all-cause mortality" compared to Moderna.

• N1-methylpseudouridine Modification: This modification, intended to enhance mRNA stability, "enhances transcriptional infidelity by promoting ribosomal miscoding, leading to elevated rates of amino acid misincorporation and a higher frequency of translation errors," raising "grave concerns about the long-term safety."

• Prolonged Persistence of Spike Protein and mRNA: While initially assumed to be transient (1-2 weeks), spike protein has been detected circulating in the body for "more than 4 months," and up to "23.6 months (709 days)" in some individuals. Pfizer vaccine-generated mRNA was found in blood "3.2 years after the modified mRNA injection." The authors state, "The best estimates to date for extended spike production post-vaccination are in the range of 24 to 38 months."

• Immune Dysregulation:IgG4 Class Switch: Repeated mRNA vaccinations can lead to an "IgG4 antibody class switch," which "may increase susceptibility to infectious diseases, IgG4-related autoimmune diseases, and various cancers." This switch "appears almost exclusively in individuals who received either multiple COVID-19 mRNA vaccinations or who were infected after receiving the vaccinations."

• T-cell Exhaustion: Chronic antigenic stimulation from persistent spike protein exposure "may drive T-cell exhaustion, impairing T-cell responses and increasing susceptibility to reinfection."

• Interferon Suppression: mRNA vaccinations have been shown to "induce autoantibodies against type I interferons in healthy individuals," suppressing antiviral and anticancer immune responses.

• Hyperinflammation and Autoimmunity: Both infections and vaccinations trigger hyperinflammation (cytokine storms) and promote autoimmune reactions (molecular mimicry, epitope spreading).

4. Overlapping Sequelae: PASC vs. PCVS

• "Long COVID" Reclassification: The paper argues that "Post-acute Sequelae of COVID-19" (PASC), or "long COVID," often overlaps with "post-COVID-19 vaccine syndrome" (PCVS).

• Evidence of PCVS:Studies show "a probable association between COVID-19 mRNA vaccination and an increased risk of PASC-like syndromes."

• Vaccinated individuals with PASC symptoms had "approximately seven times higher" spike antibody levels than unvaccinated individuals with PASC.

• A retrospective analysis found "70% of PASC cases occurred in individuals who had completed a full course of the COVID-19 mRNA vaccinations."

• Unvaccinated individuals exposed to Omicron showed the "lowest PASC incidence."

• Misclassification Bias: The "case-counting window bias" in many studies misclassifies vaccinated individuals who experience AEs shortly after injection as "unvaccinated," artificially inflating vaccine safety and efficacy. This means "vaccine-related AEs are not only misclassified as PASC, but as PASC occurring among the unvaccinated."

5. Cardiovascular and Hematological Harms

• Myocarditis: While public health agencies claimed infections caused more myocarditis than vaccines, the authors refute this, stating "evidence supports a stronger link between COVID-19 mRNA vaccines and severe cardiac complications compared to SARS-CoV-2 infections."

• Vaccine-induced spike protein has been found in cardiac tissue of those who died post-vaccination.

• mRNA vaccines showed direct cardiotoxic effects on rat cardiomyocytes, unlike SARS-CoV-2.

• Subclinical myocarditis from vaccination (estimated 2.5% in younger populations) may be exacerbated by subsequent infection, turning into "fulminant myocarditis."

• "Repeated doses of the COVID-19 mRNA product have been shown to increase the risk of myocarditis," suggesting a dose-response relationship.

• Case synopses are provided of vaccinated individuals who developed severe myocarditis post-infection, arguing the vaccine was a "precursor event."

• Clotting Disorders (Coagulopathies): "The same coagulopathies seen in severe COVID-19 disease are mirrored by the serious thrombotic complications caused by the COVID-19 mRNA vaccinations, including myocardial infarction, disseminated intravascular coagulation, and venous thromboembolism."

• Both the virus and vaccine can trigger "endothelial dysfunction, systemic inflammation, and dysregulated coagulation cascades."

• Increased risks for stroke, myocardial infarction, and pulmonary embolism were found in individuals with BTIs.

• Hyperimmune Response: The combination of mRNA injections and coronavirus infection was associated with "severe heart failure and cardiogenic shock in patients with STEMI," potentially due to a "hyperimmune response." The authors suggest "the stronger the humoral response following the COVID-19 vaccinations, the stronger the potential for serious AEs."

6. Epidemiological Observations from the Omicron Era

• Paradoxical Mortality Spikes: Despite Omicron's "relatively mild pathogenicity," many heavily vaccinated countries (e.g., South Korea, Hong Kong, Singapore, Australia, Nordic countries) experienced "unexpected spikes in mortality following the Omicron waves" in 2022-2023.

• Correlation with Vaccination Coverage: "COVID-19 mortality increased in the vaccination era, especially in regions with higher vaccination coverage."

• Africa vs. West: In Africa, with "relatively low" mRNA vaccination coverage, "COVID-19-related morbidity and mortality rates have been much lower when compared with figures from other continents." This "suggest[s] the possibility that, with minimal vaccination, COVID-19 may result in lower mortality."

• Re-infection Risks: Hospitalized reinfections with Omicron showed "significantly elevated risks of post-acute all-cause mortality, hospital readmission, and emergency department visits," even in vaccinated individuals.

Conclusions and Implications

• Challenging the Dichotomy: The paper strongly challenges the notion that COVID-19 mRNA vaccination and SARS-CoV-2 infection can be assessed in isolation regarding morbidity and mortality. The "Hybrid Harms Hypothesis" posits an additive or synergistic interaction, with vaccination potentially predisposing individuals to more severe outcomes during subsequent infections.

• Policy and Clinical Implications:Calls for re-examining public health strategies and "discontinu[ing] further booster vaccinations."

• Urges healthcare professionals to routinely record both COVID-19 vaccination history and infection dates when assessing cardiovascular and clotting issues.

• Advocates for a shift in research priorities to focus on "spike protein syndromes" and fully describe the pharmacokinetics and dynamics of vaccine components to "clear or neutralize this dangerous pathogenic entity."

• Natural Immunity vs. Hybrid Immunity: The authors argue that "Natural immunity... may well provide a superior degree of protective immunity" compared to mRNA vaccinations, citing the comprehensive immune response and absence of SAEs. While hybrid immunity may offer short-term "enhanced protection," this is "substantially counterbalanced by the large number of serious AEs that correlate strongly with the additional antibody production associated with hybrid immunity."

• Critique of Official Narratives: The authors accuse public health officials and scientists of "continually downplay[ing] the effects of the vaccines while emphasizing the risks of infection" and perpetuating a "safe and effective" narrative, possibly due to "biopharmaceutical industry-related financial incentives and political pressures."

• Future Research Needs: Emphasizes the need for rigorous placebo-controlled trials with appropriate "washout periods" (minimum three years) to truly understand the long-term safety and efficacy, given the prolonged persistence of vaccine components.

convert_to_textConvert to source

• What is the "Hybrid Harms Hypothesis" proposed in the document?

• The Hybrid Harms Hypothesis suggests that exposure to spike protein from both COVID-19 mRNA vaccinations and subsequent (or prior) SARS-CoV-2 infections interact, leading to an amplification of health problems. This interaction results in chronic immunotoxicity, persistent inflammation, immune dysregulation, and various pathological outcomes, including cardiovascular, hematological, autoimmune, and neurological conditions. The hypothesis posits that many morbidity and mortality events attributed solely to COVID-19 infection in vaccinated populations, especially in 2022-2023, were actually due to the long-term persistence of vaccine-induced spike protein and other vaccine-associated components, creating a "window of vulnerability" (WOV) for amplified adverse effects upon subsequent infection.

• What are the five fundamental features distinguishing the Hybrid Harms Hypothesis?

• The Hybrid Harms Hypothesis is characterized by five core features:

• The COVID-19 mRNA product’s three-pronged toxic payload: This includes the spike protein itself (known to cause oxidative stress, inflammation, and thrombogenesis), inflammatory lipid nanoparticles (LNPs) which can activate pro-inflammatory pathways and suppress adaptive immunity, and process-related DNA impurities (such as plasmid-sourced DNA fragments, like SV40, which raise concerns about genomic integration and autoimmunity).

• Whole-body biodistribution: Research indicates that both the mRNA and the spike protein it produces can distribute to nearly all organs, crossing barriers like the blood-brain and blood-placenta barriers. This systemic distribution explains why various organ systems (heart, liver, spleen, ovaries, nervous system) can experience inflammatory damage.

• Prolonged spike antigen exposure and overwhelming antigenic load: Contrary to initial assumptions, the synthetic mRNA and generated spike proteins do not degrade quickly. Modifications like N1-methylpseudouridine enhance mRNA durability, leading to spike protein persistence for 2-3 years (or potentially longer) post-vaccination. This prolonged exposure contributes to chronic systemic inflammation and immune-related disorders.

• Multiple mRNA injections: Repeated COVID-19 mRNA vaccinations are believed to have cumulative toxic impacts and disrupt immune system functioning, leading to "negative efficacy" where vaccinated individuals become more susceptible to SARS-CoV-2 infection and related health conditions, and increasing the risk of serious adverse events.

• Infection with SARS-CoV-2 or Omicron variants (before or after vaccination): The hypothesis emphasizes that when a coronavirus infection occurs within the 2-3 year "window of vulnerability" established by prior mRNA vaccination, the disease symptoms and "Long Covid" sequelae may be misattributed solely to the viral infection, when in fact, the persistent vaccine-induced spike protein predisposes individuals to more severe adverse impacts.

• How does the document challenge the claim that mRNA vaccinations reduce the severity of COVID-19 and its long-term effects (PASC)?

• The document challenges this claim by presenting evidence that suggests the opposite. It highlights that instead of reducing severity, mRNA vaccinations may amplify COVID-19 morbidity and contribute to "post-acute sequelae of COVID-19" (PASC). It cites studies indicating a probable association between COVID-19 mRNA vaccination and an increased risk of PASC-like syndromes. For instance, a retrospective analysis found that 70% of PASC cases occurred in fully vaccinated individuals, and that unvaccinated individuals exposed to Omicron showed the lowest PASC incidence. The document also points out that the long-term persistence of vaccine-induced spike protein is a common factor in both PASC and "post-COVID-19 vaccine syndrome" (PCVS), suggesting that many cases diagnosed as "long COVID" may actually be vaccine-related injuries or a combination of both.

• What is "negative efficacy" in the context of COVID-19 mRNA vaccines, according to the source?

• Negative efficacy, as described in the source, occurs when vaccinated individuals are more likely to contract the targeted disease (COVID-19) or experience related health conditions than unvaccinated individuals or those who received a placebo. This is quantified as a negative vaccine efficacy percentage, indicating an elevated disease risk due to vaccination. The document cites several large-scale studies (e.g., Cleveland Clinic, Japanese, Qatari, UK, Icelandic, Israeli) showing increased infection risk with successive mRNA vaccine doses, especially after several months, and a dose-dependent rise in breakthrough infections. It also references a Bayesian causal analysis across 145 countries, which suggested a causal link between vaccination programs and significantly increased global COVID-19 cases (up to 291%) and deaths (up to 205.25%) post-vaccination, correlating with the number of doses administered.

• How does the document address the concept of "breakthrough infections" (BTIs) and their true prevalence?

• The document redefines breakthrough infections (BTIs) as "vaccine failures" because vaccinated individuals become infected with the target pathogen. It argues that while initially assumed to be rare and mild, substantial evidence suggests BTIs can result in severe disease and death in fully vaccinated individuals. It highlights systemic biases in data collection and reporting, driven by financial incentives and political pressures, which likely led to vast underreporting of BTI prevalence and incidence. Factors contributing to this underreporting include asymptomatic or mild Omicron infections going undetected, testing criteria prioritizing symptomatic cases, inconsistencies in classifying "fully vaccinated" status, and limited surveillance resources. It also notes that BTI-related deaths were likely underreported, while "COVID deaths" may have been overreported by attributing unrelated deaths to the virus.

• What are the key concerns regarding myocarditis in relation to COVID-19 mRNA vaccinations versus natural infection?

• The document argues that there's stronger evidence linking COVID-19 mRNA vaccines to severe cardiac complications, including myocarditis, than to SARS-CoV-2 infections. It cites studies showing direct cardiotoxic effects of mRNA vaccines on cardiomyocytes, which have not been observed with the virus itself. The document also suggests that mRNA vaccine-related subclinical myocarditis may be exacerbated by subsequent infection-induced spike protein, leading to hyperimmune responses and greater cardiomyocyte damage. Repeated vaccine doses are linked to increased myocarditis risk, showing a dose-response relationship. The "Hybrid Harms Hypothesis" suggests that when myocarditis occurs in a previously vaccinated individual after contracting COVID-19, it is often misattributed solely to the infection, overlooking the pre-existing inflammatory state induced by the vaccine.

• What are the immunological mechanisms discussed that may account for the "negative efficacy" and increased susceptibility to infections after repeated mRNA vaccinations?

• The document identifies several immunological disruptions:

• IgG4 Class Switch: Repeated mRNA vaccinations can lead to elevated levels of IgG4 antibodies, which promote immune tolerance rather than viral elimination, potentially weakening antiviral defenses and increasing the risk of infectious, autoimmune, and malignant diseases. This class switch is observed almost exclusively in individuals who received multiple mRNA vaccinations or were infected after vaccination.

• T-cell Exhaustion: Chronic antigenic stimulation from persistent spike protein exposure may lead to T-cell exhaustion, impairing T-cell responses and increasing susceptibility to reinfection.

• Pathogenic Priming (Antibody-Dependent Enhancement - ADE): This occurs when vaccine-induced non-neutralizing antibodies bind to the virus, facilitating its entry into host cells (e.g., macrophages) and potentially exacerbating viral replication and disease severity, as seen in dengue infections.

• Interferon Suppression: Both SARS-CoV-2 infection and mRNA vaccinations can induce autoantibodies against type I interferons, suppressing antiviral and anticancer immune responses. These changes collectively increase the likelihood of various inflammatory conditions, including cancers and cardiovascular disorders, suggesting that higher antibody levels from vaccination might paradoxically lead to more serious adverse events.

• How do epidemiological observations from the Omicron era support the Hybrid Harms Hypothesis?

• The document points to paradoxical increases in mortality rates in extensively mRNA-vaccinated countries during the Omicron waves of 2022-2023, despite Omicron's generally milder pathogenicity. It highlights that countries with high vaccination coverage (e.g., South Korea, Hong Kong, Singapore, Australia, European and American nations) experienced significant spikes in both COVID-19 and all-cause mortality after vaccine rollouts were in full force and Omicron became dominant. In contrast, African countries with lower mRNA vaccination coverage reported much lower morbidity and mortality rates. This suggests that the mortality peaks during the Omicron era were not solely due to the virus, but were further amplified by the preceding vaccinations and prolonged vaccine-induced spike protein production, supporting the concept of an interaction between the injections and infections leading to "hybrid harms."

convert_to_textConvert to source

I. Core Concepts and Arguments

• The Hybrid Harms Hypothesis: This central hypothesis proposes that COVID-19 mRNA vaccination interacts with previous or subsequent coronavirus infections due to the prolonged persistence of spike protein in the body. This interaction is hypothesized to amplify "spikeopathy," leading to chronic immunotoxicity, hyper-inflammation, immune dysregulation, and various pathological sequelae.

• Spike Protein as the Common Denominator: The paper argues that the SARS-CoV-2 spike protein, whether produced by natural infection or induced by mRNA vaccination, is the primary driver of adverse health outcomes, or "spikeopathies."

• Five Fundamental Features of Hybrid Harms:Immunotoxic Payload: The mRNA products contain spike protein, inflammatory lipid nanoparticles (LNPs), and process-related DNA impurities (e.g., plasmid cDNA fragments, including SV40).

• Whole-Body Biodistribution: The mRNA and its encoded spike protein are distributed throughout nearly all organs, including the brain, heart, ovaries, and testes.

• Prolonged Antigen Exposure: The modified mRNA and spike protein persist in the body for extended periods (estimated 2-3 years, potentially longer), challenging initial assumptions of rapid clearance.

• Cumulative Adverse Effects from Multiple Injections: Repeated mRNA vaccinations are proposed to lead to increased toxic impacts and immune system disruption, a "Triple-Hit Hypothesis" when combined with infection.

• Similar Immunologic Variations/Additive/Synergistic Effects: Both mRNA vaccinations and coronavirus infections trigger similar immune responses (hyperinflammation, autoimmunity, lymphopenia, interferon suppression), leading to potential additive or synergistic adverse effects.

• Negative Efficacy: The concept that vaccinated individuals may be more likely to contract COVID-19 or experience serious adverse events than unvaccinated individuals, particularly after multiple doses or over time. This is quantified as a negative vaccine efficacy percentage.

• Waning Immunity and Breakthrough Infections (BTIs): The observation that humoral immune protection from mRNA vaccines rapidly declines within months, leading to infections in "fully vaccinated" individuals, sometimes with severe outcomes. The paper suggests "vaccine failure" is a more accurate term.

• Post-COVID Vaccination Syndrome (PCVS)/Post-acute COVID-19 Injection Syndrome (PACIS) vs. Post-acute Sequelae of COVID-19 (PASC): The paper argues that many cases diagnosed as PASC, or "Long COVID," in vaccinated individuals are in fact PCVS/PACIS, due to the overlapping clinical features and the persistent vaccine-induced spike protein.

• Methodological Flaws in Vaccine Efficacy Studies:Case-Counting Window Bias: Studies often misclassify individuals who experience adverse events shortly after vaccination as "unvaccinated" by starting the observation period too late (e.g., 14 days after the second dose).

• Misclassification of "COVID-related deaths": Deaths are often attributed solely to SARS-CoV-2 infection based on RT-PCR results, without considering the role of prior vaccination in exacerbating outcomes.

• Healthy Vaccinee Bias: A disproportionate number of individuals with underlying diseases may forgo vaccination, making vaccinated groups appear healthier.

• IgG4 Class Switch and T-cell Exhaustion: Repeated mRNA vaccination can lead to a shift towards IgG4 antibodies, which promote immune tolerance rather than viral elimination, and T-cell exhaustion, impairing immune responses and potentially increasing susceptibility to infections and cancers.

• Immunological Paradox of Hybrid Immunity: While some studies suggest hybrid immunity (infection + vaccination) offers enhanced antibody responses, the paper argues that excessive antibody production (particularly non-neutralizing antibodies) can paradoxically lead to hyperinflammation, immunopathology, and serious adverse events, including Vaccine-Associated Enhanced Disease (VAED).

• Long-Term Persistence of Spike Protein and Genetic Material: The paper emphasizes that the modified mRNA and spike protein persist for years, and raises concerns about the potential for plasmid-sourced DNA fragments to integrate into the human genome, leading to long-term health issues and sustained spike protein production.

• Ecological Observations: Comparisons between highly vaccinated and minimally vaccinated regions suggest a correlation between extensive mRNA vaccination and unexpected spikes in all-cause mortality during Omicron waves.

II. Key Arguments and Evidence

• Against the "Safe and Effective" Narrative: The paper directly challenges the widespread claim that mRNA vaccines significantly reduce COVID-19 severity and sequelae, presenting evidence of waning immunity, negative efficacy, and serious adverse events.

• Prioritization of Spike Protein Harm: The core argument is that spike protein, from either source (vaccine or virus), is inherently pathogenic and its persistence causes significant harm.

• Re-evaluating Mortality Attribution: The paper contends that many morbidity and mortality events attributed solely to COVID-19 in extensively vaccinated populations were plausibly due to the combination of vaccination and infection, with the vaccination potentially predisposing individuals to more severe outcomes.

• Call for Re-examination of Public Health Strategies: The Hybrid Harms Hypothesis advocates for a reassessment of immunopathological dynamics in vaccinated individuals, questioning the continued promotion of mRNA vaccinations, particularly given the mild pathogenicity of Omicron and the potential for cumulative harms.

III. Quiz

Instructions: Answer each question in 2-3 sentences.

• What is the primary claim of the "Hybrid Harms Hypothesis"?

• List two of the "three-pronged toxic payload" components of the COVID-19 mRNA product, as described in the paper.

• Explain the concept of "negative efficacy" as it relates to COVID-19 mRNA vaccinations.

• What is "case-counting window bias" and how does it affect the perceived efficacy of mRNA vaccines?

• How long is the "window of vulnerability (WOV)" for persistent spike protein production estimated to be after mRNA vaccination, according to the paper?

• Describe one proposed immunological consequence of multiple mRNA injections mentioned in the text.

• What is the main argument for reclassifying some cases of "Long COVID" as "Post-COVID Vaccination Syndrome (PCVS)"?

• According to the paper, how do the concentrations of spike antibodies differ between vaccinated individuals with PCVS and unvaccinated individuals with PASC?

• Provide two examples of adverse events that overlap between SARS-CoV-2 infections and mRNA vaccinations.

• What observation from comparisons of highly vaccinated vs. minimally vaccinated regions supports the Hybrid Harms Hypothesis regarding mortality spikes during Omicron waves?

Quiz Answer Key

• What is the primary claim of the "Hybrid Harms Hypothesis"? The Hybrid Harms Hypothesis claims that COVID-19 mRNA vaccination interacts with previous or subsequent coronavirus infections. This interaction amplifies "spikeopathy," leading to chronic immunotoxicity, hyper-inflammation, immune dysregulation, and various pathological sequelae.

• List two of the "three-pronged toxic payload" components of the COVID-19 mRNA product, as described in the paper. The three-pronged toxic payload consists primarily of spike protein, inflammatory lipid nanoparticles (LNPs), and process-related DNA impurities (e.g., plasmid-sourced DNA fragments, including SV40).

• Explain the concept of "negative efficacy" as it relates to COVID-19 mRNA vaccinations. Negative efficacy occurs when vaccinated individuals are paradoxically more likely to contract the targeted disease (COVID-19) or experience serious adverse outcomes than those who are unvaccinated or received a placebo. This means the vaccination elevates disease risk rather than reducing it.

• What is "case-counting window bias" and how does it affect the perceived efficacy of mRNA vaccines? Case-counting window bias is a methodological flaw where the observation period for counting adverse events in vaccinated individuals starts too late (e.g., 14 days after the second dose). This misclassifies individuals who experience early adverse events, including death, as "unvaccinated," artificially inflating vaccine efficacy and safety estimates.

• How long is the "window of vulnerability (WOV)" for persistent spike protein production estimated to be after mRNA vaccination, according to the paper? The "window of vulnerability (WOV)" for persistent spike protein production post-mRNA vaccination is estimated to be in the range of 24 to 38 months, or approximately 2-3 years, potentially longer.

• Describe one proposed immunological consequence of multiple mRNA injections mentioned in the text. One proposed immunological consequence is the class switch towards IgG4 antibodies, which are associated with immune tolerance rather than viral elimination, potentially weakening antiviral defenses. Another is T-cell exhaustion, impairing T-cell responses and increasing susceptibility to reinfection.

• What is the main argument for reclassifying some cases of "Long COVID" as "Post-COVID Vaccination Syndrome (PCVS)"? The main argument is the significant clinical and mechanistic overlap between PASC symptoms and adverse events linked to mRNA vaccinations, particularly the prolonged persistence of vaccine-induced spike protein. This suggests many "Long COVID" cases in vaccinated individuals may be exacerbated or primarily caused by vaccine-related effects.

• According to the paper, how do the concentrations of spike antibodies differ between vaccinated individuals with PCVS and unvaccinated individuals with PASC? The paper notes that vaccinated individuals with PCVS had an average spike antibody level approximately seven times higher than unvaccinated individuals with PASC, despite the vaccinated group having no recent infections. This suggests a higher spike protein burden from the mRNA injections.

• Provide two examples of adverse events that overlap between SARS-CoV-2 infections and mRNA vaccinations. Two examples are myocarditis (inflammation of the heart muscle) and thrombotic complications (clotting disorders) like myocardial infarction or pulmonary embolism.

• What observation from comparisons of highly vaccinated vs. minimally vaccinated regions supports the Hybrid Harms Hypothesis regarding mortality spikes during Omicron waves? The paper highlights that heavily mRNA-vaccinated countries (e.g., South Korea, Hong Kong, Singapore, Australia) experienced unexpected and pronounced elevations in excess mortality during Omicron waves in 2022, despite Omicron's mild pathogenicity. Conversely, regions with lower vaccination rates, like Africa, showed lower COVID-19 mortality.

III. Essay Format Questions

• Discuss the "Hybrid Harms Hypothesis" in detail, explaining its five fundamental features and how they challenge the conventional understanding of COVID-19 outcomes in vaccinated populations.

• Analyze the concept of "negative efficacy" and its implications for public health messaging and policy regarding mRNA vaccinations. How do the various biases discussed in the paper (e.g., case-counting window bias, misclassification of deaths) contribute to or obscure the phenomenon of negative efficacy?

• Compare and contrast "Post-acute Sequelae of COVID-19 (PASC)" with "Post-COVID Vaccination Syndrome (PCVS)." What evidence does the paper present to suggest an overlap or misattribution between these two conditions, and what are the clinical and public health implications of this distinction?

• Elaborate on the immunological mechanisms proposed to underlie the "Hybrid Harms" phenomenon, specifically focusing on the roles of IgG4 class switch, T-cell exhaustion, and pathogenic priming. How do these mechanisms relate to the observed paradox of "hybrid immunity"?

• Critically evaluate the paper's arguments regarding the long-term persistence of spike protein and potential genomic integration of plasmid DNA impurities. What are the potential consequences of these findings for the long-term safety of mRNA vaccinations, and what further research does the paper suggest is needed?

IV. Glossary of Key Terms

• Adverse Events (AEs): Unfavorable and unintended signs, symptoms, or diseases temporally associated with the use of a medical product, whether or not considered related to the product.

• Antigenic Load: The total quantity of antigens (substances that provoke an immune response) present in the body. In this context, it refers to the cumulative exposure to spike protein from both vaccination and infection.

• Antibody-Dependent Enhancement (ADE) / Pathogenic Priming / Vaccine-Associated Enhanced Disease (VAED): A phenomenon where antibodies, rather than neutralizing a pathogen, enhance its entry into host cells or exacerbate disease severity, often by binding to the pathogen in a non-neutralizing way that facilitates uptake by immune cells.

• Breakthrough Infections (BTIs): Infections that occur in individuals who have been fully vaccinated against a pathogen. The paper often uses the term "vaccine failure" as a more accurate description.

• Case-Counting Window Bias: A methodological flaw in observational studies where the period for counting adverse events in vaccinated groups is started too late (e.g., 14 days post-second dose), leading to the misclassification of early adverse events as occurring in "unvaccinated" individuals.

• COVID-19 Messenger RNA (mRNA) Vaccinations: Genetic injectables that deliver synthetic, modified mRNA instructions to human cells, prompting them to produce the SARS-CoV-2 spike protein to elicit an immune response.

• Cytokine Storm: An uncontrolled and excessive release of pro-inflammatory cytokines, leading to widespread inflammation and tissue damage, often seen in severe infections like COVID-19.

• D-dimer: A protein fragment produced when a blood clot dissolves. Elevated levels can indicate clot formation and are often associated with thrombotic complications.

• Effect Modification: Occurs when the effect of an exposure (e.g., coronavirus infection) on an outcome (e.g., myocarditis risk) is altered by another factor (e.g., prior mRNA vaccination).

• Endothelial Dysfunction / Endotheliitis: Impairment of the inner lining of blood vessels, contributing to inflammation, clotting, and tissue damage. The paper suggests spike protein can induce this.

• Excess Mortality: The number of deaths above what would be expected based on historical averages, often used to assess the overall impact of public health crises.

• Gene Transfer Products / Gene Therapy: Terms used by the authors to describe mRNA vaccinations, emphasizing their mechanism of delivering genetic instructions to cells.

• Hybrid Harms Hypothesis: The central hypothesis of the paper, proposing that COVID-19 mRNA vaccination interacts with previous or subsequent coronavirus infections due to prolonged spike protein persistence, amplifying adverse effects.

• Hybrid Immunity: Immune protection derived from a combination of prior natural SARS-CoV-2 infection and subsequent COVID-19 mRNA vaccination, often associated with robust antibody responses.

• Hyperinflammation: An excessive and dysregulated inflammatory response, often leading to tissue damage.

• IgG4 Class Switch: An immunological phenomenon where repeated antigen exposure (e.g., from mRNA vaccinations) leads to a shift in antibody production towards the IgG4 subclass. IgG4 antibodies are often associated with immune tolerance rather than strong neutralizing activity, potentially weakening antiviral defenses.

• Immunosenescence: The gradual deterioration of the immune system brought about by natural age-related processes, which can worsen outcomes for both infections and vaccinations.

• Insertional Mutagenesis: The process by which foreign DNA (e.g., plasmid DNA contaminants in vaccines) integrates into the host genome, potentially disrupting gene function or causing mutations.

• Interferon Suppression: The inhibition of interferon signaling, which plays a crucial role in antiviral and anticancer immune responses.

• Lipid Nanoparticles (LNPs): The delivery system for mRNA in COVID-19 vaccines, designed to encapsulate and protect the mRNA. The paper describes them as intrinsically immunotoxic.

• Long COVID / Post-acute Sequelae of COVID-19 (PASC): A condition characterized by persistent symptoms (e.g., fatigue, cognitive impairment, dyspnea) lasting for weeks, months, or longer after the acute phase of SARS-CoV-2 infection.

• Lymphopenia / Lymphocytopenia: A condition characterized by an abnormally low level of lymphocytes (a type of white blood cell) in the blood, which can increase the risk of infections.

• Molecular Mimicry: A mechanism by which a foreign antigen (like the spike protein) shares structural similarities with self-antigens, leading the immune system to mistakenly attack the body's own tissues, potentially causing autoimmune diseases.

• Myocarditis: Inflammation of the heart muscle, a known adverse event associated with both SARS-CoV-2 infection and mRNA vaccination.

• Negative Efficacy: A scenario where a vaccine paradoxically increases the risk or severity of the targeted disease or other adverse outcomes in vaccinated individuals compared to unvaccinated individuals.

• N1-methylpseudouridine: A modified nucleoside used in mRNA vaccines to enhance the stability and translation efficiency of the synthetic mRNA, leading to prolonged spike protein production.

• Original Antigenic Sin / Immune Imprinting: A phenomenon where the immune system, upon repeated exposure to related antigens, preferentially responds to the initial exposure, potentially limiting its effectiveness against newer variants.

• Plasmid-sourced DNA fragments: DNA impurities, often from the bacterial plasmids used in vaccine manufacturing, found within the mRNA vaccine product. The paper raises concerns about their potential for genomic integration.

• Post-COVID-19 Vaccine Syndrome (PCVS) / Post-acute COVID-19 Injection Syndrome (PACIS): Terms coined or advocated for by the authors to describe PASC-like symptoms that are primarily attributable to or exacerbated by COVID-19 mRNA vaccinations.

• Prion-like Fibrils / Prion Diseases: Aberrant protein structures that can misfold and aggregate, potentially causing neurodegenerative disorders. The paper suggests mRNA vaccine-induced spike protein may contribute to their formation.

• Prodrugs: Substances that are administered in an inactive or less active form and are then metabolized within the body into an active drug. The paper refers to mRNA products as prodrugs for spike protein.

• Reactogenicity: The property of a vaccine to produce common, usually mild, adverse reactions such as fever, soreness, or fatigue. The paper suggests higher reactogenicity is linked to stronger humoral responses.

• Receptor-Binding Domain (RBD): A crucial part of the SARS-CoV-2 spike protein that binds to host cell receptors, facilitating viral entry.

• RT-PCR Testing: Reverse transcription polymerase chain reaction testing, used to detect viral RNA and diagnose SARS-CoV-2 infection. The paper discusses its limitations in accurately determining true incidence and prevalence.

• SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2): The virus that causes COVID-19.

• Serious Adverse Events (SAEs): Any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization, results in persistent or significant disability/incapacity, or is a congenital anomaly/birth defect.

• Spikeopathy: A term used to describe the pathophysiological effects and tissue damage caused by the SARS-CoV-2 spike protein, whether from viral infection or vaccine induction.

• Sterilizing Immunity: A type of immunity that completely prevents infection and replication of a pathogen, preventing even mild or asymptomatic cases. The paper argues mRNA vaccines do not provide this.

• T-cell Exhaustion: A state of T-cell dysfunction characterized by impaired effector functions, sustained expression of inhibitory receptors, and altered transcriptional states, often occurring during chronic infections or antigenic stimulation.

• Temporal Bias: A type of bias in observational studies where the timing of events (e.g., vaccination and adverse event onset) can lead to inaccurate conclusions about causality, such as attributing events to the most recent exposure.

• Thrombogenesis / Thrombotic Complications: The formation of blood clots, which can lead to serious conditions like myocardial infarction, stroke, or pulmonary embolism.

• Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): A rare but severe clotting disorder observed after certain COVID-19 vaccinations, characterized by blood clots and low platelet counts.

• Window of Vulnerability (WOV): The 2-3 year (or longer) period post-mRNA vaccination during which persistent vaccine-induced spike protein may predispose individuals to amplified adverse effects from subsequent coronavirus infections.

convert_to_textConvert to source

welcome to the lenny and Maria sanchez deep dive podcast show.

I. Compound Adverse Effects of COVID-19 mRNA Vaccination and Coronavirus Infection A Convergence of Extensive Spike Protein Harms to the Human Body The core hypothesis explored is that COVID-19 mRNA vaccinations contribute to and potentially amplify the morbidity associated with COVID-19, including "post-acute sequelae of COVID-19" or PASC.

This framework is termed the **"Hybrid Harms Hypothesis,"** suggesting a convergence of extensive spike protein harms to the human body from interactions between mRNA vaccine-induced spike protein and subsequent coronavirus infections.

II. COVID-19 messenger RNA (mRNA) vaccinations are hypothesized to act as triggering mechanisms that amplify COVID-19 morbidity and PASC.

These modified mRNA injectables are considered **gene transfer products**, designed to deliver genetic instructions to cells for the endogenous production of the SARS-CoV-2 spike protein.

III. Estimates of COVID-19 mortality have been contentious, partly due to reliance on RT-PCR testing, which may overestimate mortality by detecting viral RNA in asymptomatic or non-causal cases.

The Omicron variant, emerging in November 2021, displayed notable genetic differences leading to higher transmissibility but was characterized by relatively mild pathogenicity, often comparable to a common cold or mild flu.

IV. Despite Omicron's lower intrinsic virulence, later studies paradoxically indicated elevations in both COVID-19 deaths and all-cause mortality associated with Omicron subvariants in 2022 and 2023.

The major surges in COVID-19 incidence and mortality became apparent in many countries only after the population attained at least 75% vaccine coverage.

V. The humoral immune protection provided by COVID-19 mRNA products has been shown to be short-lived, with neutralizing antibody titers declining rapidly within 2-6 months after the second dose.

Protection against symptomatic Omicron infection was observed to drop to about 10-20% by six months following the second dose, with more rapid declines for the elderly.

VI. Rapidly waning humoral immunity contributes to an increased risk of post-mRNA-vaccination infections and reinfections, even in individuals considered "fully vaccinated".

This phenomenon can be more accurately described as **"vaccine failure,"** as the individual contracts the target pathogen despite inoculation.

VII. Breakthrough infections (BTIs), initially presumed rare, have been widely documented since 2021 and can result in severe disease and death in individuals who received COVID-19 mRNA injections.

A longitudinal study in Tunisia found that approximately 11% of BTIs were considered either severe or critical, indicating the potential for serious outcomes.

VIII. BTIs have been vastly underreported since 2022, primarily due to systemic biases in data collection and reporting.

Public health agencies downplayed various risks to bolster public confidence in vaccination campaigns, leading to practices that skewed reported BTI rates downward.

IX. Subsequent studies indicated that repeated or successive doses of the modified mRNA products could lead to a disruption of immune system functioning, resulting in a range of serious disease outcomes.

This phenomenon, known as **"negative efficacy,"** means that vaccinated individuals are more likely to contract the targeted disease, or experience elevated disease risk, compared to those who did not receive the vaccine.

X. A large-scale retrospective cohort study at the Cleveland Clinic demonstrated that the risk of infection actually rose with successive doses, increasing by 107% for one dose, and up to 253% for more than three doses, compared to unvaccinated individuals.

Ecological studies using Bayesian causal analysis across 145 countries suggested a causal link between vaccination programs and elevated total deaths and cases globally.

XI. The Hybrid Harms Hypothesis posits that repeated spike antigenic exposure through mRNA vaccination may interact with either a previous or subsequent coronavirus infection due to the long-term persistence of spike protein in the body.

This interaction results in an amplification of "spikeopathy," leading to chronic immunotoxicity, persistent inflammation, and immune dysregulation.

XII. A core feature of the Hybrid Harms Hypothesis is the COVID-19 mRNA product's three-pronged immunotoxic payload: the spike protein itself, inflammatory lipid nanoparticles (LNPs), and process-related DNA impurities.

The spike protein can damage endothelial cells and inhibit mitochondrial function, while LNPs contribute to prolonged inflammation and activate pro-inflammatory pathways.

XIII. Process-related DNA impurities within the COVID-19 mRNA products include plasmid-sourced DNA fragments that can exceed acceptable limits by hundreds of times.

These DNA impurities, encapsulated within LNPs, raise concerns about their **potential integration into the human genome** through insertional mutagenesis.

XIV. Research indicates that both the mRNA encoding the spike protein and the protein itself can distribute to distal tissues throughout the body, including ovaries, adrenal glands, brain, eyes, heart, testes, and bone marrow.

The synthetic mRNA is designed to be durable, thanks to the replacement of uridine nitrogen bases with N1-methylpseudouridine, ensuring its **persistent bioavailability for an unknown period**.

XV. Initial expectations of spike protein clearance within weeks were challenged by emerging data showing its presence for months, and even up to 23.6 months (709 days) in some individuals with immune dysfunction.

This prolonged production, estimated to be between 24 to 38 months, converts transfected cells into "viral protein production factories" without an inherent "off switch".

XVI. The prolonged persistence of the mRNA vaccine-encoded spike protein, potentially extending 2-3 years post-mRNA vaccination, creates a "window of vulnerability" (WOV) where subsequent coronavirus infections may amplify adverse effects.

The N1-methylpseudouridine modification in these COVID-19 mRNA products enhances transcriptional infidelity, promoting ribosomal miscoding and a higher frequency of translation errors.

XVII. Repeated COVID-19 mRNA vaccinations are likely to result in increased and potentially cumulative toxic impacts along with a disruption of immune system functioning.

Multiple, successive COVID-19 mRNA vaccinations are likely to perpetuate various forms of immune dysregulation, contributing to serious disease outcomes.

XVIII. Successive doses of these mRNA injections may lead to T-cell exhaustion and an antibody class-switch to IgG4, observed particularly after three to four doses.

This IgG4 class switch favors immune tolerance over viral elimination and is linked to reduced protection against infections and cancers, as well as an increased risk of new-onset autoimmune disease.

XIX. COVID-19 mRNA vaccinations and natural coronavirus infections both trigger robust immune responses that can lead to similar physiological changes, suggesting a strong potential for additive or synergistic effects.

These overlapping phenomena include **hyperinflammation**, with elevated levels of inflammatory cytokines linked to tissue damage and the new onset of autoimmune-inflammatory disorders.

XX. Both SARS-CoV-2 infections and mRNA vaccinations may promote autoimmune reactions, such as rheumatoid arthritis, lupus erythematosus, and autoimmune hepatitis, possibly through molecular mimicry.

**Lymphopenia**, a reduction in lymphocytes that increases infection risk, is nearly universal in severe COVID-19 cases and has also been observed after multiple COVID-19 mRNA vaccinations.

XXI. Both the infection and the injections have been shown to induce autoantibodies against type I interferons, which can suppress antiviral and anticancer immune responses.

The convergence of immunopathological manifestations is alarming, particularly since it suggests the potential for an amplification of serious adverse events in mRNA-vaccinated individuals subsequently exposed to the infection.

XXII. Claims that COVID-19 mRNA products reduce severe disease, hospitalization, and death have been called into question due to significant methodological flaws in clinical trials and observational studies.

A critical source of bias is the **"case-counting window bias,"** where the observation period for counting adverse events in vaccinated groups often started too late (typically 1-3 weeks after the second dose).

XXIII. This common practice results in misclassifying individuals who experienced serious adverse events and were previously injected with mRNA products before the counting window as "unvaccinated".

This misclassification artificially inflates vaccine efficacy estimates and distorts the perceived safety of the products.

XXIV. Further re-analyses have revealed persistent misclassification issues in large-scale studies, where vaccinated individuals were mistakenly classified as unvaccinated for a set period post-injection.

Such erroneous claims of lower infection and mortality rates in vaccinated individuals have been used to justify the ongoing distribution of the modified mRNA products.

XXV. Some studies indicate negative efficacy in terms of increasing post-injection hospitalizations, morbidity, and mortality.

A comprehensive Israeli study found a 27-fold greater risk of symptomatic COVID-19 and an 8-fold higher likelihood of hospitalization among vaccinees compared to unvaccinated individuals.

XXVI. Among the central tenets of the Hybrid Harms Hypothesis is that serious adverse events (including death) may be misattributed to the COVID-19 infections due to temporal biases.

This often occurs because the coronavirus infection appears temporally proximal to the serious adverse event, making it the presumed cause.

XXVII. "Hybrid immunity," defined as potentially synergistic immune protection from prior SARS-CoV-2 infection followed by COVID-19 mRNA vaccination, has been shown to confer enhanced immunological responses.

However, protection against Omicron reinfection declined to about 50% within 26 weeks for individuals with hybrid immunity who received booster doses, suggesting short-lived benefits.

XXVIII. Concerns regarding hybrid immunity include the risks associated with excessive antibody production, which may contribute to vaccine-associated enhanced disease (VAED), potentially mediated by pathogenic priming.

The "case-counting window bias" may have obscured the presence of such disease enhancement in studies, as it miscategorized many vaccinees as unvaccinated.

XXIX. The COVID-19 mRNA products have been associated with transient suppression of innate immunity, including impaired type I interferon signaling and dysregulated protein synthesis, which may compromise early antiviral defenses.

This suggests potential adverse outcomes when considering the timing of vaccination in relation to SARS-CoV-2 infection.

XXX. Excessive non-neutralizing antibody production from the mRNA vaccines may increase the risk of autoimmune reactions through molecular mimicry, where antibodies cross-react with host tissues.

This could elevate the risk of chronic inflammatory conditions, including cardiovascular diseases, malignancies, and other autoimmune disorders, especially with repeated booster administrations.

XXXI. Individuals who were up-to-date with their COVID-19 vaccinations showed an average of 50 times greater antibody levels than unvaccinated, naturally infected persons.

This hyperimmune response is associated with increased risks of hyperinflammation, severe immunopathology, and heightened reactogenicity, all of which may contribute to a wide range of adverse events.

XXXII. Very high antibody levels, while associated with protection against infection, can paradoxically inhibit the capacity of macrophages to phagocytize and destroy pathogens or cancer cells.

This hyperimmune antibody-macrophage interaction helps explain why the hybrid immunity afforded by the combination of COVID-19 mRNA vaccinations and coronavirus infections may paradoxically translate into more serious adverse events.

XXXIII. Post-acute Sequelae of COVID-19 (PASC), or "long COVID," is characterized by persistent symptoms following SARS-CoV-2 infection, but emerging evidence indicates a probable association between COVID-19 mRNA vaccination and an increased risk of PASC-like syndromes.

This is referred to as **Post-COVID-19 Vaccine Syndrome (PCVS)** or "post-acute COVID-19 injection syndrome" (PACIS).

XXXIV. Vaccinated individuals with long COVID symptoms exhibited average spike antibody levels approximately seven times higher than unvaccinated individuals with prior infections, despite the vaccinated group having no recent infections.

This may suggest that the COVID-19 mRNA injections lead to a much higher spike protein burden than that associated with SARS-CoV-2 infections.

XXXV. A retrospective analysis found that 70% of PASC cases occurred in individuals who had completed a full course of COVID-19 mRNA vaccinations, suggesting the genetic injectables may exacerbate or precipitate PASC symptomology.

Conversely, unvaccinated individuals who had been exposed to Omicron showed the lowest PASC incidence.

XXXVI. Epidemiological analyses from 2021-2022 provide additional support for the Hybrid Harms Hypothesis; despite Omicron's mild pathogenicity, many countries with high vaccination coverage experienced unexpected spikes in mortality following the Omicron waves.

This suggests an interaction between prior vaccination and subsequent infection amplified these outcomes.

XXXVII. In 2022, heavily mRNA-vaccinated populations in countries like South Korea, Hong Kong, Singapore, and Australia showed pronounced elevations in percent excess mortality (PEM), often synchronizing with waves of Omicron infection.

This observation suggests that the mortality peaks were further amplified by the preceding vaccinations, generating prolonged spike protein production in these populations.

XXXVIII. Global data show a striking rise in COVID-19 deaths in tandem with vaccination coverage, with Europe and the Americas comprising over 70% of global COVID-19 deaths despite their high vaccination coverage.

Conversely, regions like Africa, with relatively low mRNA vaccination coverage, exhibited much lower COVID-19-related morbidity and mortality rates.

XXXIX. The precise sequencing of injection or infection may not be critical for causation of fulminant myocarditis, as a "priming effect" can occur with either exposure.

The myocardial stress induced by mRNA injectable products may interact additively or synergistically with the immune-inflammatory effects of SARS-CoV-2 infection on the heart, exacerbating cardiac injury.

XL. The continued occurrence of numerous adverse events among young, previously healthy individuals, even after the emergence of the milder Omicron variant, may be attributable to a "multi-spike phenomenon".

This "multi-spike phenomenon," involving repeated antigenic exposure via COVID-19 mRNA vaccination and coronavirus infections, contributes to direct toxicities, immune dysregulation, and diverse pathological sequelae.

thank you for listening to another session of the lenny and Maria sanchez deep dive podcast show produced and archived at the website daily briefs dot info.

This academic paper explores the concept of "Hybrid Harms," arguing that the COVID-19 mRNA vaccinations and subsequent coronavirus infections may interact to amplify adverse effects, rather than providing solely enhanced protection. It challenges the prevailing narrative of vaccine effectiveness, particularly against milder Omicron variants, by highlighting waning immunity and "negative efficacy," where vaccinated individuals paradoxically show increased susceptibility to infection and severe outcomes. The authors propose that the persistent presence of spike protein, whether from the vaccine or the virus, contributes to chronic issues like myocarditis, blood clotting disorders, and "long COVID" symptoms, often misattributed solely to the infection due to systemic biases in data collection. The paper advocates for a shift in research focus to understand and mitigate these "spikeopathy" syndromes. 

The sources indicate that spike protein harms can arise from both COVID-19 mRNA vaccination and natural SARS-CoV-2 infection, with evidence suggesting a convergence of these harms, particularly due to the prolonged persistence of spike protein in the human body1.... This concept is central to the "Hybrid Harms Hypothesis"1.

Here are the key harms and mechanisms associated with spike protein:

• Pathophysiological Effects ("Spikeopathy")

    ◦ The spike protein itself has toxic and pathogenic potential5.

    ◦ It can cause oxidative stress, inflammation, thrombogenesis, and endotheliitis-related tissue damage5.

    ◦ It damages endothelial cells by downregulating ACE2, which in turn inhibits mitochondrial function5.

    ◦ Spike protein can trigger a pro-inflammatory response in brain endothelial cells, potentially altering the blood-brain barrier6.

    ◦ It can cross the blood-brain barrier, exerting direct neuroinflammatory and neurotoxic effects6.

    ◦ Frameshifting events due to mistranslation of the modified mRNA can lead to the production of aberrant proteins that form toxic prion-like fibrils in neurons, potentially causing or accelerating neurodegenerative disorders. A surge in rare prion diseases has been documented post-injection67.

    ◦ It has been linked to inflammatory organ damage affecting the heart, liver, spleen, ovaries, and nervous system6.

• Coagulation and Hematological Issues

    ◦ The spike protein is a common denominator in clotting disorders and serious thrombotic complications observed in both severe COVID-19 and following mRNA vaccination, including myocardial infarction, disseminated intravascular coagulation, and venous thromboembolism8.

    ◦ Both the virus and the vaccine can trigger endothelial dysfunction, systemic inflammation, and dysregulated coagulation cascades8.

    ◦ In COVID-19, the spike protein's interaction with ACE2 receptors drives a hypercoagulable state, leading to microvascular thrombosis and myocardial injury8.

    ◦ It is hypothesized that spike protein acts as a primary initiator in vaccine-induced immune thrombotic thrombocytopenia (VITT), promoting thrombosis910.

• Immune Dysregulation

    ◦ Prolonged spike protein exposure can lead to chronic immunotoxicity, hyper-inflammation, and immune dysregulation2....

    ◦ It can induce autoimmunity, including autoimmune nerve damage, increased autoimmune disease overall (e.g., rheumatoid arthritis, lupus erythematosus, autoimmune hepatitis) through mechanisms like molecular mimicry13....

    ◦ The homologous peptides in the translated spike protein from mRNA injections are 100% matched to many human proteins, leading to extensive cross-reactivity and a potential for autoimmune and multisystem disorders15.

    ◦ It contributes to lymphopenia (reduced lymphocytes) and T-cell exhaustion, which can increase the risk of infections16....

    ◦ Autoantibodies against type I interferons can be induced, suppressing antiviral and anticancer immune responses19.

    ◦ Repeated mRNA vaccinations lead to a class switch toward non-inflammatory, spike-specific IgG4 antibodies, which favors immune tolerance over viral elimination, potentially weakening antiviral defenses and increasing the risk of infectious, autoimmune, and malignant diseases17.... This switch is notably observed in individuals with multiple mRNA vaccinations or those infected after vaccination21.

• Overlap with Post-Acute Sequelae of COVID-19 (PASC)

    ◦ Many of the serious adverse events (AEs) linked with mRNA vaccinations overlap with the symptoms of PASC, also known as "long COVID"22....

    ◦ This overlap suggests that Post-COVID Vaccination Syndrome (PCVS) or "post-acute COVID-19 injection syndrome" (PACIS) may subsume many PASC cases, as it is difficult to distinguish the prolonged spike protein production from vaccinations from spike-related effects of prior or subsequent infections24....

    ◦ Vaccinated individuals appear more susceptible to PASC-like syndromes than unvaccinated individuals, with studies showing a higher spike antibody level in vaccinated cohorts with long COVID symptoms, suggesting a much higher spike protein burden23....

• Prolonged Persistence of Spike Protein

    ◦ A critical aspect of spike protein harm is its prolonged presence in the body, challenging initial assumptions of rapid clearance1....

    ◦ While initially thought to clear in 1-2 weeks, evidence shows vaccine-derived spike protein can persist for months to years, detected on exosomes for over 4 months, in circulation for 6-8 months, in cerebral arteries for up to 17 months, and even detected at 23.6 months (709 days) in individuals with immune dysfunction29. One case report found Pfizer vaccine-generated mRNA in blood 3.2 years post-injection29.

    ◦ The best estimates for sustained spike protein production post-vaccination are 24 to 38 months, indicating no inherent "off switch" mechanism12.

    ◦ This prolonged presence creates a "window of vulnerability" (WOV) of at least 2-3 years, during which subsequent coronavirus infections can amplify adverse effects30....

• Hybrid Harms Hypothesis

    ◦ The hypothesis posits that the long-term persistence of vaccine-induced spike protein interacts with subsequent coronavirus infections, leading to an amplification of spikeopathy1133.

    ◦ This interaction can result in a greater risk for serious AEs (cardiac, hematologic, immunologic, and neurological) than either exposure alone, particularly in susceptible populations33.

    ◦ For instance, subclinical myocarditis induced by vaccine-derived spike protein may be exacerbated by later infection-induced spike protein, transforming into fulminant myocarditis, arrhythmias, or heart failure4....

    ◦ The temporal association between infection and AEs often leads to misattribution of causality solely to the viral infection, overlooking the significant contribution of the prolonged vaccine-induced spike protein11.... This misclassification has profoundly distorted risk-benefit analyses and exaggerated claims of vaccine safety and effectiveness39.

In summary, the sources strongly suggest that the spike protein, whether from mRNA vaccination or natural infection, can cause extensive and prolonged harm to the human body, with the "Hybrid Harms Hypothesis" highlighting the synergistic and additive effects of repeated spike antigen exposure from both sources1....

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Waning immunity.

Waning immunity refers to the decline in immune protection over time following COVID-19 mRNA vaccination1.... This phenomenon has been a subject of considerable debate, with early assessments of vaccine safety and efficacy being based on insufficient data collection timeframes of only 2-3 months from registrational trials15.

Key aspects of waning immunity include:

• Rapid Decline of Humoral Immune Protection:

    ◦ After an initial surge in IgG and neutralizing antibody levels that peak following the second mRNA dose, these titers rapidly decline within 2-6 months1....

    ◦ The sharpest declines are observed in elderly and other vulnerable populations13.

    ◦ Protection against symptomatic Omicron infection dropped to about 10-20% by 6 months after the second dose of COVID-19 mRNA products, with quicker declines in the elderly and those with comorbid diseases27.

    ◦ For example, vaccine effectiveness against Omicron for those who received two BNT162b2 doses was 65.5% two to four weeks post-second dose, but fell to 15.4% at around four months, and further to 8.8% after six months28.

    ◦ The COVID-19 mRNA vaccine-induced neutralizing antibodies are initially higher but decline much faster in mRNA recipients compared to naturally infected, non-vaccinated individuals29.

• Contributing Factors to Waning Immunity:

    ◦ Viral Evolution: Continuous mutations in the SARS-CoV-2 spike protein, particularly around the receptor-binding domain, facilitate the emergence of escape variants that evade neutralizing antibodies, reducing the efficacy of subsequent mRNA doses1011. Mass vaccination amidst high Omicron variant transmission is suggested to exert selective immune pressure, fostering ongoing immune-escape variants10.

    ◦ Immune Imprinting (Original Antigenic Sin): When the immune system is repeatedly exposed to earlier SARS-CoV-2 variants, it tends to focus its antibody response on those variants, potentially limiting its effectiveness against newer, dominant strains10.... This phenomenon impacts an individual's response to both SARS-CoV-2 infections and COVID-19 mRNA vaccinations1014. Studies show SARS-CoV-2-naïve individuals have robust humoral responses to each successive mRNA vaccine dose, while previously infected individuals show diminished responses to subsequent doses1015. The reduced effectiveness of bivalent mRNA boosters has been linked to immune systems primed for ancestral strains1016.

• Impact on Breakthrough Infections (BTIs):

    ◦ The rapid drop in immunological protection likely accounts for the increased risk of post-mRNA-vaccination infection and reinfection by Delta and Omicron variants, even in "fully vaccinated" individuals17....

    ◦ BTIs refer to individuals contracting COVID-19 at least two weeks post-inoculation, a period when vaccine-induced immunity is presumed to take effect17. A more accurate term might be "vaccine failure"17.

    ◦ Surveys have shown a significant percentage of participants (e.g., 43.5% in Saudi Arabia) contracted COVID-19 after full vaccination, with infections occurring after the first (46%), second (41.2%), and third (12.8%) doses2122.

    ◦ The true extent of BTI prevalence and incidence is unknown due to lack of screening for asymptomatic cases and testing criteria often prioritizing symptomatic or hospitalized cases, leading to underreporting21....

    ◦ Severe BTI cases have been documented, with approximately 10.8% of 765 BTIs in a Tunisia study being severe or critical, and patients with cardiovascular diseases being twice as likely to have severe outcomes2526. Hospitalized BTI rates have ranged from 9-35%25....

    ◦ A study of 1479 BTI cases reported a mortality rate of 0.9%, which is approximately 22.5 times higher than the typical infection fatality rate (IFR) for natural COVID-19 infection in a similar age distribution (0.03%-0.05%)25....

    ◦ Data from the UK and US also support the severe morbidity and potential lethality of some BTIs, with a significant percentage of Delta variant deaths in June 2021 occurring in fully vaccinated individuals32....

    ◦ These BTI death counts are likely underestimated due to systemic biases in data collection and reporting, driven by financial incentives and political pressures to promote vaccine efficacy40....

• Negative Efficacy:

    ◦ Later studies showed that repeated or successive doses of modified mRNA products could disrupt immune system functioning, leading to negative efficacy45. This means vaccinated individuals are more likely to contract the targeted disease than unvaccinated individuals, resulting in an elevated disease risk45.

    ◦ A large-scale retrospective cohort study at the Cleveland Clinic (n=51,017) demonstrated that while mRNA vaccinations initially reduced infection risk, this protection diminished and the risk of infection actually rose with successive doses (e.g., 107% higher risk for 1 dose, 253% for >3 doses compared to unvaccinated individuals)4647.

    ◦ Similar findings from Japan, Qatar, UK, Iceland, and other US studies highlight increased infection rates post-vaccination, especially after six months or additional doses46....

    ◦ An Israeli study of 32,000 COVID-19 vaccinees showed a 27-fold higher risk of contracting symptomatic COVID-19 compared to non-vaccinated individuals4856.

    ◦ VAERS data also indicated a dose-dependent rise in breakthrough infections4857.

    ◦ An ecological study found that COVID-19 vaccinations significantly increased global COVID-19 cases by up to 291% and COVID-19 deaths by up to 205.25%5859. These increases correlated positively with the number of vaccine doses administered58.

• Illusions of Protection Against Severe Disease:

    ◦ Despite claims that mRNA products reduce severe COVID-19 disease, hospitalizations, and death6061, detailed analyses reveal significant methodological flaws in studies supporting these claims962.

    ◦ Flaws include inconsistent follow-up, uneven exclusion criteria, varying testing rates, selection biases, and selective reporting962.

    ◦ The "case-counting window bias," where the observation period for counting adverse events began too late (typically 1-3 weeks after the second dose), can greatly inflate vaccine efficacy estimates and misclassify individuals experiencing adverse events as "unvaccinated"11.... This can make an ineffective vaccine appear moderately effective1166.

    ◦ Some studies suggest negative efficacy in terms of increasing post-injection hospitalizations, morbidity, and mortality. An Israeli study found an 8-fold higher likelihood of hospitalization among vaccinated individuals compared to unvaccinated within the same healthcare system1367.

    ◦ Mortality rates after developing severe COVID-19 disease were higher following additional doses of mRNA products in hospitalized recipients13....

• Hybrid Immunity and Waning Protection:

    ◦ While hybrid immunity (prior infection + vaccination) has been shown to confer enhanced immunological responses, these benefits are often short-lived18....

    ◦ Protection against Omicron reinfection for individuals with hybrid immunity who received booster doses declined from 80.6% to 36.9% within 16 weeks19.

    ◦ The clinical necessity of augmented antibody responses from hybrid immunity is questioned given the mild pathogenicity of Omicron variants20.

    ◦ Concerns exist regarding the risks associated with excessive antibody production, potentially contributing to vaccine-associated enhanced disease (VAED) or pathogenic priming2073. While VAED has mainly been observed in animal models, methodological biases in human studies may obscure its presence20....

In summary, despite initial high efficacy claims, evidence indicates that immunity provided by COVID-19 mRNA vaccines wanes rapidly, leading to increased susceptibility to infection (breakthrough infections) and potentially more severe adverse outcomes due to factors like viral evolution and immune imprinting1.... This waning protection and the phenomenon of negative efficacy challenge the narrative of sustained effectiveness, especially when considering the potential for interactions with natural infections4579.Waning immunity refers to the decline in immune protection over time following COVID-19 mRNA vaccination1.... This phenomenon has been a subject of considerable debate, with early assessments of vaccine safety and efficacy being based on insufficient data collection timeframes of only 2-3 months from registrational trials15.

Key aspects of waning immunity include:

• Rapid Decline of Humoral Immune Protection:

    ◦ After an initial surge in IgG and neutralizing antibody levels that peak following the second mRNA dose, these titers rapidly decline within 2-6 months1....

    ◦ The sharpest declines are observed in elderly and other vulnerable populations13.

    ◦ Protection against symptomatic Omicron infection dropped to about 10-20% by 6 months after the second dose of COVID-19 mRNA products, with quicker declines in the elderly and those with comorbid diseases27.

    ◦ For example, vaccine effectiveness against Omicron for those who received two BNT162b2 doses was 65.5% two to four weeks post-second dose, but fell to 15.4% at around four months, and further to 8.8% after six months28.

    ◦ The COVID-19 mRNA vaccine-induced neutralizing antibodies are initially higher but decline much faster in mRNA recipients compared to naturally infected, non-vaccinated individuals29.

• Contributing Factors to Waning Immunity:

    ◦ Viral Evolution: Continuous mutations in the SARS-CoV-2 spike protein, particularly around the receptor-binding domain, facilitate the emergence of escape variants that evade neutralizing antibodies, reducing the efficacy of subsequent mRNA doses1011. Mass vaccination amidst high Omicron variant transmission is suggested to exert selective immune pressure, fostering ongoing immune-escape variants10.

    ◦ Immune Imprinting (Original Antigenic Sin): When the immune system is repeatedly exposed to earlier SARS-CoV-2 variants, it tends to focus its antibody response on those variants, potentially limiting its effectiveness against newer, dominant strains10.... This phenomenon impacts an individual's response to both SARS-CoV-2 infections and COVID-19 mRNA vaccinations1014. Studies show SARS-CoV-2-naïve individuals have robust humoral responses to each successive mRNA vaccine dose, while previously infected individuals show diminished responses to subsequent doses1015. The reduced effectiveness of bivalent mRNA boosters has been linked to immune systems primed for ancestral strains1016.

• Impact on Breakthrough Infections (BTIs):

    ◦ The rapid drop in immunological protection likely accounts for the increased risk of post-mRNA-vaccination infection and reinfection by Delta and Omicron variants, even in "fully vaccinated" individuals17....

    ◦ BTIs refer to individuals contracting COVID-19 at least two weeks post-inoculation, a period when vaccine-induced immunity is presumed to take effect17. A more accurate term might be "vaccine failure"17.

    ◦ Surveys have shown a significant percentage of participants (e.g., 43.5% in Saudi Arabia) contracted COVID-19 after full vaccination, with infections occurring after the first (46%), second (41.2%), and third (12.8%) doses2122.

    ◦ The true extent of BTI prevalence and incidence is unknown due to lack of screening for asymptomatic cases and testing criteria often prioritizing symptomatic or hospitalized cases, leading to underreporting21....

    ◦ Severe BTI cases have been documented, with approximately 10.8% of 765 BTIs in a Tunisia study being severe or critical, and patients with cardiovascular diseases being twice as likely to have severe outcomes2526. Hospitalized BTI rates have ranged from 9-35%25....

    ◦ A study of 1479 BTI cases reported a mortality rate of 0.9%, which is approximately 22.5 times higher than the typical infection fatality rate (IFR) for natural COVID-19 infection in a similar age distribution (0.03%-0.05%)25....

    ◦ Data from the UK and US also support the severe morbidity and potential lethality of some BTIs, with a significant percentage of Delta variant deaths in June 2021 occurring in fully vaccinated individuals32....

    ◦ These BTI death counts are likely underestimated due to systemic biases in data collection and reporting, driven by financial incentives and political pressures to promote vaccine efficacy40....

• Negative Efficacy:

    ◦ Later studies showed that repeated or successive doses of modified mRNA products could disrupt immune system functioning, leading to negative efficacy45. This means vaccinated individuals are more likely to contract the targeted disease than unvaccinated individuals, resulting in an elevated disease risk45.

    ◦ A large-scale retrospective cohort study at the Cleveland Clinic (n=51,017) demonstrated that while mRNA vaccinations initially reduced infection risk, this protection diminished and the risk of infection actually rose with successive doses (e.g., 107% higher risk for 1 dose, 253% for >3 doses compared to unvaccinated individuals)4647.

    ◦ Similar findings from Japan, Qatar, UK, Iceland, and other US studies highlight increased infection rates post-vaccination, especially after six months or additional doses46....

    ◦ An Israeli study of 32,000 COVID-19 vaccinees showed a 27-fold higher risk of contracting symptomatic COVID-19 compared to non-vaccinated individuals4856.

    ◦ VAERS data also indicated a dose-dependent rise in breakthrough infections4857.

    ◦ An ecological study found that COVID-19 vaccinations significantly increased global COVID-19 cases by up to 291% and COVID-19 deaths by up to 205.25%5859. These increases correlated positively with the number of vaccine doses administered58.

• Illusions of Protection Against Severe Disease:

    ◦ Despite claims that mRNA products reduce severe COVID-19 disease, hospitalizations, and death6061, detailed analyses reveal significant methodological flaws in studies supporting these claims962.

    ◦ Flaws include inconsistent follow-up, uneven exclusion criteria, varying testing rates, selection biases, and selective reporting962.

    ◦ The "case-counting window bias," where the observation period for counting adverse events began too late (typically 1-3 weeks after the second dose), can greatly inflate vaccine efficacy estimates and misclassify individuals experiencing adverse events as "unvaccinated"11.... This can make an ineffective vaccine appear moderately effective1166.

    ◦ Some studies suggest negative efficacy in terms of increasing post-injection hospitalizations, morbidity, and mortality. An Israeli study found an 8-fold higher likelihood of hospitalization among vaccinated individuals compared to unvaccinated within the same healthcare system1367.

    ◦ Mortality rates after developing severe COVID-19 disease were higher following additional doses of mRNA products in hospitalized recipients13....

• Hybrid Immunity and Waning Protection:

    ◦ While hybrid immunity (prior infection + vaccination) has been shown to confer enhanced immunological responses, these benefits are often short-lived18....

    ◦ Protection against Omicron reinfection for individuals with hybrid immunity who received booster doses declined from 80.6% to 36.9% within 16 weeks19.

    ◦ The clinical necessity of augmented antibody responses from hybrid immunity is questioned given the mild pathogenicity of Omicron variants20.

    ◦ Concerns exist regarding the risks associated with excessive antibody production, potentially contributing to vaccine-associated enhanced disease (VAED) or pathogenic priming2073. While VAED has mainly been observed in animal models, methodological biases in human studies may obscure its presence20....

In summary, despite initial high efficacy claims, evidence indicates that immunity provided by COVID-19 mRNA vaccines wanes rapidly, leading to increased susceptibility to infection (breakthrough infections) and potentially more severe adverse outcomes due to factors like viral evolution and immune imprinting1.... This waning protection and the phenomenon of negative efficacy challenge the narrative of sustained effectiveness, especially when considering the potential for interactions with natural infections4579.

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Negative efficacy.

Negative efficacy, in the context of COVID-19 mRNA products, describes a paradoxical situation where vaccinated individuals are more likely to contract the targeted disease, COVID-19, than those who received no vaccine or a placebo1. This phenomenon can be quantified as a negative vaccine efficacy percentage, indicating an elevated disease risk resulting from the vaccinations1.

Key Aspects of Negative Efficacy:

• Definition and Indication

    ◦ Negative efficacy signifies that mRNA products paradoxically increase COVID-19 disease risk or severity compared to a placebo12.

    ◦ Beyond increased disease risk, it can also encompass unexpected adverse outcomes such as serious cardiac events or other diseases and disabilities not definitively related to COVID-192.

• Causes and Mechanisms

    ◦ Waning Humoral Immunity and Immune Dysregulation: Rapidly waning humoral immunity is a major limitation of these injections. Later studies showed that repeated or successive doses of modified mRNA products disrupt immune system functioning, leading to a wide range of serious disease outcomes13.

    ◦ Direct Toxic Effects: This can arise from direct toxic effects related to the spike protein induced by the mRNA products2.

    ◦ Immunological Dysfunction: It can also be due to immune responses, specifically immunological dysfunction induction (e.g., in regulatory T cells or Tregs, which are crucial for preventing excessive immune responses) to the mRNA vaccine-induced spike protein2.

    ◦ Interactions with Coronavirus Infection: Negative efficacy is strongly linked to interactions between the mRNA products and coronavirus infections, whether directly or indirectly2.

    ◦ Components of mRNA Products: Specific components, such as lipid nanoparticles (LNPs) and plasmid DNA contaminants, can contribute2.

    ◦ Concurrent Health Issues: Underlying health issues can complicate the attribution of adverse events2.

    ◦ IgG4 Class Switch and T-Cell Exhaustion: Repeated mRNA vaccinations can lead to chronic immune dysfunction, including T-cell exhaustion and an antibody class-switching to IgG445. This IgG4 class switch, particularly observed in individuals receiving multiple doses or infected post-vaccination, may favor immune tolerance over viral elimination, potentially weakening antiviral defenses and increasing the risk of infectious, autoimmune, and malignant diseases56.

    ◦ Pathogenic Priming/Antibody-Dependent Enhancement (ADE): There is a potential for vaccine-induced antibodies to bind to the virus with insufficient neutralizing capacity, facilitating its entry into host cells and potentially exacerbating viral replication and disease severity78.

• Evidence and Studies Supporting Negative Efficacy

    ◦ Cleveland Clinic Study (2023): A large-scale retrospective cohort study (n=51,017) showed that while mRNA vaccinations initially reduced infection risk, this protection diminished over time and the risk of infection actually rose with successive doses, with concurrent increases of 107%, 150%, 210%, and 253% for 1, 2, 3, and >3 doses, respectively, compared to unvaccinated individuals9.

    ◦ Japanese Case-Control Study: Reported an elevated infection risk among vaccinated individuals, with a dose-dependent trend: 63% higher risk for 1-2 doses, 104% for 3-4 doses, and 121% for 5-7 doses9.

    ◦ Comparable Findings: Similar observations of increased infection rates post-vaccination, especially after six months or additional doses, were highlighted in studies from Qatar, the UK, Iceland, and four other US studies10.

    ◦ Israeli Study (2021): Found a 27-fold higher risk of contracting symptomatic COVID-19 in 32,000 COVID-19 vaccinees compared to non-vaccinated individuals within the same healthcare system1011. This study also noted an 8-fold higher likelihood of hospitalization for vaccinated individuals11.

    ◦ VAERS Data (November 2024): Showed a dose-dependent rise in breakthrough infections, with a 30% increase after the fourth dose compared to 16% after the third, confirming declining vaccine efficacy with additional doses10.

    ◦ Beattie's Ecological Study (2021): A Bayesian causal analysis across 145 countries indicated that approximately 90% (89.84%) of countries exhibited increased mortality rates post-vaccination12. The analysis suggested that COVID-19 vaccinations significantly increased global COVID-19 cases by up to 291% and COVID-19 deaths by up to 205.25%, with these increases correlating positively with the number of vaccine doses administered12.

    ◦ Johns Hopkins Coronavirus Resource Center Data: Time-series charts for Nordic and Southeast Asian countries show that major surges in COVID-19 incidence and mortality became apparent only after the population attained at least 75% vaccine coverage1314. This occurred primarily in 2022, when the milder Omicron variant was dominant15.

    ◦ Hospitalized Patients: Two separate studies examining hospitalized mRNA recipients indicated that mortality rates after developing severe COVID-19 disease were higher following additional doses of the COVID-19 mRNA injectable products11.

    ◦ Nordic Cohort Study (Karlstad et al.): In a study of 23 million residents, mRNA vaccine-associated myocarditis rates in young males (16-24) were approximately four times higher after the second Pfizer dose and over 13 times higher after the second Moderna dose compared to infection-related myocarditis (based on positive tests)16.

• Connection to the Hybrid Harms Hypothesis

    ◦ The Hybrid Harms Hypothesis offers an alternative explanation for paradoxical elevations in COVID-19 cases and deaths, particularly during the Omicron era, suggesting that these cannot be reasonably ascribed to Omicron infections alone due to their mild pathogenicity15.

    ◦ Instead, the hypothesis posits an interaction between the infections and injections, especially after widespread vaccination coverage, as the driving force behind increased morbidity and mortality215. This interaction may lead to a greater risk for serious adverse events (cardiac, hematologic, immunologic, neurological) than either exposure alone17.

    ◦ The observed increase in adverse events among young, previously healthy individuals, despite Omicron's reduced virulence, is understood as a "multi-spike phenomenon," where repeated antigenic exposure from both vaccination and infection contributes to toxicities and immune dysregulation18.

• Obscuring Negative Efficacy through Bias

    ◦ Case-Counting Window Bias: This bias, stemming from errors in diagnosing cases and assigning individuals to vaccinated or unvaccinated groups, can greatly inflate vaccine efficacy estimates1920. Studies often start the observation period for counting adverse events too late (e.g., 1-3 weeks after the second dose), misclassifying individuals experiencing serious adverse events within this early period as "unvaccinated"1921. This methodological flaw can make an ineffective or even negatively effective vaccine appear moderately effective19.

    ◦ Misclassification of "Unvaccinated" Status: Many observational studies have falsely claimed lower COVID-19 infection and mortality rates for mRNA-vaccinated individuals by miscategorizing vaccinated individuals (e.g., those not yet fully "immunologically mature" after two doses, partially vaccinated, or those with waning immunity) as "unvaccinated"2021. This leads to adverse health outcomes among mRNA-injected individuals being attributed to the "unvaccinated" group, reinforcing the "safe and effective" narrative and distorting risk-benefit analyses2122.

    ◦ Healthy Vaccinee Bias: A disproportionate number of individuals with underlying diseases may have chosen to forgo the injections, further skewing data towards an appearance of vaccine safety23.

In summary, the sources present substantial evidence suggesting that COVID-19 mRNA vaccinations exhibit negative efficacy, increasing the risk of infection, severe disease, and mortality, particularly with successive doses. This effect is hypothesized to be due to complex immunological dysregulations, including prolonged spike protein persistence, IgG4 class switching, T-cell exhaustion, and pathogenic priming, which can be exacerbated by subsequent SARS-CoV-2 infections in a "hybrid harms" scenario. These effects have been obscured by systemic biases in data collection and reporting1....

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Hybrid harms hypothesis.

The "Hybrid Harms Hypothesis" proposes a conceptual framework for understanding the complex interplay between COVID-19 mRNA vaccination and SARS-CoV-2 infections, suggesting that their combined impact can amplify adverse health outcomes1.... It directly counters the claim that mRNA vaccinations reduce the severity of COVID-19 and its sequelae, instead hypothesizing that they trigger mechanisms that amplify morbidity, including "post-acute sequelae of COVID-19" (PASC)1.

The hypothesis posits that morbidity and mortality events attributed to COVID-19 in extensively vaccinated populations, particularly in 2022-2023, were plausibly due to a combination of mass vaccination and coronavirus infections, given the long-term persistence of spike protein and other vaccine-associated components from previous mRNA vaccinations15. This leads to overlapping spike-related toxicities and immunological effects, resulting in pronounced immune dysregulation and inflammatory cascades1.

The Hybrid Harms Hypothesis is distinguished by five fundamental features6:

1. The COVID-19 mRNA product’s three-pronged toxic payload: This includes the spike protein itself, lipid nanoparticles (LNPs), and process-related DNA impurities7.

    ◦ Spike Protein: Regardless of its origin (vaccine or virus), the spike protein has toxic and pathogenic potential, causing "spikeopathy" through mechanisms like oxidative stress, inflammation, thrombogenesis, endotheliitis-related tissue damage, and prion-related dysregulation7.... It can damage endothelial cells by downregulating ACE2 and inhibiting mitochondrial function, and cross the blood-brain barrier to exert neuroinflammatory and neurotoxic effects7.... Frameshifting events due to pseudouridinated mRNA can lead to toxic prion-like fibrils in neurons, potentially causing neurodegenerative disorders, with a documented surge in rare prion diseases post-injection12.... It is linked to inflammatory organ damage in the heart, liver, spleen, ovaries, and nervous system12....

    ◦ Lipid Nanoparticles (LNPs): The LNP delivery system contributes to prolonged inflammation by inducing inflammatory cytokines and chemokines21.... The ionizable cationic lipids in LNPs are immunotoxic, activating pro-inflammatory and pro-apoptotic pathways, and stimulating inflammasome and TLR pathways, which have been linked to cancer progression5.... Pre-existing inflammation can amplify the inflammatory impacts of LNPs, relevant for individuals with chronic inflammatory diseases or "inflammaging"21....

    ◦ Process-related DNA impurities: The production process introduces plasmid-sourced DNA fragments, which can exceed acceptable limits (e.g., Pfizer's Comirnaty product)30.... These contaminants can integrate into the human genome through insertional mutagenesis, potentially disrupting immune function, leading to autoimmune conditions by triggering autoantibodies, and oncogenesis30.... Differences in DNA contamination levels (e.g., higher in Pfizer than Moderna) may account for observed divergent mortality risks36.

2. Whole-body biodistribution: Both the mRNA and the spike protein can distribute to distal tissues throughout the body, including the spleen, liver, ovaries, adrenal glands, brain, eyes, heart, testes, uterus, pituitary gland, spinal cord, and bone marrow, resembling an invasive blood-borne infectious agent37.

3. Multiple mRNA injections: Repeated vaccinations are surmised to lead to increased and potentially cumulative toxic impacts and disruption of immune system functioning, referred to as the "Triple-Hit Hypothesis" when including a subsequent infection38. Successive doses may increase the risk of infections, autoinflammatory phenomena, and serious hematologic events38.

4. Prolonged exposure to the mRNA product’s payload: The synthetic mRNA and generated spike proteins do not decay immediately but persist due to LNP encapsulation and N1-methylpseudouridine modification, designed for durability39.... Initial estimates of 1-2 weeks for spike protein presence were challenged by later data showing persistence for 4-8 weeks, then 4 months on exosomes, 6-8 months in circulation, and up to 17 months in cerebral arteries42.... Detectable Pfizer vaccine-generated mRNA was even found 3.2 years post-injection in one case4252. The best estimates for extended spike production post-vaccination are 24 to 38 months, suggesting no inherent "off switch"53. This prolonged generation and cumulative antigenic load can lead to ongoing systemic inflammation, immunologic dysfunction, and immune-related disorders53.... This persistence defines the "window of vulnerability" (WOV), a 2-3 year period during which subsequent coronavirus infections can amplify adverse events related to the vaccine-induced spike protein56....

5. Infection with SARS-CoV-2 or Omicron variants: Infections, whether occurring before or many months after vaccination, can lead to disease symptoms often misattributed solely to the viral infection, rather than considering the amplifying effect of the pre-existing vaccine-induced spike protein milieu1.... Case studies illustrate this misattribution, where COVID-19 was cited as the cause of death, but the hypothesis suggests prior vaccination predisposed individuals to more severe outcomes6061.

Proposed Mechanisms and Pathological Outcomes:

The hypothesis suggests that both vaccine and infection contribute to a total toxic burden of spike protein, either additively or synergistically, leading to a range of "hybrid harms"62. These include:

• Endothelial Dysfunction and Inflammation: Direct toxic effects focus on disrupting endothelial function and triggering inflammation, contributing to complications like myocarditis or thrombosis62.

• Coagulation and Hematological Issues: The spike protein is a common denominator in clotting disorders observed in severe COVID-19 and post-mRNA vaccination, including myocardial infarction, disseminated intravascular coagulation, and venous thromboembolism63. Both exposures can trigger endothelial dysfunction, systemic inflammation, and dysregulated coagulation cascades63. The spike protein is hypothesized to act as a primary initiator in vaccine-induced immune thrombotic thrombocytopenia (VITT)6465. D-dimer and C-reactive protein (CRP) elevations are also common66.

• Immune Dysregulation: Hybrid harms occur via the induction of autoimmunity or chronic inflammation, particularly in "Long COVID," where persistent spike protein and/or immune complexes may drive symptoms and pathogenesis67. This includes conditions like rheumatoid arthritis, lupus erythematosus, and autoimmune hepatitis, possibly through molecular mimicry68.... Prolonged spike exposure can lead to chronic immunotoxicity, hyper-inflammation, and immune dysregulation3.

    ◦ IgG4 Class Switch and T-cell Exhaustion: Repeated mRNA vaccinations can result in a shift towards IgG4 antibodies, which favors immune tolerance over viral elimination, potentially weakening antiviral defenses and increasing the risk of infectious, autoimmune, and malignant diseases73.... This switch is predominantly seen in those who received multiple mRNA vaccines or were infected post-vaccination7580. Chronic antigenic stimulation can also lead to T-cell exhaustion, impairing T-cell responses and increasing susceptibility to reinfection7381.

    ◦ Hyperinflammation: Both vaccination and infection trigger robust immune responses, including pro-inflammatory cytokines like IL-6 and IL-1β, which are linked to autoimmune-inflammatory disorders and severe COVID-1982....

    ◦ Lymphopenia and Interferon Suppression: Lymphopenia (T-cell reductions) has been observed after multiple mRNA vaccinations, similar to severe COVID-1987.... Both infection and vaccination can induce autoantibodies against type I interferons, suppressing antiviral and anticancer immune responses and potentially increasing the risk of viral myocarditis92....

• Neurological Problems: Cardiovascular, hematologic, autoimmune, and neurological problems can be triggered by either the mRNA inoculations or coronavirus infections, or both67. Vaccine-induced spike protein can exert direct neuroinflammatory and neurotoxic effects1112.

Misattribution and Challenges to "Hybrid Immunity":

The hypothesis highlights that "breakthrough infections" (BTIs), often assumed to be rare and mild, can result in severe disease and death in vaccinated individuals, suggesting a "vaccine failure" rather than a true "breakthrough"99100. Symptoms occurring after infection in vaccinated individuals are often solely attributed to the virus, overlooking the background "noise" of vaccine-generated spike protein3.

While "hybrid immunity" (prior infection followed by vaccination) has been promoted as conferring enhanced immunological responses, the hypothesis argues that most studies supporting this benefit are short-term and suffer from temporal bias101102. The "gain in protection" with boosters declines rapidly102. Moreover, hybrid immunity raises concerns about excessive antibody production, which may contribute to vaccine-associated enhanced disease (VAED) or "pathogenic priming"103.... High antibody levels can paradoxically inhibit macrophage capacity to destroy pathogens or cancer cells, potentially explaining why hybrid immunity might translate into more serious adverse events109110. This amplified humoral response is associated with increased risks of hyperinflammation, severe immunopathology, and heightened reactogenicity111....

Epidemiological studies from the Omicron era, particularly in heavily vaccinated countries, paradoxically show unexpected spikes in mortality despite Omicron's mild pathogenicity, suggesting an interaction between vaccination and infection2.... The hypothesis suggests that the extensive mRNA vaccination established a milieu of prolonged spike protein production, which was then amplified by subsequent Omicron infections5125.

In conclusion, the Hybrid Harms Hypothesis posits that the prolonged persistence of spike protein (from vaccination) creates a "window of vulnerability" where subsequent SARS-CoV-2 infections can amplify pre-existing vaccine-induced harms, leading to severe adverse events often misattributed solely to the viral infection4.... This underscores the need for integrated risk assessments that consider the interaction between vaccine and infection exposures and their cumulative impact on health2659.

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Hybrid harms hypothesis.

The Hybrid Harms Hypothesis proposes that repeated exposure to spike antigen via mRNA vaccination, interacting with either a prior or subsequent coronavirus infection, amplifies "spikeopathy". This amplification manifests as chronic immunotoxicity, persistent inflammation, immune dysregulation, and a diverse range of pathological sequelae, many of which are associated with both COVID-19 vaccinations and coronavirus infections12.

The hypothesis challenges the assumption that spike protein production after mRNA vaccinations is brief and has no impact on subsequent coronavirus infections3. Instead, it suggests that mRNA vaccine-induced spike protein production, and its associated pathologies ("spikeopathies"), may persist for at least 2-3 years, creating a "window of vulnerability" (WOV). During this timeframe, any exposure to SARS-CoV-2 or Omicron could trigger a disease or disability that, while logically attributed to the infection based on timing, is in fact predisposed to be more severe due to the persistent vaccine-induced spike protein34.

The Hybrid Harms Hypothesis is distinguished by five fundamental features5:

• COVID-19 mRNA product's three-pronged toxic payload: This includes the spike protein itself, which exhibits toxic and pathogenic potential (oxidative stress, inflammation, thrombogenesis, endothelial damage, prion-related dysregulation), lipid nanoparticles (LNPs) that contribute to prolonged inflammation and can activate pro-inflammatory pathways, and process-related DNA impurities (such as plasmid DNA fragments like SV40, which raise concerns about integration into the human genome and potential for autoimmune conditions or oncogenesis)6....

• Whole-body biodistribution: Research indicates that both the mRNA encoding the spike protein and the protein itself can distribute to nearly all organs, including the spleen, liver, ovaries, adrenal glands, brain, eyes, heart, testes, uterus, pituitary gland, spinal cord, and bone marrow. This systemic distribution explains why vaccine-induced spike protein has been linked to inflammatory organ damage affecting these systems910.

• Prolonged spike antigen exposure and overwhelming antigenic load: The synthetic mRNA and generated spike proteins do not immediately decay. Modifications like N1-methylpseudouridine enhance mRNA durability, ensuring persistent spike protein bioavailability for an unknown period. Spike protein has been detected in circulation for 6-8 months, and in some cases, up to 17 months in cerebral arteries and 23.6 months in individuals with immune dysfunction. Pfizer vaccine-generated mRNA has even been found in blood 3.2 years post-injection. This prolonged generation of spike protein and the cumulative antigenic load can lead to ongoing systemic inflammation and immune dysfunction11.... The best estimates for extended spike production post-vaccination are in the range of 24 to 38 months, suggesting no inherent "off switch" for spike protein generation by transfected cells13.

• Multiple mRNA injections with cumulative adverse effects: Repeated COVID-19 mRNA vaccinations are theorized to result in increased and potentially cumulative toxic impacts and immune system disruption, a concept termed the "Triple-Hit Hypothesis" when combined with a coronavirus infection14. Successive doses can perpetuate immune dysregulation, including T-cell exhaustion and a shift to IgG4 antibody production15. This IgG4 class switch, particularly after multiple doses or post-vaccination infection, may favor immune tolerance over viral elimination, potentially weakening antiviral defenses and increasing the risk of infectious, autoimmune, and malignant diseases15....

• Similar immunologic variations with additive or synergistic effects from both vaccinations and infections: Both mRNA vaccines and natural infections trigger robust immune responses, including pro-inflammatory cytokines and cell-mediated immunity, leading to overlapping physiological changes. These redundant phenomena suggest additive or synergistic effects, potentially amplifying immune activation or increasing adverse effects19. Examples include:

    ◦ Hyperinflammation: Elevated inflammatory cytokines (e.g., IL-6, IL-1β) are linked to both vaccine AEs and severe COVID-1920.

    ◦ Autoimmunity: Both SARS-CoV-2 infections and mRNA vaccinations can promote autoimmune reactions, likely through molecular mimicry, epitope spreading, and bystander activation21.

    ◦ Lymphopenia: Reduction in T-cells, which increases infection risk, is seen in severe COVID-19 and after multiple mRNA vaccinations22.

    ◦ Interferon suppression: Autoantibodies against type I interferons, crucial for antiviral and anticancer responses, can be induced by both severe COVID-19 and mRNA vaccinations23.

Support for the Hybrid Harms Hypothesis:

• Epidemiological studies from the Omicron era: Despite Omicron's mild pathogenicity, extensively vaccinated countries experienced unexpected spikes in COVID-19 deaths and all-cause mortality in 2022 and 2023, coinciding with Omicron waves and high vaccination coverage (e.g., South Korea, Hong Kong, Singapore, Australia, Nordic countries, Europe, the Americas)24.... This suggests an interaction between vaccinations and subsequent Omicron infection rather than Omicron alone32....

• Negative Efficacy: Studies have shown that repeated doses of mRNA products can disrupt immune system functioning, leading to negative efficacy where vaccinated individuals are more likely to contract COVID-19 than unvaccinated ones3536. For example, a Cleveland Clinic study (n=51,017) found that while mRNA vaccinations initially reduced infection risk, this protection diminished over time, and the risk of infection rose with successive doses (107% for 1 dose, up to 253% for >3 doses compared to unvaccinated individuals)36. A Japanese case-control study reported an elevated infection risk among vaccinated individuals with a dose-dependent trend (63% higher risk for 1-2 doses, up to 121% for 5-7 doses)36. Other studies from Qatar, the UK, Iceland, and the US have shown increased infection rates post-vaccination, particularly after six months or additional doses37.

• Increased Mortality Post-Vaccination: An ecological study across 145 countries indicated that vaccination programs significantly increased global COVID-19 cases by up to 291% and COVID-19 deaths by up to 205.25%, with these increases correlating positively with the number of vaccine doses administered38. Visualizations from the Johns Hopkins Coronavirus Resource Center show major surges in COVID-19 incidence and mortality occurring in many countries only after reaching at least 75% vaccine coverage3940.

• Serious Adverse Events (SAEs): Negative efficacy can also include unexpected adverse outcomes unrelated or not definitively related to COVID-19, such as serious cardiac events41. A re-analysis of Pfizer trial data found a 36% increased risk of SAEs in the mRNA-injected group compared to placebo, estimating one serious AE for every 800 doses, a rate 125 times higher than the historical threshold for vaccine withdrawal42. Confidential Pfizer documents revealed approximately 1.6 million AEs linked to mRNA injections by August 2022, with a third involving serious injuries to various organ systems and a notable rise in cancers42.

• Cardiovascular and Hematologic AEs: The same coagulopathies seen in severe COVID-19 are mirrored by serious thrombotic complications from mRNA vaccinations43. Myocarditis, initially reported as a safety signal by the CDC, shows a stronger link to mRNA vaccines than to SARS-CoV-2 infections, with vaccine-induced spike protein found in cardiac tissue44. Subclinical myocarditis from mRNA vaccines may be exacerbated by subsequent infection, transforming into fulminant myocarditis and increasing the likelihood of arrhythmias and heart failure45. Repeated doses increase myocarditis risk, showing a dose-response relationship46. Case reports illustrate individuals developing severe myocarditis after COVID-19 infection, following prior mRNA vaccination, suggesting a potential priming effect where the vaccine predisposes the heart to more severe outcomes from subsequent infection47.... Studies in South Korea also showed a nearly four-fold higher heart disease risk in infected mRNA recipients compared to uninfected ones50.

• Post-COVID-19 Vaccine Syndrome (PCVS) subsuming Post-acute Sequelae of COVID-19 (PASC): The hypothesis suggests that many cases classified as "long COVID" or PASC may actually be PCVS or "post-acute COVID-19 injection syndrome" (PACIS)5152. mRNA vaccinations have been associated with an increased risk of PASC-like syndromes, with the prolonged presence of vaccine-induced spike protein implicated in symptoms53. One study found vaccinated individuals with long COVID symptoms had average spike antibody levels seven times higher than unvaccinated individuals, despite no recent infections in the vaccinated group54. A retrospective analysis indicated 70% of PASC cases occurred in fully vaccinated individuals, with unvaccinated individuals exposed to Omicron showing the lowest PASC incidence55.

Distinction from Hybrid Immunity: While "hybrid immunity" refers to the synergistic immune protection from prior infection followed by vaccination, the Hybrid Harms Hypothesis focuses on the adverse interactions56. Studies claiming benefits of hybrid immunity often had short follow-up periods, and protection against Omicron reinfection declined significantly within months57. The hypothesis raises concerns that the theoretical "enhanced" immune response from hybrid immunity may be counterbalanced by the risk of excessive antibody production, innate immune suppression, and serious adverse events, particularly vaccine-associated enhanced disease (VAED) or pathogenic priming5859.

Misclassification Issues: The true scope of negative efficacy and hybrid harms has likely been obscured by systemic biases in data collection and reporting6061.

• Case-counting window bias: Studies often begin counting adverse events (AEs) too late (e.g., 1-3 weeks after the second dose), leading to the misclassification of individuals experiencing AEs during this period as "unvaccinated." This artificially inflates vaccine efficacy and conceals harms62.... Even a negatively effective vaccine can appear moderately effective due to this bias62.

• Overreporting of "COVID deaths" and underreporting of "BTI-related deaths": Deaths are often attributed solely to COVID-19 based on a positive RT-PCR test, even if the virus was not the direct cause6165. Conversely, BTI-related deaths (deaths in vaccinated individuals) may be underreported due to external pressures, inconsistent definitions of "fully vaccinated," and deprioritized investigations6061.

• Temporal bias: Clinicians and studies often attribute severe AEs (e.g., myocarditis) solely to the most recent event, such as a coronavirus infection, overlooking prior mRNA vaccination as a predisposing factor due to prolonged spike protein persistence2....

In essence, the Hybrid Harms Hypothesis posits that the complex interplay between prolonged vaccine-induced spike protein and subsequent SARS-CoV-2 infection is a crucial, often overlooked, driver of severe morbidity and mortality in extensively vaccinated populations, particularly given Omicron's otherwise mild pathogenicity3....

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Misclassification issues.

Misclassification issues have significantly distorted the assessment of COVID-19 mRNA vaccine efficacy and safety, particularly in observational studies and public health reporting1.... These issues lead to an inaccurate understanding of disease causation and the true impact of both infection and vaccination5....

Here are the key aspects of misclassification identified in the sources:

• Case-Counting Window Bias

    ◦ This is a significant flaw in many studies that compare vaccinated and unvaccinated groups11....

    ◦ It occurs when the observation period for counting adverse events (AEs) in vaccinated individuals is started too late, typically 1-3 weeks after the second dose11.

    ◦ As a result, individuals who received mRNA products but experienced serious AEs (including death) within this early post-injection period are misclassified as "unvaccinated"311.

    ◦ This methodological error can artificially inflate vaccine efficacy estimates, making an ineffective or even negatively effective vaccine appear to be moderately effective (e.g., between 50% and 65% effective)1114.

• Misclassification of "Unvaccinated" Status

    ◦ Many observational studies have falsely claimed lower COVID-19 infection and mortality rates for mRNA-vaccinated individuals by incorrectly categorizing vaccinated people as "unvaccinated"2.

    ◦ This includes individuals who:

        ▪ Have not yet reached "immunologic maturity" (e.g., within 14-28 days after the second dose)3.

        ▪ Are only partially vaccinated3.

        ▪ Were vaccinated too long ago to be considered "up-to-date" and thus counted as having vaccine-induced immunity3.

    ◦ Any Post-Acute Sequelae of COVID-19 (PASC)-like AEs occurring in these miscategorized mRNA-injected individuals are then attributed to the "unvaccinated" group, further distorting risk assessments3. This practice unfairly characterizes the truly unvaccinated group and reinforces the "safe and effective" narrative15.

• Misattribution of Deaths and Serious Adverse Events

    ◦ The Hybrid Harms Hypothesis posits that serious AEs, including deaths, are often misattributed solely to COVID-19 infections due to temporal biases6....

    ◦ Since 2021, coronavirus infections often occurred after widespread mRNA vaccination, creating a "preexisting mRNA vaccine-induced milieu of toxic spike protein, inflammatory lipid nanoparticles, and residual process-related DNA impurities"5.

    ◦ Because the mRNA vaccine-induced spike protein can persist for months to years, any subsequent COVID-19 infection can trigger or amplify disease or disability that is then logically but erroneously attributed solely to the viral infection based on timing6....

    ◦ This issue is particularly relevant for Post-Acute Sequelae of COVID-19 (PASC), or "Long COVID." The sources suggest that many PASC cases, especially in extensively vaccinated populations, may actually be "post-COVID-19 vaccination syndrome" (PCVS) or "post-acute COVID-19 injection syndrome" (PACIS)8....

        ▪ PCVS/PACIS shares overlapping clinical features with PASC, and it is difficult to disentangle the prolonged spike protein production from vaccination from the spike-related effects of natural infection18....

        ▪ For example, studies have shown that 70% of PASC cases occurred in fully vaccinated individuals, and vaccine-generated spike antibody levels were seven times higher in vaccinated patients with long COVID symptoms compared to unvaccinated patients with confirmed prior infection2124.

        ▪ When vaccine-related AEs like myocarditis, stroke, or thromboembolism are misclassified as PASC, it inflates reported PASC incidence in vaccinated groups and wrongly attributes vaccine injuries to the virus38.

    ◦ Myocarditis and cardiac events: Public health agencies initially claimed that infections caused more myocarditis than vaccines, but this claim has been refuted, with evidence supporting a stronger link between mRNA vaccines and severe cardiac complications25. The temporal bias means that myocarditis occurring after infection in a previously vaccinated individual is often solely attributed to the infection, despite the potential priming effect or residual inflammation from the vaccine4....

    ◦ Overestimation of infection-related myocarditis rates: Studies that rely on RT-PCR testing to count infections for myocarditis risk calculations can overestimate the infection-related risk by underestimating the true denominator of infected individuals, making vaccine-related myocarditis appear less common in comparison29....

• Underreporting of Adverse Events (AEs)

    ◦ Systemic biases, influenced by biopharmaceutical industry-related financial incentives and political pressures, have led public health agencies to downplay various risks or potential harms of mRNA vaccines to maintain public confidence32....

    ◦ Inconsistencies in classifying "fully vaccinated" status (e.g., excluding individuals within 14 days of their second dose or those with waning immunity) have further contributed to the underreporting of vaccine-related morbidity and mortality36.

    ◦ Many serious AEs, such as ischemic stroke, myocardial infarction, and pulmonary embolism, are common conditions, making it less likely that clinicians will attribute them to mRNA products, leading to underreporting in public health statistics and hindering signal detection3738. This concealment within routine disease statistics skews risk-benefit assessments and limits transparency38.

These misclassification issues have led to distorted perceptions of mRNA vaccine effectiveness and safety, hindering accurate risk-benefit analyses and impacting public health recommendations1.... The sources emphasize the need for rigorous diagnostic criteria, temporal analysis, and comprehensive data collection to disentangle the complex interactions between vaccination and infection4....

keep_pinSave to note

copy_all

thumb_up

thumb_down

text of podcast

Welcome to the Lenny and Maria Sanchez deep dive podcast show.

Great to be here.

Today we're taking a deep dive into a well quite a challenging review paper. It looks at CO 19, specifically the interplay between mRNA vaccination and actually getting infected with the corona virus.

That's right.

Our mission really is to unpack what this paper calls the hybrid harms hypothesis. It's this idea that there might be a convergence, a combination of adverse effects from both the vaccine exposure and the infection itself. It's definitely a fascinating re-examination. It looks at how corona virus infection plays out in people who've had the mRNA vaccines and it um it really encourages us to look at the health outcomes we've seen since say 2021 maybe through a different lens

asking some different questions

asking some critical questions about what might be contributing factors.

Okay, so let's start right there with the core idea the hybrid harms hypothesis. The paper is suggesting that these mRNA vaccines they might not just be reduced ing severity which was the main selling point later on but could potentially be amplifying overall sickness

especially things like uh long covid or pace as it's technically called

right PSE postacute sec of co 19 and the hypothesis um proposes it's a mix of things you've got the spike protein from the vaccine maybe the inflammatory lipid nano particles potentially DNA impurities and then you combine that with a natural SARS KV2 infection

the paper calls this combination overlapping spike related toxicity.

overlapping toxicity like a double hit

kind of. Yeah, double hit scenario. And the paper argues this interaction leads to well significant immune system imbalance, widespread inflammation, and that this could help explain some of the waves of illness and unfortunately deaths we've observed.

All right, moving to the next point. The paper really digs into the effectiveness or maybe the waning effectiveness of these mRNA products. We all remember those initial reports, you know, up to 95% efficacy against symptoms. atic infection.

High numbers initially,

very high. But this paper points to subsequent studies showing well pretty rapid declines in that protection.

Exactly. And what's striking according to the paper is how quickly that protection seemed to fade. For example, um it highlights studies where effectiveness against symptomatic omocrron infection just plummeted down to maybe 10 20% by 6 months after the second dose.

Wow. That low.

Yeah. And this of course led to a lot of breakthrough infections. BTS eyes people fully vaccinated still getting COVID 19.

We heard a lot about those.

We did. And one survey mentioned, I think it was in Saudi Arabia, found almost half, 43.5% of fully vaccinated people later caught CO.

Nearly half.

And maybe more concerning, the paper cites some studies, one in Tunisia, for instance, where over 10% of these breakthrough infections were actually severe or critical. And another observational study reported a uh.9% mortality rate in BTI cases.

0.9%. How does that compare

well the paper notes that's significantly higher than the typical say 030.05% mortality rate often seen for natural infection in similar age groups it suggests these BTI might have been vastly under reportported too maybe due to testing biases or other factors giving us a potentially skewed picture

that leads right into this next concept which honestly sounds quite counterintuitive negative efficacy.

It does sound strange doesn't it?

Yeah it's not just protection fading but suggesting vaccinated people might actually become more likely to get the disease than unvaccinated people.

It's a strong claim and the paper presents some data to back it up. It points particularly to a large study from the Cleveland Clinic over 51,000 people. And while there might have been some initial risk reduction, this study apparently showed the risk of infection actually rose with each additional vaccine dose.

Rose how much?

The figures cited are uh 107% higher risk after one dose and surprisingly up to 253 3% higher after more than three doses compared to the unvaccinated group in that study.

That's quite a reversal.

It is. And the paper also mentions a uh global analysis 145 countries using something called Beijian causal analysis.

Sounds complex.

It is. But the finding they report is a suggested correlation between vaccination programs and significant increases in global COVID cases up to 291% and also deaths up to around 205%. Again, relation but a concerning one presented in the paper

and they try to visualize this too right using data from John's Hopkins

yes exactly they use charts from countries like Sweden, Denmark, Norway, Finland but also places like South Korea, Australia, Hong Kong, Singapore, highly vaccinated places.

And what do the charts show according to the paper?

They highlight that major surges in COVID cases and importantly deaths seem to really become apparent after these places hit high levels of vaccine coverage like 75% or more.

So the argument is If omccron was supposed to be milder,

right, that's the question the figure raises. If omccron was generally milder, why these paradoxical, unexpectedly high mortality rates in 2022, 2023 in these very highly vaccinated populations?

Yeah.

The paper argues it's maybe unreasonable to blame those surges solely on a mild variant. Instead, the hybrid harms hypothesis offers this alternative. Maybe was an interaction effect between the widespread infections and the widespread injections, especially after mass vaccin. campaigns that this interaction was driving the surges.

Let's dig into those harms. Then the paper breaks down the mRNA product components, calling it a three-pronged toxic payload. What are the prongs?

Okay, so prong one, according to the paper, is the spike protein itself, which they argue isn't benign. It can potentially damage endothelial cells. The lining of blood vessels, cause oxidative stress, trigger inflammation, and maybe even blood clotting.

Okay, spike protein. What's prong two?

Prong two is the delivery system, the lipid nanoparticle. or LNPS, those tiny fat bubbles carrying the mRNA. The paper suggests these aren't just passive carriers, but can contribute to prolonged inflammation themselves and activate pro-inflammatory pathways.

So, the delivery system itself might be an issue. And the third

the third prong uh involves process related impurities, specifically fragments of DNA like plasma DNA left over from manufacturing. The paper notes concerns that levels of these impurities, particularly in er's product according to some analyses cited were found to be hundreds of times higher than regulatory limits allow.

Hundreds of times. Wow. And the concern there is

the concern raised is about potential integration into the human genome though that's highly debated and also potentially triggering autoimmunity. The paper even brings up a Florida study that suggested a higher risk of death both all cause and COVID specific for recipients of the Fiser vaccine compared to Madna and speculates this might be linked to higher DNA contamination in the lots studied.

Okay. So you had these three comp components and a crucial point seems to be that they don't just stay in your arm.

Exactly. That's a major point in the paper. It contradicts some of the early assumptions. It highlights studies indicating that both the mRNA instructions and the resulting spike protein can distribute throughout the entire body,

the whole body.

Yes. They don't just stay localized. They can cross important barriers like the bloodb brain barrier and the blood placenta barrier,

which would explain effects in different organs.

Precisely. This systemic distribution, the paper argues, helps explain why inflammatory damage has been linked to various organ systems, heart, liver, spleen, ovaries, the nervous system. It even notes a reported surge in rare uh neurodeenerative conditions, pryion diseases starting in 2021 with symptoms appearing quite quickly post injection on average around 11 days.

That's rapid. Now, another early idea was that this stuff, the mRNA and spike protein would degrade quickly, days, maybe weeks. What does the paper say about persistence?

Yeah, that initial Assumption of rapid clearance is strongly challenged in this paper. While yes, early estimates were short, the paper points to accumulating data showing the spike protein can persist for well much longer. Months in fact

months like how many?

Examples cited include 4 to 8 months in some individuals up to 17 months found in cerebral arteries of stroke patients and even detectable spike protein and circulation for almost 2 years, 23.6 months,

nearly two years.

And maybe most strikingly, the paper mentions a case report where Fiser vaccine derived mRNA was found in the blood 3.2 years after the last injection

3 years later the mRNA itself

that's what the case report cited suggests so this prolonged exposure the authors term it a window of vulnerability lasting maybe 2 to 3 years they argue this could lead to chronic inflammation and ongoing immune dysfunction like your cells are turned into long-term spike protein factories

okay so if it sticks around that long what about multiple doses boosters does the effect just add up

well logic ically the paper suggests that repeated vaccinations would likely lead to increased and potentially cumulative toxic impacts. More exposure

makes sense if it persists,

right? And this cumulative exposure, they argue, could lead to problems like immune dysregulation. They mention things like te- cell exhaustion where key immune cells get worn out. Okay?

And also a shift in the type of antibodies produced specifically towards something called IGG4 particularly after multiple doses.

IG4, what's the significance? of that.

The paper suggests this IGG4 switch might favor immune tolerance rather than actively clearing the virus. So, ironically, it could potentially increase susceptibility to infections, maybe even certain cancers or autoimmune diseases because the immune system isn't fighting as aggressively.

And is there data linking more doses to more infections?

The paper does highlight studies from both the US and Japan that apparently found higher rates of CO 19 correlating with an increasing number of mRNA vaccine doses. This would seem to suggest um a potential worsening of efficacy or even negative efficacy with more shots.

H and another point they make is about similarities between the vaccine effects and the virus effects like they overlap.

Exactly. That's a key part of the hybrid idea, the potential for additive or even synergistic meaning amplified effects because both exposures can trigger similar biological responses.

Such is

well things like hyperinflammation, those cytoine storms we heard about, both the vaccine and the virus can apparently trigger them. The paper asks if Some severe ICU cases were maybe worsened by recent vaccination. Both might also promote autoimmunity where the body attacks itself through mechanisms like molecular mimicry.

Okay.

Both can lead to lympopenia which is a reduction in crucial tea cells. And both can suppress the body's natural interferon responses vital for fighting viruses and maybe even cancer surveillance. So these overlapping immunological issues, the paper argues, suggest the combination could amplify serious adverse events.

So the dominant ative especially later on was that the vaccines protect against severe disease, hospitalization, death. Does this paper take issue with that?

It absolutely does vigorously. It argues there are significant methodological flaws in many of the studies that claimed that strong protection.

Flaws like what?

Things like inconsistent follow-up periods between vaccinated and unvaccinated groups, selection biases, and particularly something called case counting window bias.

Case counting window bias. What's that?

It's basically about when you start counting cases or adverse events after vaccination. The paper argues that often people who had an adverse event shortly after getting the shot, say within the first week or two, were sometimes mclassified as unvaccinated because the vaccine hadn't kicked in yet, according to the study protocol.

Ah, I see. So that could make the vaccine look safer or more effective than it is.

Potentially, yes. It could artificially inflate the efficacy numbers. The paper suggests that if you start tracking outcomes too late, even an ineffective product could appear maybe 50 65% effective just because of this windowing effect. It even cites an Israeli study of 32,000 vaccinees that apparently found an eight-fold higher likelihood of hospitalization compared to unvaccinated individuals within the same health care system.

Eight times higher.

That's the finding cited. The paper suggests this points towards either superior natural immunity in the unvaccinated group studied or perhaps worryingly worsening protection for the vaccine recipients in that specific context.

Now, this next point feels crucial. We all know about longco or pace, but the paper introduces postcoid9 vaccine syndrome, PCVS. How are they related or different?

Well, the paper proposes a kind of reclassification, really arguing that PCVS might actually subsume many cases currently labeled as pacey. The key link again is the spike protein. It cites research indicating that vaccinated individuals who had long COVID symptoms showed spike antibbody levels roughly seven times higher than un vaccinated people who'd recovered from infection even when the vaccinated group hadn't had a recent infection.

Seven times higher antibodies suggesting more spike protein exposure.

That's the implication drawn in the paper. A significantly higher or more persistent spike protein burden in the vaccinated group with long symptoms. And another analysis mentioned found that 70% of PSSE cases occurred in fully vaccinated people.

70%.

Yes. Leading the paper to suggest the vaccines themselves might exacerbate or even precipitate these PSC like symptoms. Essentially, it argues many cases we call longcoid might actually be vaccine injuries or PCVS. Due to the prolonged presence of vaccine induced spike protein, it becomes hard to disentangle the two.

Okay. And finally, let's talk about the really serious adverse events, cardiovascular issues, clotting problems. How does the paper see the interaction there?

This is a major focus of the hybrid harms argument. The paper states that both exposures the vaccine and the virus can trigger and potentially Amplify clotting disorders and heart inflammation like myocarditis.

Amplify them.

Yes. It notes that the same kinds of blood clotting issues seen in severe COVID are also seen as complications from the mRNA vaccines. And it cites autopsy studies suggesting direct toxic effects on heart tissue from the vaccines. Something apparently not observed to the same degree with the virus itself.

Direct heart toxicity from the vaccine.

That's what the cited autopsy studies suggest. And the paper hypothesizes a scenario where maybe sub technical hidden mocarditis caused by the vaccine could later be triggered into a full-blown severe myocarditis if the person subsequently gets infected. The infection acts as a second hit or stressor.

And is there broader population data to support this hybrid harms idea for severe outcomes?

The paper points to epidemiological data from several highly vaccinated countries. South Korea, Australia, Singapore are mentioned again. It highlights paradoxical spikes in all-c causeed mortality that seem to synchronize with the relatively mild omocron waves in 2022

synchronized with omccron but omccron was mild.

Exactly. The argument is that these death spikes don't really fit the narrative of a mild variant causing havoc. Instead, the paper suggests this data supports the hybrid harms phenomenon, the interaction driving excess mortality. It mentions South Korea's excess mortality rising sharply in early 2022 during omccron and Hong Kong showing an average excess mortality of uh a staggering 71.14% during its wave.

Wow. Okay. A lot to think about there. As we wrap up this deep dive, what's the main takeaway for you from this paper's perspective?

Well, if we connect all those points, the paper really concludes that the simple dichotomy we often hear, you know, vaccine versus virus, good versus bad, might be uh untenable or overly simplistic,

not so black and white.

Not according to this hypothesis. The prolonged persistence of the vaccine induced spike protein, the paper argues, sets the stage for these harmful interactions that could amplify serious adverse events when combined with infection. It leads to a potentially new understanding of postcoid conditions may be challenging us to re-evaluate how we assess health outcomes, especially considering concepts like natural immunity versus vaccine immunity versus this proposed hybrid state.

A challenging perspective indeed. Thank you for listening to another session of the Lenny and Ria Sanchez deep dive podcast show produced and archived at the website dailybriefs.info.

Discuss Hybrid Harms Hypothesis.

The Hybrid Harms Hypothesis is a core idea examined in the review paper discussed on the "Lenny and Maria Sanchez deep dive podcast show"1. It proposes a convergence or combination of adverse effects from both mRNA vaccine exposure and natural SARS-CoV-2 infection12.

Here's a breakdown of the hypothesis:

• Core Idea: The paper suggests that mRNA vaccines might not just reduce severity, but could potentially amplify overall sickness, particularly conditions like long COVID, technically called Post-Acute Sequelae of COVID-19 (PASC)2.

• Components of the "Overlapping Spike-Related Toxicity": The hypothesis posits that this amplification stems from a mix of factors introduced by the vaccine combining with a natural infection. These factors include:

    ◦ The spike protein from the vaccine2.

    ◦ Inflammatory lipid nanoparticles (LNPs), the delivery system for the mRNA23.

    ◦ DNA impurities from the manufacturing process24. When these combine with a natural SARS-CoV-2 infection, the paper calls this "overlapping spike-related toxicity" or a "double hit scenario"25.

• Proposed Effects: This interaction is argued to lead to significant immune system imbalance, widespread inflammation, and could help explain waves of illness and deaths observed, particularly since 20215.

The paper presents several points to support and elaborate on this hypothesis:

• Waning Vaccine Effectiveness and Breakthrough Infections (BTIs): While initial reports showed high efficacy (up to 95% against symptomatic infection), subsequent studies indicated rapid declines in protection, with effectiveness against symptomatic Omicron infection plummeting to 10-20% by six months after the second dose56. This led to many breakthrough infections (BTIs), with some studies reporting that nearly half of fully vaccinated people later contracted COVID-197. More concerningly, some BTIs were severe or critical, with one observational study reporting a 0.9% mortality rate in BTI cases, which the paper notes is significantly higher than the typical 0.03-0.05% mortality rate for natural infection in similar age groups7.

• Negative Efficacy: This concept suggests that vaccinated individuals might become more likely to contract the disease than unvaccinated people8.

    ◦ A large study from the Cleveland Clinic, involving over 51,000 people, is cited, which reportedly showed that the risk of infection actually rose with each additional vaccine dose, with a 107% higher risk after one dose and up to 253% higher after more than three doses compared to the unvaccinated group89.

    ◦ A global analysis of 145 countries using Beijian causal analysis reportedly found a correlation between vaccination programs and significant increases in global COVID cases (up to 291%) and deaths (up to around 205%)9.

• Paradoxical Surges Post-Vaccination: The paper uses charts from highly vaccinated countries (e.g., Sweden, Denmark, Norway, Finland, South Korea, Australia, Hong Kong, Singapore) to highlight that major surges in COVID cases and deaths appeared after these places reached high levels of vaccine coverage (75% or more)10. It questions why these "paradoxical, unexpectedly high mortality rates" occurred in 2022-2023 in highly vaccinated populations if Omicron was generally milder, suggesting it was an interaction effect between widespread infections and widespread injections driving the surges11.

• "Three-Pronged Toxic Payload" of mRNA Products:

    ◦ Spike Protein: The paper argues it's not benign, potentially damaging endothelial cells, causing oxidative stress, inflammation, and blood clotting3.

    ◦ Lipid Nanoparticles (LNPs): Suggested to contribute to prolonged inflammation and activate pro-inflammatory pathways3.

    ◦ Process-Related Impurities (DNA Fragments): Concerns are raised about plasma DNA fragments, particularly in Pfizer's product, reportedly found at levels hundreds of times higher than regulatory limits4. The paper notes concerns about potential integration into the human genome (though debated) and triggering autoimmunity4.

• Systemic Distribution and Persistence:

    ◦ The paper asserts that the mRNA instructions and resulting spike protein do not just stay localized in the arm but can distribute throughout the entire body, crossing barriers like the blood-brain barrier and the blood-placenta barrier1213. This systemic distribution is argued to explain inflammatory damage linked to various organ systems, including the heart, liver, spleen, ovaries, and nervous system13.

    ◦ Contrary to initial assumptions of rapid degradation, the paper cites data showing the spike protein can persist for months (4-8 months, up to 17 months in cerebral arteries, almost 2 years in circulation)14. A case report is even mentioned where Pfizer vaccine-derived mRNA was found in the blood 3.2 years after the last injection1415. This prolonged exposure creates a "window of vulnerability" (2-3 years), leading to chronic inflammation and ongoing immune dysfunction15.

• Cumulative Toxic Impacts from Multiple Doses: Logically, repeated vaccinations are suggested to lead to increased and potentially cumulative toxic impacts, including immune dysregulation, T-cell exhaustion, and a shift towards IGG4 antibodies, which might favor immune tolerance and potentially increase susceptibility to infections, cancers, or autoimmune diseases1516. Studies from the US and Japan are cited that reportedly found higher rates of COVID-19 correlating with an increasing number of mRNA vaccine doses17.

• Overlapping Biological Responses: A key part of the hybrid idea is the potential for additive or synergistic (amplified) effects because both vaccine exposure and natural infection can trigger similar biological responses17. These include hyperinflammation (cytokine storms), autoimmunity (molecular mimicry), lymphopenia (reduction in T-cells), and suppression of natural interferon responses18. These overlapping immunological issues are argued to amplify serious adverse events18.

• Critique of Efficacy Studies: The paper "vigorously" challenges claims of strong protection against severe disease, hospitalization, and death, citing methodological flaws such as inconsistent follow-up periods, selection biases, and "case counting window bias"1920. This bias, where adverse events shortly after vaccination are misclassified, could artificially inflate efficacy numbers20. An Israeli study is cited, which apparently found an eight-fold higher likelihood of hospitalization for vaccinees within the same healthcare system, suggesting either superior natural immunity or worsening protection for vaccine recipients2021.

• Post-COVID-19 Vaccine Syndrome (PCVS): The paper proposes reclassifying many cases currently labeled as PASC as PCVS, due to the prolonged presence of vaccine-induced spike protein2122. Research is cited indicating that vaccinated individuals with long COVID symptoms showed spike antibody levels roughly seven times higher than unvaccinated people who had recovered from infection21. Another analysis mentioned found that 70% of PASC cases occurred in fully vaccinated people, leading to the suggestion that vaccines might exacerbate or even precipitate these PASC-like symptoms22.

• Severe Adverse Events and Population Data: The hybrid harms argument focuses heavily on cardiovascular issues and clotting problems23. Both exposures (vaccine and virus) can reportedly trigger and potentially amplify clotting disorders and heart inflammation (myocarditis)23. Autopsy studies are cited suggesting direct toxic effects on heart tissue from the vaccines, hypothesized to lead to subclinical myocarditis that could be triggered into full-blown severe myocarditis by subsequent infection, acting as a "second hit"2324. Epidemiological data from highly vaccinated countries like South Korea, Australia, and Singapore is presented, showing paradoxical spikes in all-cause mortality that synchronized with the relatively mild Omicron waves in 2022, supporting the interaction driving excess mortality2425.

In summary, the Hybrid Harms Hypothesis challenges the simple "vaccine versus virus" dichotomy, suggesting that the prolonged persistence of vaccine-induced spike protein sets the stage for harmful interactions that can amplify serious adverse events when combined with natural infection, leading to a potentially new understanding of post-COVID conditions26.

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Vaccine Effectiveness.

The provided source, a podcast discussing a review paper, offers a challenging perspective on vaccine effectiveness, suggesting it may not be as straightforward as initially presented12.

Here's a discussion of vaccine effectiveness as presented in the source:

• Initial Efficacy Claims and Rapid Decline:

    ◦ Initial reports indicated high efficacy, up to 95% against symptomatic infection23.

    ◦ However, the paper points to subsequent studies showing a rapid decline in protection3.

    ◦ For instance, effectiveness against symptomatic Omicron infection reportedly plummeted to 10-20% by six months after the second dose3.

• Breakthrough Infections (BTIs):

    ◦ The rapid decline in protection led to many breakthrough infections (BTIs), where fully vaccinated people still contracted COVID-1934.

    ◦ A survey in Saudi Arabia found that almost half (43.5%) of fully vaccinated individuals later caught COVID4.

    ◦ More concerningly, some studies cited in the paper reported that over 10% of these BTIs were severe or critical (e.g., in Tunisia)4.

    ◦ Another observational study reported a 0.9% mortality rate in BTI cases, which the paper notes is significantly higher than the typical 0.03-0.05% mortality rate often seen for natural infection in similar age groups4. The paper also suggests BTIs might have been vastly underreported4.

• Negative Efficacy:

    ◦ The paper introduces the concept of negative efficacy, suggesting that vaccinated individuals might become more likely to contract the disease than unvaccinated people5.

    ◦ A large study from the Cleveland Clinic, involving over 51,000 people, reportedly showed that the risk of infection actually rose with each additional vaccine dose5.

        ▪ Specifically, the risk was cited as 107% higher after one dose and up to 253% higher after more than three doses compared to the unvaccinated group in that study6.

    ◦ A global analysis of 145 countries using Bayesian causal analysis reportedly found a suggested correlation between vaccination programs and significant increases in global COVID cases (up to 291%) and deaths (up to around 205%)6.

    ◦ The paper also highlights studies from the US and Japan that apparently found higher rates of COVID-19 correlating with an increasing number of mRNA vaccine doses, suggesting a potential worsening of efficacy or negative efficacy with more shots7.

• Paradoxical Surges in Highly Vaccinated Populations:

    ◦ The paper uses charts from countries like Sweden, Denmark, Norway, Finland, South Korea, Australia, Hong Kong, and Singapore – all highly vaccinated places8.

    ◦ These charts reportedly show that major surges in COVID cases and deaths became apparent after these places hit high levels of vaccine coverage (75% or more)8.

    ◦ The paper questions why, if Omicron was generally milder, there were paradoxical, unexpectedly high mortality rates in 2022-2023 in these highly vaccinated populations9.

    ◦ It argues that blaming these surges solely on a mild variant is unreasonable9. Instead, the "hybrid harms hypothesis" offers an alternative: an interaction effect between widespread infections and widespread injections, especially after mass vaccination campaigns, was driving these surges9.

• Critiques of Studies Claiming Strong Protection:

    ◦ The paper vigorously takes issue with the dominant narrative that vaccines protect against severe disease, hospitalization, and death10.

    ◦ It argues that many studies claiming strong protection have significant methodological flaws10.

    ◦ These flaws include:

        ▪ Inconsistent follow-up periods between vaccinated and unvaccinated groups10.

        ▪ Selection biases10.

        ▪ Case counting window bias: This involves when cases or adverse events are counted after vaccination1011. The paper argues that people experiencing an adverse event shortly after vaccination (e.g., within the first one or two weeks) were sometimes misclassified as unvaccinated because the vaccine was considered not yet effective by study protocols11. This could artificially inflate efficacy numbers, potentially making an ineffective product appear 50-65% effective11.

    ◦ An Israeli study of 32,000 vaccine recipients was cited, which reportedly found an eight-fold higher likelihood of hospitalization compared to unvaccinated individuals within the same healthcare system1112. The paper suggests this points towards either superior natural immunity in the unvaccinated group or potentially worsening protection for the vaccine recipients in that specific context12.

• Impact of Multiple Doses and Immune Dysregulation:

    ◦ Logically, the paper suggests that repeated vaccinations would likely lead to increased and potentially cumulative toxic impacts due to more exposure if the vaccine components persist1314.

    ◦ This cumulative exposure, they argue, could lead to problems like immune dysregulation, including T-cell exhaustion and a shift towards an IgG4 antibody type, particularly after multiple doses14.

    ◦ This IgG4 switch might favor immune tolerance rather than active viral clearance, potentially increasing susceptibility to infections, certain cancers, or autoimmune diseases14.

Overall, the paper discussed in the podcast challenges the conventional understanding of mRNA vaccine effectiveness, suggesting that initial efficacy wanes rapidly, negative efficacy may occur, and that the vaccines could contribute to or exacerbate illness, especially when combined with natural infection2....

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Negative Efficacy.

Negative efficacy, as discussed in the review paper featured on the "Lenny and Maria Sanchez deep dive podcast show," is a concept that might sound "strange" or "counterintuitive"1. It suggests that instead of just protection fading, vaccinated individuals could actually become more likely to contract the disease than unvaccinated people1.

The paper presents several points and data to support this "strong claim":

• Cleveland Clinic Study: A large study from the Cleveland Clinic, involving over 51,000 individuals, is cited as evidence. While there might have been some initial risk reduction, this study reportedly showed that the risk of infection actually increased with each additional vaccine dose1.

    ◦ Specifically, the figures cited indicate a 107% higher risk after one dose and a surprisingly up to 253% higher risk after more than three doses when compared to the unvaccinated group in that study2. The hosts describe this as "quite a reversal"2.

• Global Analysis: A global analysis across 145 countries, utilizing a method called Bayesian causal analysis, is also mentioned. This analysis reportedly found a suggested correlation between vaccination programs and significant increases in global COVID cases (up to 291%) and deaths (up to around 205%)2. While noting it's a correlation, the paper presents it as a concerning finding2.

• Visualization of Data: The paper reportedly uses charts from John's Hopkins data for highly vaccinated countries, including Sweden, Denmark, Norway, Finland, South Korea, Australia, Hong Kong, and Singapore3. These charts are said to highlight that major surges in COVID cases and deaths appeared after these locations achieved high levels of vaccine coverage, specifically 75% or more3.

• Paradoxical Mortality Rates: The paper questions why there were "paradoxical, unexpectedly high mortality rates in 2022 and 2023" in these highly vaccinated populations, especially given that the Omicron variant was generally considered milder4. The paper argues that it is "unreasonable to blame those surges solely on a mild variant"4.

• Hybrid Harms as an Explanation: Instead of solely blaming a mild variant, the Hybrid Harms Hypothesis offers an alternative explanation: that an interaction effect between widespread infections and widespread injections (mass vaccination campaigns) was driving these surges4.

• Cumulative Toxic Impacts: The paper logically suggests that repeated vaccinations could lead to increased and potentially cumulative toxic impacts due to prolonged exposure to vaccine components like the spike protein5. This cumulative exposure, they argue, could result in immune dysregulation, such as T-cell exhaustion, and a shift in antibody production towards IgG4, which might favor immune tolerance over active viral clearance6. This could "ironically, potentially increase susceptibility to infections, maybe even certain cancers or autoimmune diseases"6.

• Correlation with Doses and Infection Rates: Furthermore, the paper highlights studies from the US and Japan that apparently found higher rates of COVID-19 correlating with an increasing number of mRNA vaccine doses7. This data, according to the paper, "would seem to suggest... a potential worsening of efficacy or even negative efficacy with more shots"7.

In essence, the concept of negative efficacy, within the framework of the Hybrid Harms Hypothesis, challenges the idea that mRNA vaccines solely reduce disease severity and instead posits that they could, under certain circumstances, increase susceptibility to infection or worsen health outcomes, especially when combined with natural SARS-CoV-2 infection1....

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Vaccine Components.

According to the review paper discussed on the "Lenny and Maria Sanchez deep dive podcast show", mRNA vaccines are described as having a "three-pronged toxic payload"1. The paper raises concerns about these components and their potential interplay with SARS-CoV-2 infection, forming the basis of the Hybrid Harms Hypothesis12.

The three main components discussed are:

• Spike Protein:

    ◦ This is the spike protein from the vaccine itself2.

    ◦ The paper argues that it is "not benign"1.

    ◦ It is suggested to potentially damage endothelial cells (the lining of blood vessels), cause oxidative stress, trigger inflammation, and possibly lead to blood clotting1.

    ◦ A significant concern raised is the persistence of this spike protein in the body. While early assumptions suggested rapid clearance, the paper points to accumulating data indicating it can persist for months (4 to 8 months in some individuals, up to 17 months in cerebral arteries of stroke patients, and even detectable in circulation for almost 2 years, 23.6 months)3.

• Lipid Nanoparticles (LNPs):

    ◦ These are the inflammatory lipid nanoparticles that serve as the delivery system for the mRNA12.

    ◦ The paper suggests that LNPs are not just passive carriers but can "contribute to prolonged inflammation themselves" and activate pro-inflammatory pathways1.

• Process-Related Impurities (DNA Fragments):

    ◦ These are specifically fragments of DNA, like plasma DNA, left over from the manufacturing process24.

    ◦ The paper notes concerns that the levels of these impurities, particularly in Pfizer's product, were reportedly "hundreds of times higher than regulatory limits allow" according to some cited analyses4.

    ◦ Concerns raised include potential integration into the human genome (though this is highly debated) and potentially triggering autoimmunity4.

    ◦ A Florida study is mentioned which reportedly suggested a higher risk of death (both all-cause and COVID-specific) for recipients of the Pfizer vaccine compared to Moderna, speculating this might be linked to higher DNA contamination in the lots studied4.

A crucial point made by the paper about these components is that they are not necessarily localized to the injection site5. It highlights studies indicating that both the mRNA instructions and the resulting spike protein can distribute throughout the entire body, crossing important barriers like the blood-brain barrier and the blood-placenta barrier5. This systemic distribution is argued to help explain why inflammatory damage has been linked to various organ systems, including the heart, liver, spleen, ovaries, and the nervous system6.

Furthermore, the paper challenges the initial assumption of rapid degradation, citing a case report where Pfizer vaccine-derived mRNA was reportedly found in the blood 3.2 years after the last injection37. This prolonged exposure is termed a "window of vulnerability", which authors argue could lead to chronic inflammation and ongoing immune dysfunction7. The paper also suggests that repeated vaccinations would likely lead to increased and potentially cumulative toxic impacts due to this persistence78.

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Spike Protein Persistence.

The review paper discussed on the "Lenny and Maria Sanchez deep dive podcast show" strongly challenges the initial assumption that the mRNA vaccine components, particularly the spike protein, degrade quickly within days or weeks1. Instead, it presents accumulating data suggesting prolonged persistence of the spike protein within the body.

Here's what the paper states about spike protein persistence:

• Challenged Assumption of Rapid Clearance: Early estimates suggested rapid clearance of mRNA and spike protein, but the paper argues this assumption is "strongly challenged" by accumulating data1.

• Extended Durations of Persistence:

    ◦ The spike protein has been found to persist for months in some individuals, specifically cited as 4 to 8 months1.

    ◦ In more extreme cases, it was found for up to 17 months in the cerebral arteries of stroke patients1.

    ◦ It was also detectable in circulation for almost two years (23.6 months)1.

    ◦ Most strikingly, the paper mentions a case report where Pfizer vaccine-derived mRNA was found in the blood 3.2 years after the last injection12.

• Systemic Distribution: This persistence is linked to the paper's argument that the mRNA instructions and the resulting spike protein do not just stay localized in the arm but can distribute throughout the entire body3. They can even cross critical barriers like the blood-brain barrier and the blood-placenta barrier, potentially explaining effects in various organs34.

• Implications of Prolonged Exposure: The authors term this prolonged exposure a "window of vulnerability," potentially lasting 2 to 3 years2. They argue this could lead to:

    ◦ Chronic inflammation2.

    ◦ Ongoing immune dysfunction, where cells are effectively "turned into long-term spike protein factories"2.

    ◦ When combined with subsequent natural infection, this prolonged presence of vaccine-induced spike protein is a key factor in the "Hybrid Harms Hypothesis," potentially amplifying serious adverse events5.

• Link to Post-COVID Conditions: The paper also connects this prolonged persistence to post-COVID-19 vaccine syndrome (PCVS). It cites research suggesting that vaccinated individuals with long COVID symptoms showed spike antibody levels roughly seven times higher than unvaccinated people who had recovered from infection, even without a recent infection, implying a significantly higher or more persistent spike protein burden in the vaccinated group67.

Re-evaluating COVID-19 Morbidity and Mortality: An Analysis of the "Hybrid Harms Hypothesis"

Executive Summary

This report delves into the "Hybrid Harms Hypothesis," a new conceptual framework that challenges conventional understandings of COVID-19 morbidity and mortality, particularly in extensively vaccinated populations. Contrary to the widely promoted narrative that COVID-19 messenger RNA (mRNA) vaccinations reduce disease severity and sequelae, this hypothesis posits that these vaccinations may act as triggering mechanisms that amplify COVID-19 morbidity and "post-acute sequelae of COVID-19" (PASC).

The core of the hypothesis lies in the convergence of extensive spike protein harms from both mRNA vaccination and natural SARS-CoV-2 infection. Key findings supporting this perspective include:

• Rapidly waning vaccine efficacy: Initial high efficacy claims rapidly declined, with protection against symptomatic Omicron infection plummeting to 10-20% by 6 months after the second dose. This led to widespread "breakthrough infections" (BTIs), some of which were severe or critical, with a reported mortality rate significantly higher than that of natural infection in similar age groups.

• Negative efficacy: Studies suggest that repeated mRNA vaccine doses paradoxically increase the risk of contracting COVID-19. For instance, one large study showed infection risk rising by 107% after one dose and up to 253% after more than three doses compared to unvaccinated individuals. Global analyses further suggest a correlation between vaccination programs and significant increases in both COVID-19 cases (up to 291%) and deaths (up to 205%).

• Three-pronged toxic payload and whole-body distribution: The mRNA products are described as having an immunotoxic payload consisting of spike protein, inflammatory lipid nanoparticles (LNPs), and process-related DNA impurities (some exceeding regulatory limits by hundreds of times). These components do not remain localized but can distribute throughout the entire body, crossing barriers like the blood-brain and blood-placenta barriers, leading to systemic inflammatory organ damage and potential neurodegenerative issues.

• Prolonged spike antigen exposure: Early assumptions of rapid clearance (days to weeks) are refuted by evidence showing vaccine-induced spike protein can persist for months, up to 17 months in cerebral arteries, almost 2 years in circulation, and even mRNA itself detected 3.2 years post-injection. This prolonged exposure creates a "window of vulnerability" (WOV) of 2-3 years, potentially leading to chronic inflammation and immune dysfunction.

• Cumulative adverse effects and immune dysregulation: Multiple doses are linked to increased toxic impacts, T-cell exhaustion, and a problematic shift to IgG4 antibodies, which may favor immune tolerance over viral elimination, increasing susceptibility to infections, cancers, and autoimmune diseases.

• Overlapping pathologies and misattribution: Both mRNA vaccinations and SARS-CoV-2 infections can trigger similar immunologic changes, including hyperinflammation, autoimmunity, lymphopenia, and interferon suppression, suggesting amplified adverse effects when combined. Many "long COVID" (PASC) cases in vaccinated individuals may in fact be "post-COVID-19 vaccine syndrome" (PCVS), as vaccinated individuals with long COVID symptoms showed significantly higher spike antibody levels. Systemic biases in data collection and misclassification have obscured the true scope of vaccine-related harms, often attributing them solely to the virus.

• Co-amplification of cardiovascular and hematological adverse events (AEs): There is strong evidence linking mRNA vaccines to severe cardiac complications like myocarditis, with a more direct mechanistic pathway than the virus itself. Subclinical vaccine-induced myocarditis may be exacerbated into fulminant disease by subsequent infection. Epidemiological data from highly vaccinated countries show paradoxical spikes in all-cause mortality synchronizing with mild Omicron waves, suggesting the interaction amplified these outcomes.

This report advocates for a re-examination of public health strategies, emphasizing the need for comprehensive long-term safety data, accurate attribution of adverse events, and a balanced assessment of natural versus vaccine-induced immunity. It challenges the simplistic "vaccine versus virus" dichotomy, proposing that the interaction between the two may be a primary driver of adverse outcomes in extensively vaccinated populations.

1. Introduction: Re-evaluating COVID-19 Morbidity and Mortality

The coronavirus disease of 2019 (COVID-19) profoundly impacted global health, leading to hundreds of millions of infections and fatalities. Public health authorities initially attributed severe COVID-19 outcomes predominantly to uncontrolled viral replication and aberrant host immune responses, particularly in vulnerable populations. During this period, COVID-19 messenger RNA (mRNA) vaccinations were vigorously promoted as the primary solution to mitigate the pandemic's severity, with claims that they would significantly reduce the severity of COVID-19 and its sequelae.

However, the rapid authorization of these novel gene transfer products, after only 2-3 months of trial data, left significant gaps in long-term safety and efficacy assessments. This report will unpack a challenging perspective presented in a recent review paper, the "Hybrid Harms Hypothesis," which counters the widespread claims of vaccine-induced protection and instead proposes that mRNA vaccinations are triggering mechanisms that amplify COVID-19 morbidity and "post-acute sequelae of COVID-19" (PASC).

The core argument is that in extensively vaccinated populations (post-2021), many morbidity and mortality events attributed to COVID-19 were, in fact, due to the long-term background persistence of toxic spike protein and other vaccine-associated components resulting from prior mRNA vaccinations, superimposed with natural SARS-CoV-2 infection. This "convergence of extensive spike protein harms" leads to overlapping toxicities and immunological effects, causing pronounced immune dysregulation and inflammatory cascades. The paper calls for a re-examining of the unique immunopathological dynamics of coronavirus infection in COVID-19 mRNA-vaccinated individuals and their implications for public health strategies.

2. Waning Immunity and the "Breakthrough Infections" Phenomenon

Initial assessments of the COVID-19 mRNA products, such as BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), reported efficacy of up to 95% for preventing symptomatic SARS-CoV-2 infection within weeks of the second dose. These claims were based on short-term randomized trial data.

However, subsequent observational studies revealed a rapid decline in humoral immune protection. Neutralizing antibody titers, after an initial surge, declined quickly within 2-6 months, especially in elderly and vulnerable populations.

• Protection against symptomatic Omicron infection was observed to drop to about 10-20% by 6 months following the second dose of mRNA products. For example, vaccine effectiveness against Omicron for those who received two BNT162b2 doses fell from 65.5% (2-4 weeks post-dose) to 15.4% (at ~4 months) and further to 8.8% (after 6 months).

• mRNA vaccine-induced neutralizing antibodies, while initially higher, declined much faster in mRNA recipients compared to individuals with natural infection.

• This rapid waning immunity, along with viral evolution and immune imprinting (where the immune system focuses on earlier variants, limiting effectiveness against newer strains), contributed to an increased risk of post-mRNA-vaccination infection and reinfection by Delta and Omicron variants, even in "fully vaccinated" individuals. These are termed "breakthrough infections" (BTIs).

The prevalence and severity of BTIs challenge initial assumptions that they would be extremely rare.

• A survey in Saudi Arabia found that 43.5% of fully vaccinated participants contracted COVID-19 after full vaccination. The true extent of BTIs is likely underreported due to a lack of screening for asymptomatic cases and testing biases.

• More concerning, BTIs were not always mild. A longitudinal study in Tunisia reported that approximately 11% (10.8%) of 765 BTIs were severe or critical, with patients having cardiovascular diseases being twice as likely to experience severe outcomes.

• Another observational study of 1479 BTI cases reported a mortality rate of 0.9%. This is significantly higher than the typical 0.03%-0.05% infection fatality rate (IFR) for natural COVID-19 infection in similar age groups.

• Population statistics from the U.K. and U.S. further indicate the potential lethality of some BTIs, with 29% of Delta variant deaths in June 2021 in the U.K. occurring in fully vaccinated individuals, rising to 43% by June 25th. In the U.S., states like Illinois and Massachusetts reported hundreds to thousands of BTI deaths by early 2022.

• These BTI death counts are likely underestimated due to systemic biases in data collection and reporting, driven by biopharmaceutical industry financial incentives and political pressures to promote vaccine efficacy. For instance, inconsistencies in classifying "fully vaccinated" status or limiting surveillance resources may have contributed to underreporting.

3. Negative Efficacy of mRNA Products

Beyond waning immunity and vaccine failures, later studies also revealed a phenomenon termed "negative efficacy," where repeated or successive doses of modified mRNA products lead to a further disruption of immune system functioning, increasing the likelihood of contracting the targeted disease—COVID-19—compared to unvaccinated individuals.

• In September 2021, the European Medicines Agency warned that frequent COVID-19 booster shots could adversely affect the immune response.

• A Swedish study found that eight months after receiving two mRNA injections, vaccinated individuals had lower immune function compared to their non-vaccinated counterparts, especially older adults and those with pre-existing conditions.

This paradoxical heightening of susceptibility was demonstrated in a large-scale retrospective cohort study at the Cleveland Clinic (n=51,017).

• While mRNA vaccinations initially reduced infection risk by 29% during the BA.4/5 wave, this protection diminished significantly.

• Crucially, the risk of infection actually rose with successive doses: 107% higher risk for 1 dose, 150% for 2 doses, 210% for 3 doses, and 253% higher for >3 doses compared to unvaccinated individuals.

• In contrast, unvaccinated Cleveland Clinic employees with prior SARS-CoV-2 exposure showed no reinfections over five months, suggesting robust natural immunity.

• Similar findings from a Japanese case-control study reported an elevated infection risk among vaccinated individuals (adjusted OR, 1.85), with a dose-dependent trend: 63% higher risk for 1-2 doses, 104% for 3-4 doses, and 121% for 5-7 doses.

• Comparable findings from Qatar, the UK, Iceland, and four other US studies reinforce increased infection rates post-vaccination, particularly after six months or additional doses. An Israeli study found a 27-fold higher risk of contracting symptomatic COVID-19 in vaccinees compared to unvaccinated individuals within the same healthcare system.

A global Bayesian causal analysis of 145 countries evaluated the impact of vaccination programs on cumulative cases and deaths per million.

• Approximately 90% (89.84%) of countries exhibited increased mortality rates post-vaccination.

• The analysis suggested a causal link between vaccination programs and elevated total deaths and cases, finding that COVID-19 vaccinations significantly increased global COVID-19 cases by up to 291% and COVID-19 deaths by up to 205.25%. These increases correlated positively with the number of vaccine doses administered.

Visual data from the Johns Hopkins Coronavirus Resource Center further illustrate this phenomenon. Charts for eight countries (four Nordic and four Southeast Asian) show that major surges in COVID-19 incidence and mortality became apparent only after the population attained at least 75% vaccine coverage. Given that the Omicron variant, which was dominant in 2022, was characterized by mild pathogenicity, the authors argue that these elevations cannot be reasonably ascribed to Omicron infections alone. Instead, the Hybrid Harms Hypothesis offers an alternative explanation: an interaction between widespread infections and widespread injections.

4. The "Three-Pronged Toxic Payload" and Whole-Body Distribution

The Hybrid Harms Hypothesis posits that the COVID-19 mRNA product's immunotoxic payload consists of three primary components: spike protein, lipid nanoparticles (LNPs), and process-related impurities.

Prong 1: Spike Protein Harm The spike protein, central to both SARS-CoV-2 infection and mRNA vaccines, is itself argued to exhibit toxic and pathogenic potential. Its pathological effects, or "spikeopathy," are believed to arise from mechanisms causing:

• Oxidative stress and inflammation.

• Thrombogenesis (blood clot formation).

• Endotheliitis-related tissue damage by downregulating ACE2 and inhibiting mitochondrial function.

• Prion-related dysregulation, potentially contributing to neurodegenerative disorders.

Prong 2: Lipid Nanoparticle (LNP) Harm The LNP delivery system, designed to protect the synthetic mRNA, is presented as a significant source of potential harm due to its inflammatory properties.

• LNPs contribute to prolonged inflammation through excessive production of inflammatory cytokines and chemokines.

• The ionizable cationic lipids in LNPs are intrinsically immunotoxic, capable of activating pro-inflammatory and pro-apoptotic pathways, including the NLRP3 inflammasome and toll-like receptor (TLR) pathways (e.g., TLR4, linked to cancer progression).

• Pre-existing inflammation in animal models was shown to amplify the inflammatory impacts of the mRNA vaccine's LNPs, raising concerns for individuals with chronic inflammatory diseases or "inflammaging".

Prong 3: Process-Related DNA Impurities The third source of concern is the billions of plasmid-sourced DNA fragments introduced into each dose during the mRNA vaccine production process.

• Pfizer’s Comirnaty product reportedly contains plasmid DNA contaminants exceeding acceptable limits by hundreds of times, sometimes over 500-fold.

• A major concern is the potential for these DNA fragments (e.g., SV40) to integrate into the human genome through insertional mutagenesis, which could disrupt immune function, trigger autoimmune conditions, and potentially lead to oncogenesis.

• A Florida Department of Health study suggested a 38% greater risk of all-cause mortality and 88% higher COVID-19-specific mortality in Pfizer BNT162b2 recipients compared to Moderna mRNA-1273 recipients over 12 months, speculating a link to higher DNA contamination levels in Pfizer products. This study also noted that boosting with Pfizer's vaccine resulted in higher IgG2 and IgG4 levels compared to Moderna, with IgG4 class switching potentially increasing susceptibility to infectious diseases, autoimmune conditions, and cancers.

Whole-Body Biodistribution Contrary to early assumptions that mRNA products remain localized, research indicates that both the mRNA encoding the spike protein and the protein itself can distribute to distal tissues throughout the entire body, resembling an invasive, blood-borne infectious agent.

• Japanese rodent biodistribution studies showed LNPs deliver synthetic mRNA to nearly all organs, crossing the blood-brain and blood-placenta barriers.

• This systemic distribution explains why vaccine-induced spike protein has been linked to inflammatory organ damage affecting the heart, liver, spleen, ovaries, and nervous system.

• Spike protein can trigger neuroinflammation and neurotoxic effects, and frameshifting events during translation of pseudouridinated mRNA can produce aberrant proteins capable of forming toxic prion-like fibrils in neurons, potentially accelerating neurodegenerative disorders. A "startling surge" in rare prion diseases was reported beginning in 2021, with symptoms appearing on average 11.38 days post-injection.

5. Prolonged Spike Antigen Exposure and Cumulative Effects

A crucial aspect of the Hybrid Harms Hypothesis is the prolonged persistence of vaccine-derived spike protein and mRNA in the human body, which contradicts early assertions of rapid clearance.

• Initially, it was assumed spike protein would clear within 1-2 weeks. However, emerging data indicated persistence for 4-8 weeks, then over 4 months on exosomes circulating throughout the body.

• More recent studies have shown detectable spike protein in circulation for 6-8 months (187-245 days).

• In one Japanese study, spike protein was found in cerebral arteries up to 17 months following mRNA vaccination in hemorrhagic stroke patients.

• Detectible post-vaccination spike protein levels persisted for 23.6 months (709 days) in individuals with substantial immune dysfunction.

• Most strikingly, a well-adjudicated case report cited in the paper documented detectable Pfizer vaccine-generated mRNA in the blood 3.2 years after the modified mRNA injection.

This prolonged persistence, estimated to be in the range of 24 to 38 months (2-3 years), is termed the "window of vulnerability" (WOV). It suggests that vaccinated cells become "viral protein production factories" without an inherent "off switch" to regulate spike production. The primary concern is that this prolonged generation of spike protein and the resulting cumulative antigenic load may lead to ongoing systemic inflammation, immunologic dysfunction, and a host of immune-related disorders.

Cumulative Adverse Effects from Multiple Doses The hypothesis logically extends to suggest that repeated COVID-19 mRNA vaccinations result in increased and potentially cumulative toxic impacts along with disruption of immune system functioning, a "Triple-Hit Hypothesis" where additional exposure to coronavirus infection further triples spike protein exposures.

• Successive doses are linked to chronic immune dysfunction, including T-cell exhaustion (where key immune cells become worn out) and an antibody class-switching to IgG4.

• This IgG4 class switch, notably observed almost exclusively in individuals who received multiple mRNA vaccinations or who were infected after vaccination, may favor immune tolerance over viral elimination, potentially weakening antiviral defenses and increasing the risk of infectious diseases, IgG4-related autoimmune diseases, and various cancers.

• Studies from the U.S. and Japan show elevated rates of COVID-19 correlating with an increasing number of mRNA vaccine doses, indicating worsening or negative efficacy with more shots. This suggests that regular, successive doses of the COVID-19 mRNA product may have a more deleterious impact when followed by coronavirus infection.

6. Overlapping Immunologic Variations & Misattribution of Harms

The Hybrid Harms Hypothesis emphasizes that COVID-19 mRNA vaccinations and natural coronavirus infections can result in similar immunologic variations, leading to strong potential for additive or synergistic effects. This convergence of pathophysiological manifestations is alarming, as it suggests an amplification of serious adverse events (AEs) in mRNA-vaccinated individuals subsequently exposed to infection.

Shared Pathophysiological Mechanisms

• Hyperinflammation: Both vaccination and severe SARS-CoV-2 infection trigger elevated levels of inflammatory cytokines (e.g., IL-6, IL-1β), leading to "cytokine storms" and tissue damage, particularly in the lungs.

• Autoimmunity: Both exposures can promote autoimmune reactions through mechanisms like molecular mimicry, epitope spreading, and bystander activation, potentially leading to new-onset autoimmune conditions (e.g., rheumatoid arthritis, lupus erythematosus, autoimmune hepatitis).

• Lymphopenia: A reduction in T-lymphocytes, which raises the risk of infections, is nearly universal in severe COVID-19 cases and has also been observed after multiple mRNA vaccinations.

• Interferon Suppression: Both the infection and the mRNA injections have been shown to induce autoantibodies against type I interferons, which are critical for antiviral and anticancer immune responses.

Post-Vaccine Syndrome (PCVS) vs. Post-COVID Syndrome (PASC) Initially, it was assumed that mRNA vaccines would reduce the incidence of PASC (Long COVID). However, emerging evidence challenges this, indicating a probable association between COVID-19 mRNA vaccination and an increased risk of PASC-like syndromes.

• The spike protein is implicated in the pathogenesis of both PASC and post-vaccination syndromes, with vaccine-induced spike protein persisting for at least 2-3 years.

• A study measuring SARS-CoV-2 spike antibody levels in patients with long COVID symptoms found that vaccinated individuals (with "post-COVID-19 vaccine syndrome" or PCVS) had an average spike antibody level of 11,356 U/mL, approximately seven times higher than unvaccinated individuals (1,632 U/mL), despite the vaccinated group having no recent infections. This suggests a much higher and persistent spike protein burden in vaccinated individuals experiencing long COVID-like symptoms.

• A retrospective analysis found that 70% of PASC cases occurred in individuals who had completed a full course of mRNA vaccinations, suggesting these injectables may exacerbate or precipitate PASC symptomology. Unvaccinated individuals exposed to Omicron showed the lowest PASC incidence.

• Given the mechanistic overlap and identical signs/symptoms, researchers advocate reclassifying PASC cases as PCVS or "post-acute COVID-19 injection syndrome" (PACIS), especially in extensively vaccinated regions, as it is difficult to disentangle the prolonged vaccine-elicited spike protein production from spike-related effects of prior or subsequent infections. A table of overlapping sequelae across various organ systems (cardiovascular, hematological, neurological, autoimmune, etc.) highlights this.

Misattribution of Causality A critical concern is the systematic misclassification of AEs, often attributed solely to the viral infection due to temporal association, overlooking the contribution of prior mRNA vaccination.

• The "case-counting window bias" is a fundamental flaw in many studies comparing vaccinated to unvaccinated groups, where individuals experiencing serious AEs shortly after vaccination (e.g., within 14 days of the second dose) are misclassified as "unvaccinated". This practice artificially inflates vaccine efficacy and safety estimates, making an ineffective vaccine appear moderately effective.

• This misclassification leads to vaccine-related AEs being erroneously attributed to PASC, and worse, as PASC occurring among the unvaccinated, thereby distorting risk-benefit analyses and reinforcing the "safe and effective" narrative.

7. Hybrid Harms due to Co-Amplification of Cardiovascular and Hematologic AEs

The Hybrid Harms Hypothesis finds strong support in the overlapping risks and co-amplification of cardiovascular and hematologic adverse events following both mRNA vaccination and coronavirus infection.

Myocarditis and Pericarditis

• While initially reported as a safety signal by the CDC in May 2021, public health agencies often claimed that coronavirus infections caused more myocarditis than mRNA vaccinations. However, this claim has been soundly refuted, with evidence supporting a stronger link between mRNA vaccines and severe cardiac complications.

• Vaccine-induced spike protein has been identified in cardiac tissue of individuals who died post-vaccination, and experimental models show direct cardiotoxic effects of BNT162b2 and mRNA-1273 vaccines on rat cardiomyocytes, leading to pathophysiological impairments linked to cardiomyopathy, effects not observed with SARS-CoV-2 itself.

• The hypothesis posits that mRNA vaccine-related subclinical myocarditis may be exacerbated by subsequent exposure to infection-induced spike protein, triggering hyperimmune responses and cardiomyocyte damage. A second immune challenge from coronavirus infection could transform subclinical myocarditis into fulminant myocarditis, increasing the likelihood of arrhythmias and heart failure.

• There is a dose-response relationship for myocarditis risk: Multi-country analyses show a three- to five-fold increase in risk with the second mRNA dose, especially in young males. Moderna's mRNA-1273, with three times the mRNA concentration, resulted in a doubling of myocarditis/pericarditis risk compared to Pfizer's BNT162b2.

• Case synopses highlight this "hybrid harms" phenomenon, where young, previously healthy vaccinated males developed acute myocarditis or severe cardiac events after Omicron infection, suggesting the infection was a precipitating factor on a background of vaccine-induced vulnerability.

• A Nordic study of 23 million residents estimated that mRNA vaccine-associated myocarditis rates were significantly higher than those linked to infections: approximately four times higher after the second Pfizer dose and over 13 times higher after the second Moderna dose in young males aged 16-24, compared to infection-related myocarditis based on positive tests. This study, despite potential underestimation of infection rates, provides strong support for vaccine-attributed cardiac risk.

Other Serious Cardiac and Hematological Events

• The same coagulopathies and thrombotic complications seen in severe COVID-19 disease are mirrored by serious AEs from mRNA vaccinations, including myocardial infarction, disseminated intravascular coagulation, and venous thromboembolism. Both exposures can trigger endothelial dysfunction, systemic inflammation, and dysregulated coagulation cascades.

• A study found that the combination of mRNA injections and coronavirus infection was associated with the development of severe heart failure and cardiogenic shock in patients with a severe type of myocardial infarction (STEMI).

• A South Korea study of nearly 3.4 million people found that mRNA recipients infected by SARS-CoV-2 showed a nearly four-fold higher heart disease risk than uninfected mRNA recipients.

• In a retrospective study of hospitalized elderly COVID-19 patients, vaccinated individuals had twice the odds of dying compared to their never-vaccinated counterparts.

• Breakthrough infections were associated with significantly increased risks for stroke (HR=1.76), myocardial infarction (HR=1.93), and pulmonary embolism (HR=3.94), with these risks progressively higher with increasing disease severity.

8. Epidemiological Support from the Omicron Era and Broader Implications

Epidemiological patterns from 2021-2023 provide compelling support for the Hybrid Harms Hypothesis, particularly the paradoxical increase in mortality during the Omicron era. Despite Omicron's relatively mild pathogenicity, many countries with high vaccination coverage experienced unexpected spikes in mortality following Omicron waves.

• In the U.S. and U.K., age-adjusted mortality rates peaked during 2022 Omicron surges.

• France saw a case fatality rate from Omicron four times higher than influenza in 2022-2023.

• Germany recorded Omicron infection peaks with a 12.4% in-hospital mortality rate for severe cases.

• Nordic countries (Denmark, Norway, Finland) experienced excess mortality in 2022, coinciding with widespread Omicron infections and strong vaccination coverage, unlike Sweden which showed excess mortality earlier in 2020 (when restrictions were lighter).

• South Korea, Hong Kong, Singapore, and Australia, all heavily mRNA-vaccinated by 2022 (75-90% coverage), showed pronounced elevations in excess mortality synchronizing with Omicron waves. For instance, Hong Kong had an average excess mortality of 71.14% during its Omicron wave in early 2022.

• A multi-country study found a striking rise in COVID-19 deaths in tandem with vaccination coverage, from 43.3% in Africa to 1275% in the Western Pacific. Paradoxically, COVID-19 mortality surged in 2022-2023 when the milder Omicron variant dominated, particularly in heavily vaccinated regions.

• In contrast, regions with low mRNA vaccination coverage, like Africa and Haiti, exhibited much lower COVID-19-related morbidity and mortality rates.

• Even individuals with "hybrid immunity" (prior infection + vaccination) who were re-infected and hospitalized showed elevated risks of post-acute all-cause mortality and hospital readmission.

The conventional explanation, that Omicron's intrinsic virulence was increasing exponentially, is challenged. Instead, the authors argue it is more likely that extensive mRNA vaccination created a background of prolonged vaccine-induced spike protein production, interacting with Omicron to amplify excess mortality.

Broader Discussion and Implications The fundamental question of whether COVID-19 mRNA vaccination or Omicron infection causes more morbidity and mortality is, from the Hybrid Harms perspective, biologically untenable as a simple dichotomy. The persistence of spike protein for months or years post-injection creates a complex interaction.

• Clinical misunderstanding and misreporting can arise when this interaction is overlooked. A patient's myocarditis after COVID-19 may be attributed solely to the infection, ignoring the prior mRNA vaccination as a "catalyst" or "effect modifier" that significantly increased risk due to pre-primed myocardium.

• The "multi-spike phenomenon" explains continued AEs in young, healthy individuals, even with mild Omicron. It suggests mRNA injections predispose low-risk individuals to infection and severe AEs, yet these are often misattributed solely to COVID-19.

• Negative efficacy and serious AEs stem from immune dysregulation linked with multiple doses. Repeated exposures to vaccine-induced spike protein can lead to elevated IgG4 antibodies, favoring immune tolerance and potentially weakening antiviral defenses, increasing the risk of infectious, autoimmune, and malignant diseases. This IgG4 class switch is notable for appearing almost exclusively in individuals who received multiple mRNA vaccinations or were infected after vaccination, unlike conventional vaccines.

• Attempting to vaccinate an entire population during an active epidemic is epidemiologically dangerous:

  • It drives mutation and selects for vaccine-resistant viral strains when transmission remains uncontrolled in highly vaccinated populations. Vaccinated individuals may carry and transmit the virus at comparable or even higher viral loads than unvaccinated individuals.

  • There is a real potential for direct mRNA vaccine spike-induced endothelial damage, pathogenic priming (antibody-dependent enhancement), and autoimmune-inflammatory disease processes. Pathogenic priming, observed in other viral infections, could exacerbate disease severity if vaccine-induced antibodies are non-neutralizing.

  • The concept of steric immune refocusing suggests that updated mRNA products and BTIs promote broadly cross-reactive but sub-neutralizing antibodies, fostering immune selection pressure for highly infectious, immune-evasive variants.

  • Molecular mimicry between SARS-CoV-2 spike glycoprotein and human proteomes contributes to extensive cross-reactivity, potentially triggering or exacerbating autoimmune and multisystem disorders.

The epidemiological implication is that temporal causal reasoning leads to systematic misclassification, attributing serious AEs in vaccinated individuals solely to the virus, thereby underestimating the mRNA vaccination's role. This distorts perceived relative risks and hinders accurate public health recommendations.

9. Conclusions and Recommendations

The "Hybrid Harms Hypothesis" posits that interactions between COVID-19 mRNA injections and subsequent coronavirus infections explain the manifestation and/or persistence of serious adverse events (AEs) in previously vaccinated individuals. The biological impact of mRNA vaccination may be a precursor event, predisposing individuals to post-COVID-19 sequelae (e.g., cardiovascular, hematological, neurological, autoimmune conditions) within a post-injection "window of vulnerability" of up to 3 years. Coronavirus infections can then amplify these adverse effects. A plausible mechanism for the prolonged persistence of spike protein is the latent integration of the vaccine product’s genetic material (including plasmid-sourced foreign DNA like SV40) into the human genome, enabling persistent spike protein production from latently infected cells.

Despite the mild pathogenicity of the Omicron variant, which became dominant in 2022, extensively vaccinated countries experienced paradoxical spikes in all-cause mortality that synchronized with Omicron waves. This strongly suggests that these infections were superimposed on a pre-existing vaccine-induced milieu of toxic spike protein, inflammatory lipid nanoparticles, and residual DNA impurities. For example, subclinical vaccine-induced myocarditis could be exacerbated into clinical myocarditis and severe sequelae by a subsequent infection, due to the combined inflammatory impact of persistent vaccine-derived spike protein and infection-induced spike protein.

Key immunological mechanisms, including IgG4 class switch, T-cell exhaustion, and pathogenic priming, appear to account for the increased susceptibility to coronavirus infections observed after repeated mRNA product administration. These post-vaccination infections are then more likely to trigger clinically significant health problems if the individual received an mRNA injection within the preceding 2-3 years. The misattribution of such events solely to the viral infection, due to strong temporal associations or incidental RT-PCR findings, distorts true causality. The presence of spike protein from both sources in affected tissues (e.g., myocardium, cerebral arteries) reinforces the combined causation.

The current understanding of spike protein clearance from the body, now recognized as prolonged persistence rather than short-term expression, challenges earlier assumptions about mRNA product kinetics and their biological implications. This new perspective underscores that natural immunity, derived from prior infection, may offer superior protective immunity due to its comprehensive immune response and the absence of serious AEs linked to mRNA vaccinations.

Strategic Recommendations:

Based on the Hybrid Harms Hypothesis and the evidence presented, a fundamental shift in public health approach is warranted:

• Re-examine Immunopathological Dynamics: Public health strategies must acknowledge and re-examine the unique immunopathological dynamics that arise from coronavirus infection in COVID-19 mRNA-vaccinated individuals.

• Prioritize Research on Spike Protein Syndromes: Federal agencies should immediately shift research priorities to fully describe the pharmacokinetics and dynamics of mRNA, adenoviral DNA, and spike protein, aiming to clear or neutralize this pathogenic entity.

• Discontinue Further Booster Vaccinations: Given the potential for cumulative adverse effects and immune dysregulation, further booster vaccinations should be discontinued as a safety measure.

• Implement Comprehensive Patient Histories: Medical professionals should routinely document both COVID-19 vaccination history (including dates) and Omicron variant infection history when assessing cardiovascular, hematological, and neurological issues.

• Promote Natural Immunity and Self-Care: Public health education should prioritize self-care practices (e.g., nutrition, exercise, stress management) for optimizing natural immunity as a viable strategy for minimizing COVID-19 risk.

• Conduct Rigorous Clinical Trials with Adequate Washout Periods: Future vaccine assessments must involve placebo-controlled trials using saline placebos to accurately document AE profiles. Crucially, a minimum "washout" period of three years should be established to ensure the clearance of synthetic mRNA and vaccine-associated spike protein, thereby allowing for valid trial outcomes and accurate attribution of AEs and efficacy.

• Reclassify and Acknowledge Post-Vaccination Syndromes: The scientific community should consider recognizing "post-COVID-19 vaccination syndrome" (PCVS) or "post-acute COVID-19 injection syndrome" (PACIS) as distinct diagnostic categories or as conditions that subsume many PASC cases, to reflect the contribution of mRNA injectables.

• Address Methodological Biases in Reporting: A transparent review and correction of systemic biases, particularly the "case-counting window bias" and miscategorization of vaccination status, are essential to ensure accurate risk-benefit assessments and public trust in public health data. The current practice of downplaying vaccine effects while emphasizing infection risks, and maintaining the "benefits outweigh risks" narrative despite evidence, needs critical re-evaluation.

lm

The "Hybrid Harms Hypothesis" proposes that interactions between COVID-19 mRNA vaccinations and subsequent coronavirus infections can explain the manifestation and/or persistence of serious adverse events (AEs) in previously vaccinated individuals, even with milder Omicron variants. This hypothesis challenges the notion of a simple dichotomy between vaccine effects and viral infection effects, suggesting a convergence of extensive spike protein harms to the human body.

Here's how vaccinated individuals, due to the persistent presence of spike protein in their bodies, may experience an increase in chronic issues like myocarditis, blood clotting disorders, and "long COVID" symptoms:

• Persistent Spike Protein and Overlapping Toxicities:
  
  

  • The Hybrid Harms Hypothesis posits that coronavirus infections are often superimposed on a pre-existing milieu of toxic spike protein, inflammatory lipid nanoparticles (LNPs), and residual process-related DNA impurities induced by mRNA vaccination.

  • Spike proteins generated from both mRNA vaccination and natural SARS-CoV-2 infection have been shown to persist for extended periods, raising concerns for long-term safety. While initial assumptions suggested spike protein would clear within days or weeks, evidence indicates it can persist for 4-8 months, up to 17 months in cerebral arteries of stroke patients, and even for 23.6 months (nearly two years) in circulation in some individuals. One case report cited by the authors suggests detectable Pfizer vaccine-generated mRNA was found in the blood 3.2 years after injection.

  • This prolonged presence and cumulative antigenic load can lead to ongoing systemic inflammation, immunological dysfunction, and various immune-related disorders. The authors refer to this prolonged presence as a "window of vulnerability" (WOV), potentially lasting 2-3 years post-vaccination, during which subsequent coronavirus infections may amplify adverse effects linked to the vaccine-induced spike protein.

• Three-Pronged Immunotoxic Payload and Whole-Body Distribution:
  
  

  • The COVID-19 mRNA products are described as having a "three-pronged toxic payload": spike protein, lipid nanoparticles (LNPs), and process-related impurities.

  • Spike protein itself is not benign; it can damage endothelial cells, cause oxidative stress, trigger inflammation, and promote thrombogenesis.

  • Lipid nanoparticles (LNPs), the delivery system for mRNA, are intrinsically immunotoxic and can contribute to prolonged inflammation by activating pro-inflammatory and pro-apoptotic pathways. Pre-existing inflammation (e.g., from chronic diseases like obesity or diabetes) can amplify these inflammatory impacts.

  • Process-related DNA impurities, such as plasmid-sourced DNA fragments (e.g., SV40 fragments), can exceed acceptable limits by hundreds of times in some products (e.g., Pfizer's Comirnaty). Concerns are raised about their potential for integration into the human genome and triggering autoimmune conditions.

  • These components are distributed throughout the entire body, crossing barriers like the blood-brain barrier and blood-placenta barrier, rather than remaining localized. This systemic biodistribution explains why vaccine-induced spike protein has been linked to inflammatory organ damage in the heart, liver, spleen, ovaries, and nervous system, and can exert direct neuroinflammatory and neurotoxic effects.

• Increased Risk of Chronic Issues:
  
  

  • Myocarditis and Cardiovascular Conditions:
    
    

    • Both COVID-19 mRNA vaccinations and coronavirus infections can cause myocarditis (inflammation of the heart muscle).

    • Evidence suggests a stronger link between COVID-19 mRNA vaccines and severe cardiac complications compared to SARS-CoV-2 infections alone. Autopsy studies have identified vaccine-derived mRNA and spike protein in cardiac tissue post-vaccination, and in vitro studies show direct cardiotoxic effects of mRNA vaccines on heart cells, which have not been observed with the virus itself.

    • The hypothesis suggests that subclinical myocarditis induced by the mRNA vaccine may be exacerbated by a subsequent infection. Persistent vaccine-derived spike protein in cardiac tissues, combined with infection-induced spike protein, can trigger hyperimmune responses and cardiomyocyte damage. The subsequent viral infection acts as an "additional cardiac stressor," potentially transforming subclinical myocarditis into fulminant myocarditis, leading to arrhythmias and heart failure.

    • Repeated doses increase the risk of myocarditis, with the second mRNA dose associated with a three- to five-fold increase in risk, particularly in young males. Studies indicate a dose-response relationship, where higher mRNA concentration (e.g., Moderna vs. Pfizer) or more doses lead to greater cardiac AEs.

    • Case reports illustrate this "hybrid harms" phenomenon, where individuals, vaccinated months prior, developed severe myocarditis after Omicron infection, despite the variant's mild pathogenicity. The authors argue that the temporal proximity leads to misattribution, blaming the infection solely, when the prior vaccination likely predisposed the individual to the severe outcome.

  • Blood Clotting Disorders (Thrombotic Events):
    
    

    • Both mRNA injections and coronavirus infections can trigger and amplify clotting disorders and endothelial dysfunction.

    • The same coagulopathies seen in severe COVID-19 are mirrored by serious thrombotic complications from mRNA vaccinations, including myocardial infarction, disseminated intravascular coagulation, and venous thromboembolism.

    • Spike protein, whether from the virus or vaccine, can interact with ACE2 receptors and promote a hypercoagulable state through cytokine storms and upregulation of procoagulant factors. Vaccine-induced immune thrombotic thrombocytopenia (VITT), involving autoantibodies and transient spike protein-mediated endothelial activation, also promotes thrombosis.

    • A study in South Korea found that vaccinated individuals who contracted SARS-CoV-2 had a nearly four-fold higher heart disease risk than uninfected vaccinated individuals. Another study found significantly increased risks for stroke, myocardial infarction, and pulmonary embolism in individuals with breakthrough infections after mRNA vaccination.

  • "Long COVID" (Post-Acute Sequelae of COVID-19 - PASC) and Post-COVID-19 Vaccine Syndrome (PCVS):
    
    

    • The paper suggests that Post-COVID-19 Vaccine Syndrome (PCVS), caused by mRNA vaccinations, may subsume many cases currently classified as PASC (commonly known as "long COVID").

    • The spike protein is implicated in the pathogenesis of both PASC and PCVS.

    • Studies show that vaccinated individuals with "long COVID" symptoms exhibited spike antibody levels approximately seven times higher than unvaccinated individuals who recovered from infection, even without a recent infection in the vaccinated group. This implies a potentially higher or more persistent spike protein burden in vaccinated individuals experiencing long-term symptoms.

    • A retrospective analysis found that 70% of PASC cases occurred in individuals who had completed a full course of COVID-19 mRNA vaccinations, suggesting the injections may exacerbate or precipitate PASC symptomatology. Conversely, unvaccinated individuals exposed to Omicron showed the lowest PASC incidence.

    • The overlapping clinical features (e.g., cardiovascular, neurological, dermatological, gastrointestinal issues) between PASC and PCVS make it difficult to disentangle the causality, leading to potential misclassification where vaccine injuries are erroneously attributed solely to viral infection.

• Immunological Dysfunction from Multiple Doses:
  
  

  • Repeated mRNA vaccinations are likely to lead to cumulative toxic impacts and immune system disruption. This "Triple-Hit Hypothesis" (two vaccine doses plus infection) could result in chronic immune dysfunction.

  • T-cell exhaustion (where key immune cells become worn out) and an antibody class-switch to IgG4 are observed after multiple mRNA vaccine doses. This IgG4 switch may promote immune tolerance rather than viral elimination, potentially increasing susceptibility to infections, cancers, and autoimmune diseases.

  • The paper notes that this switch towards spike-specific IgG4 appears almost exclusively in individuals who received multiple COVID-19 mRNA vaccinations or were infected after vaccination, unlike conventional vaccines.

• Misattribution of Causality ("Case-Counting Window Bias"):
  
  

  • The paper argues that studies often suffer from methodological flaws, such as "case-counting window bias," which can artificially inflate vaccine efficacy and safety estimates.

  • This bias occurs when individuals experiencing adverse events shortly after vaccination (e.g., within 14 days of the second dose) are misclassified as "unvaccinated" because the vaccine's protective effect is presumed not to have fully "kicked in" yet. This practice effectively shifts vaccine-related harms to the "unvaccinated" group, distorting risk-benefit analyses and underestimating the vaccine's role in adverse outcomes.

  • As a result, many morbidity and mortality events attributed to COVID-19 in heavily vaccinated populations (2022-2023) were likely due to the long-term background persistence of vaccine-induced spike protein and other vaccine-associated components, creating a false appearance of viral causation.

In summary, the Hybrid Harms Hypothesis suggests that the prolonged presence of vaccine-induced spike protein, combined with its systemic distribution and inherent toxicity, sets the stage for immune dysregulation. When a subsequent SARS-CoV-2 infection occurs during this "window of vulnerability," it can act as a "second hit," amplifying existing subclinical harms (like myocarditis or coagulopathies) or precipitating PASC-like symptoms, leading to an increased incidence and severity of chronic health issues that are then misattributed solely to the viral infection.

grok

Persistent Spike Protein from mRNA Vaccination: Overview and Hybrid Harms Hypothesis

The core idea discussed in the provided documents is the "Hybrid Harms Hypothesis," which posits that COVID-19 mRNA vaccines lead to prolonged production and persistence of the SARS-CoV-2 spike protein in the body, far beyond the initially assumed 1-2 weeks. This persistence creates a "window of vulnerability" (WOV) lasting at least 2-3 years, during which subsequent coronavirus infections (e.g., Omicron variants) can interact with the existing vaccine-derived spike protein. This interaction amplifies "spikeopathy"—a term for the toxic effects of the spike protein—resulting in compounded harms that manifest as chronic conditions. These harms are often misattributed solely to the infection due to temporal biases (e.g., symptoms appearing soon after infection) and systemic issues in data collection, which overlook the role of prior vaccination.

The spike protein, whether from the vaccine or natural infection, is pathogenic on its own. It causes oxidative stress, inflammation, endothelial cell damage (downregulating ACE2 receptors and impairing mitochondrial function), thrombogenesis (blood clotting), immune dysregulation (e.g., autoimmunity via molecular mimicry, T-cell exhaustion, and IgG4 class switching), and neurotoxic effects (crossing the blood-brain barrier). In vaccinated individuals, the mRNA vaccines instruct cells to produce spike protein systemically, and evidence shows this production can persist for months to years due to factors like frameshifting (mistranslation leading to aberrant proteins), lack of an inherent "off switch," and detection in exosomes, circulation, cerebral arteries, and even blood up to 3.2 years post-injection in some cases. This prolonged exposure sets the stage for amplified chronic issues when an infection adds more spike protein, leading to hyperinflammation, immune tolerance, and organ damage.

Below, I detail the mechanisms for each specified chronic issue, drawing from the hypothesis and supporting evidence in the documents.

Increased Risk of Myocarditis

Myocarditis (inflammation of the heart muscle) in vaccinated individuals arises from the direct and indirect toxic effects of persistent spike protein, which is exacerbated by subsequent infections:

• Direct Mechanisms from Persistent Vaccine-Derived Spike: The spike protein binds to ACE2 receptors on cardiac cells, triggering endothelial dysfunction, oxidative stress, and pro-inflammatory responses. This can lead to subclinical (mild, undetected) myocarditis shortly after vaccination, with spike protein detected in cardiac tissue via autopsies. For instance, vaccine-induced spike has been found in heart biopsies and is linked to dose-dependent innate immune activation, causing myocyte damage and inflammation. Studies cited in the documents show mRNA vaccine-associated myocarditis rates in young males (16-24 years) are 4-13 times higher after second doses compared to infection-related cases, with autopsies confirming spike in fatal cases.

• Amplification via Hybrid Harms (Infection Interaction): During the WOV, persistent vaccine spike in cardiac tissues creates a primed state of low-level inflammation. A subsequent infection introduces additional spike protein, triggering hyperimmune responses (e.g., cytokine storms) that transform subclinical myocarditis into fulminant (severe) forms. This can result in arrhythmias, heart failure, or cardiogenic shock. Case reports highlight sequences where vaccination precedes infection, leading to MRI-confirmed myocarditis with significant ventricular involvement (e.g., 19-22% left ventricular mass). Temporal bias often attributes this to the infection alone, but the hypothesis argues the vaccine's persistent spike is the underlying modifier, increasing severity. Repeated doses further elevate risk, as seen in Nordic cohort studies of 23 million people.

• Why Higher in Vaccinated Individuals: Vaccinated cohorts show higher spike antibody levels (up to 7 times more than unvaccinated), indicating a greater spike burden. This overlaps with PASC-like cardiac outcomes, where mRNA vaccination is not considered a risk factor in many studies, leading to underestimation of vaccine contributions.

Increased Risk of Blood Clotting Disorders

Blood clotting disorders (e.g., thrombosis, thromboembolism, vaccine-induced immune thrombotic thrombocytopenia or VITT) stem from the spike protein's ability to promote a hypercoagulable state, amplified in vaccinated individuals with persistent spike:

• Direct Mechanisms from Persistent Vaccine-Derived Spike: Spike protein interacts with ACE2 on endothelial cells, causing dysfunction, systemic inflammation, and dysregulated coagulation cascades. It upregulates procoagulant factors, leading to microvascular thrombosis, platelet activation, and clot formation. In mRNA vaccines, this manifests as VITT, where spike acts as a primary initiator, promoting antibodies against Platelet Factor 4 or transient endothelial activation. Persistent spike extends this risk, with detection in circulation for 6-8 months or longer, contributing to chronic thromboinflammatory processes like deep vein thrombosis, pulmonary embolism, or disseminated intravascular coagulation.

• Amplification via Hybrid Harms (Infection Interaction): Infections add viral spike, which mirrors vaccine effects by driving hypercoagulability through cytokine storms and endothelial damage. In vaccinated people, the preexisting spike from vaccination creates a cumulative burden, leading to more severe clotting events (e.g., myocardial infarction or stroke). The documents note that clotting disorders are a "common denominator" in both severe COVID-19 and post-vaccination complications, with hybrid exposure resulting in greater risks for venous thromboembolism or coagulopathy. For example, the pathophysiology involves shared mechanisms like endothelialitis and immune complexes, where persistent vaccine spike primes the system for amplified thrombosis upon infection.

• Why Higher in Vaccinated Individuals: Vaccinated populations show overlapping hematological AEs with PASC, such as anemia or immune thrombocytopenia. Studies indicate mRNA vaccines trigger these more frequently than infections alone, especially in susceptible groups, with misclassification inflating infection-attributed cases while downplaying vaccine roles.

Increased Risk of "Long COVID" Symptoms (PASC)

"Long COVID" or Post-Acute Sequelae of COVID-19 (PASC) symptoms—such as fatigue, dyspnea, cognitive impairment, myalgia, and dysautonomia—often overlap with Post-COVID Vaccination Syndrome (PCVS) or "post-acute COVID-19 injection syndrome" (PACIS), driven by persistent spike in vaccinated individuals:

• Direct Mechanisms from Persistent Vaccine-Derived Spike: Prolonged spike exposure leads to chronic immunotoxicity, hyperinflammation, and dysregulation (e.g., lymphopenia, T-cell exhaustion, autoimmunity via 100% homology to human proteins, and IgG4 class switching favoring tolerance over viral clearance). This mimics PASC by causing multisystem damage: neuroinflammation (brain fog, paresthesia), cardiovascular issues (tachycardia), and immune suppression (recurrent infections). Evidence shows vaccine-derived spike persists on exosomes for over 4 months, in arteries up to 17 months, and in some cases up to 38 months, creating sustained "spikeopathy" syndromes.

• Amplification via Hybrid Harms (Infection Interaction): Infections superimpose on this background, amplifying spike burden and leading to PASC-like outcomes that are more severe or frequent in vaccinated people. The hypothesis suggests many PASC cases are subsumed by PCVS, as it's hard to distinguish prolonged vaccine spike from infection effects. Vaccinated individuals with long COVID have spike antibody levels 7 times higher than unvaccinated, indicating higher exposure. Hybrid exposure increases risks for autoimmunity (e.g., rheumatoid arthritis, lupus), neurological disorders (e.g., transverse myelitis), and mast cell activation syndrome, contributing to excessive inflammation.

• Why Higher in Vaccinated Individuals: Emerging data show vaccinated cohorts are more susceptible to PASC-like syndromes than unvaccinated, with studies claiming vaccines reduce PASC often flawed by not accounting for vaccination status or hybrid effects. Misclassification (e.g., attributing vaccine AEs like stroke to PASC) inflates infection-related reports, while vaccinated groups show consistent multi-organ involvement (e.g., cardiovascular, neurological). This is particularly evident in extensively vaccinated populations during Omicron waves, where mild infections paradoxically led to higher PASC incidence due to underlying spike persistence.

In summary, the persistent spike protein from mRNA vaccines creates a chronic toxic milieu that interacts synergistically with infections, amplifying harms through shared pathways. This challenges narratives of vaccine protection and calls for re-evaluating risk-benefit analyses, especially for low-risk groups. The documents emphasize the need for studies distinguishing these effects to inform public health strategies.

PODCAST TRANSCRIPT

Welcome to the Lenny and Maria Sanchez deep dive podcast show.

Great to be here.

Today we're taking a deep dive into a well quite a challenging review paper. It looks at CO 19, specifically the interplay between mRNA vaccination and actually getting infected with the corona virus.

That's right.

Our mission really is to unpack what this paper calls the hybrid harms hypothesis. It's this idea that there might be a convergence, a combination of adverse effects from both the vaccine exposure and the infection itself. It's definitely a fascinating re-examination. It looks at how corona virus infection plays out in people who've had the mRNA vaccines and it um it really encourages us to look at the health outcomes we've seen since say 2021 maybe through a different lens

asking some different questions

asking some critical questions about what might be contributing factors.

Okay, so let's start right there with the core idea the hybrid harms hypothesis. The paper is suggesting that these mRNA vaccines they might not just be reduced ing severity which was the main selling point later on but could potentially be amplifying overall sickness

especially things like uh long covid or pace as it's technically called

right PSE postacute sec of co 19 and the hypothesis um proposes it's a mix of things you've got the spike protein from the vaccine maybe the inflammatory lipid nano particles potentially DNA impurities and then you combine that with a natural SARS KV2 infection

the paper calls this combination overlapping spike related toxicity.

overlapping toxicity like a double hit

kind of. Yeah, double hit scenario. And the paper argues this interaction leads to well significant immune system imbalance, widespread inflammation, and that this could help explain some of the waves of illness and unfortunately deaths we've observed.

All right, moving to the next point. The paper really digs into the effectiveness or maybe the waning effectiveness of these mRNA products. We all remember those initial reports, you know, up to 95% efficacy against symptoms. atic infection.

High numbers initially,

very high. But this paper points to subsequent studies showing well pretty rapid declines in that protection.

Exactly. And what's striking according to the paper is how quickly that protection seemed to fade. For example, um it highlights studies where effectiveness against symptomatic omocrron infection just plummeted down to maybe 10 20% by 6 months after the second dose.

Wow. That low.

Yeah. And this of course led to a lot of breakthrough infections. BTS eyes people fully vaccinated still getting COVID 19.

We heard a lot about those.

We did. And one survey mentioned, I think it was in Saudi Arabia, found almost half, 43.5% of fully vaccinated people later caught CO.

Nearly half.

And maybe more concerning, the paper cites some studies, one in Tunisia, for instance, where over 10% of these breakthrough infections were actually severe or critical. And another observational study reported a uh.9% mortality rate in BTI cases.

0.9%. How does that compare

well the paper notes that's significantly higher than the typical say 030.05% mortality rate often seen for natural infection in similar age groups it suggests these BTI might have been vastly under reportported too maybe due to testing biases or other factors giving us a potentially skewed picture

that leads right into this next concept which honestly sounds quite counterintuitive negative efficacy.

It does sound strange doesn't it?

Yeah it's not just protection fading but suggesting vaccinated people might actually become more likely to get the disease than unvaccinated people.

It's a strong claim and the paper presents some data to back it up. It points particularly to a large study from the Cleveland Clinic over 51,000 people. And while there might have been some initial risk reduction, this study apparently showed the risk of infection actually rose with each additional vaccine dose.

Rose how much?

The figures cited are uh 107% higher risk after one dose and surprisingly up to 253 3% higher after more than three doses compared to the unvaccinated group in that study.

That's quite a reversal.

It is. And the paper also mentions a uh global analysis 145 countries using something called Beijian causal analysis.

Sounds complex.

It is. But the finding they report is a suggested correlation between vaccination programs and significant increases in global COVID cases up to 291% and also deaths up to around 205%. Again, relation but a concerning one presented in the paper

and they try to visualize this too right using data from John's Hopkins

yes exactly they use charts from countries like Sweden, Denmark, Norway, Finland but also places like South Korea, Australia, Hong Kong, Singapore, highly vaccinated places.

And what do the charts show according to the paper?

They highlight that major surges in COVID cases and importantly deaths seem to really become apparent after these places hit high levels of vaccine coverage like 75% or more.

So the argument is If omccron was supposed to be milder,

right, that's the question the figure raises. If omccron was generally milder, why these paradoxical, unexpectedly high mortality rates in 2022, 2023 in these very highly vaccinated populations?

Yeah.

The paper argues it's maybe unreasonable to blame those surges solely on a mild variant. Instead, the hybrid harms hypothesis offers this alternative. Maybe was an interaction effect between the widespread infections and the widespread injections, especially after mass vaccin. campaigns that this interaction was driving the surges.

Let's dig into those harms. Then the paper breaks down the mRNA product components, calling it a three-pronged toxic payload. What are the prongs?

Okay, so prong one, according to the paper, is the spike protein itself, which they argue isn't benign. It can potentially damage endothelial cells. The lining of blood vessels, cause oxidative stress, trigger inflammation, and maybe even blood clotting.

Okay, spike protein. What's prong two?

Prong two is the delivery system, the lipid nanoparticle. or LNPS, those tiny fat bubbles carrying the mRNA. The paper suggests these aren't just passive carriers, but can contribute to prolonged inflammation themselves and activate pro-inflammatory pathways.

So, the delivery system itself might be an issue. And the third

the third prong uh involves process related impurities, specifically fragments of DNA like plasma DNA left over from manufacturing. The paper notes concerns that levels of these impurities, particularly in er's product according to some analyses cited were found to be hundreds of times higher than regulatory limits allow.

Hundreds of times. Wow. And the concern there is

the concern raised is about potential integration into the human genome though that's highly debated and also potentially triggering autoimmunity. The paper even brings up a Florida study that suggested a higher risk of death both all cause and COVID specific for recipients of the Fiser vaccine compared to Madna and speculates this might be linked to higher DNA contamination in the lots studied.

Okay. So you had these three comp components and a crucial point seems to be that they don't just stay in your arm.

Exactly. That's a major point in the paper. It contradicts some of the early assumptions. It highlights studies indicating that both the mRNA instructions and the resulting spike protein can distribute throughout the entire body,

the whole body.

Yes. They don't just stay localized. They can cross important barriers like the bloodb brain barrier and the blood placenta barrier,

which would explain effects in different organs.

Precisely. This systemic distribution, the paper argues, helps explain why inflammatory damage has been linked to various organ systems, heart, liver, spleen, ovaries, the nervous system. It even notes a reported surge in rare uh neurodeenerative conditions, pryion diseases starting in 2021 with symptoms appearing quite quickly post injection on average around 11 days.

That's rapid. Now, another early idea was that this stuff, the mRNA and spike protein would degrade quickly, days, maybe weeks. What does the paper say about persistence?

Yeah, that initial Assumption of rapid clearance is strongly challenged in this paper. While yes, early estimates were short, the paper points to accumulating data showing the spike protein can persist for well much longer. Months in fact

months like how many?

Examples cited include 4 to 8 months in some individuals up to 17 months found in cerebral arteries of stroke patients and even detectable spike protein and circulation for almost 2 years, 23.6 months,

nearly two years.

And maybe most strikingly, the paper mentions a case report where Fiser vaccine derived mRNA was found in the blood 3.2 years after the last injection

3 years later the mRNA itself

that's what the case report cited suggests so this prolonged exposure the authors term it a window of vulnerability lasting maybe 2 to 3 years they argue this could lead to chronic inflammation and ongoing immune dysfunction like your cells are turned into long-term spike protein factories

okay so if it sticks around that long what about multiple doses boosters does the effect just add up

well logic ically the paper suggests that repeated vaccinations would likely lead to increased and potentially cumulative toxic impacts. More exposure

makes sense if it persists,

right? And this cumulative exposure, they argue, could lead to problems like immune dysregulation. They mention things like te- cell exhaustion where key immune cells get worn out. Okay?

And also a shift in the type of antibodies produced specifically towards something called IGG4 particularly after multiple doses.

IG4, what's the significance? of that.

The paper suggests this IGG4 switch might favor immune tolerance rather than actively clearing the virus. So, ironically, it could potentially increase susceptibility to infections, maybe even certain cancers or autoimmune diseases because the immune system isn't fighting as aggressively.

And is there data linking more doses to more infections?

The paper does highlight studies from both the US and Japan that apparently found higher rates of CO 19 correlating with an increasing number of mRNA vaccine doses. This would seem to suggest um a potential worsening of efficacy or even negative efficacy with more shots.

H and another point they make is about similarities between the vaccine effects and the virus effects like they overlap.

Exactly. That's a key part of the hybrid idea, the potential for additive or even synergistic meaning amplified effects because both exposures can trigger similar biological responses.

Such is

well things like hyperinflammation, those cytoine storms we heard about, both the vaccine and the virus can apparently trigger them. The paper asks if Some severe ICU cases were maybe worsened by recent vaccination. Both might also promote autoimmunity where the body attacks itself through mechanisms like molecular mimicry.

Okay.

Both can lead to lympopenia which is a reduction in crucial tea cells. And both can suppress the body's natural interferon responses vital for fighting viruses and maybe even cancer surveillance. So these overlapping immunological issues, the paper argues, suggest the combination could amplify serious adverse events.

So the dominant ative especially later on was that the vaccines protect against severe disease, hospitalization, death. Does this paper take issue with that?

It absolutely does vigorously. It argues there are significant methodological flaws in many of the studies that claimed that strong protection.

Flaws like what?

Things like inconsistent follow-up periods between vaccinated and unvaccinated groups, selection biases, and particularly something called case counting window bias.

Case counting window bias. What's that?

It's basically about when you start counting cases or adverse events after vaccination. The paper argues that often people who had an adverse event shortly after getting the shot, say within the first week or two, were sometimes mclassified as unvaccinated because the vaccine hadn't kicked in yet, according to the study protocol.

Ah, I see. So that could make the vaccine look safer or more effective than it is.

Potentially, yes. It could artificially inflate the efficacy numbers. The paper suggests that if you start tracking outcomes too late, even an ineffective product could appear maybe 50 65% effective just because of this windowing effect. It even cites an Israeli study of 32,000 vaccinees that apparently found an eight-fold higher likelihood of hospitalization compared to unvaccinated individuals within the same health care system.

Eight times higher.

That's the finding cited. The paper suggests this points towards either superior natural immunity in the unvaccinated group studied or perhaps worryingly worsening protection for the vaccine recipients in that specific context.

Now, this next point feels crucial. We all know about longco or pace, but the paper introduces postcoid9 vaccine syndrome, PCVS. How are they related or different?

Well, the paper proposes a kind of reclassification, really arguing that PCVS might actually subsume many cases currently labeled as pacey. The key link again is the spike protein. It cites research indicating that vaccinated individuals who had long COVID symptoms showed spike antibbody levels roughly seven times higher than un vaccinated people who'd recovered from infection even when the vaccinated group hadn't had a recent infection.

Seven times higher antibodies suggesting more spike protein exposure.

That's the implication drawn in the paper. A significantly higher or more persistent spike protein burden in the vaccinated group with long symptoms. And another analysis mentioned found that 70% of PSSE cases occurred in fully vaccinated people.

70%.

Yes. Leading the paper to suggest the vaccines themselves might exacerbate or even precipitate these PSC like symptoms. Essentially, it argues many cases we call longcoid might actually be vaccine injuries or PCVS. Due to the prolonged presence of vaccine induced spike protein, it becomes hard to disentangle the two.

Okay. And finally, let's talk about the really serious adverse events, cardiovascular issues, clotting problems. How does the paper see the interaction there?

This is a major focus of the hybrid harms argument. The paper states that both exposures the vaccine and the virus can trigger and potentially Amplify clotting disorders and heart inflammation like myocarditis.

Amplify them.

Yes. It notes that the same kinds of blood clotting issues seen in severe COVID are also seen as complications from the mRNA vaccines. And it cites autopsy studies suggesting direct toxic effects on heart tissue from the vaccines. Something apparently not observed to the same degree with the virus itself.

Direct heart toxicity from the vaccine.

That's what the cited autopsy studies suggest. And the paper hypothesizes a scenario where maybe sub technical hidden mocarditis caused by the vaccine could later be triggered into a full-blown severe myocarditis if the person subsequently gets infected. The infection acts as a second hit or stressor.

And is there broader population data to support this hybrid harms idea for severe outcomes?

The paper points to epidemiological data from several highly vaccinated countries. South Korea, Australia, Singapore are mentioned again. It highlights paradoxical spikes in all-c causeed mortality that seem to synchronize with the relatively mild omocron waves in 2022

synchronized with omccron but omccron was mild.

Exactly. The argument is that these death spikes don't really fit the narrative of a mild variant causing havoc. Instead, the paper suggests this data supports the hybrid harms phenomenon, the interaction driving excess mortality. It mentions South Korea's excess mortality rising sharply in early 2022 during omccron and Hong Kong showing an average excess mortality of uh a staggering 71.14% during its wave.

Wow. Okay. A lot to think about there. As we wrap up this deep dive, what's the main takeaway for you from this paper's perspective?

Well, if we connect all those points, the paper really concludes that the simple dichotomy we often hear, you know, vaccine versus virus, good versus bad, might be uh untenable or overly simplistic,

not so black and white.

Not according to this hypothesis. The prolonged persistence of the vaccine induced spike protein, the paper argues, sets the stage for these harmful interactions that could amplify serious adverse events when combined with infection. It leads to a potentially new understanding of postcoid conditions may be challenging us to re-evaluate how we assess health outcomes, especially considering concepts like natural immunity versus vaccine immunity versus this proposed hybrid state.

A challenging perspective indeed. Thank you for listening to another session of the Lenny and Ria Sanchez deep dive podcast show produced and archived at the website dailybriefs.info.

The "Lenny and Maria Sanchez deep dive podcast" dissects a challenging review paper, introducing the "hybrid harms hypothesis" which posits that a combination of mRNA vaccine exposure and SARS-CoV-2 infection could amplify adverse effects. The podcast explores the concept of "negative efficacy," suggesting that, contrary to initial claims, vaccinated individuals might become more susceptible to infection over time, citing studies that indicate an increased risk of infection with additional vaccine doses and a correlation between mass vaccination campaigns and surges in COVID-19 cases and deaths. It delves into a "three-pronged toxic payload" of the mRNA products—the spike protein, lipid nanoparticles, and DNA impurities—arguing that these components are not localized and can persist in the body for extended periods, potentially causing chronic inflammation and immune dysfunction. Finally, the podcast discusses how this hybrid scenario might lead to severe outcomes like cardiovascular issues, reclassifying many "long COVID" cases as "post-COVID-19 vaccine syndrome (PCVS)" due to persistent vaccine-induced spike protein, thereby challenging the conventional understanding of vaccine efficacy and post-infection health outcomes. 

Discuss Hybrid harms hypothesis.

The "Hybrid Harms Hypothesis" is a conceptual framework that proposes a complex interplay between COVID-19 mRNA vaccination and subsequent SARS-CoV-2 infections, suggesting that their combined impact can amplify adverse health outcomes rather than solely providing enhanced protection1.... This hypothesis challenges the conventional understanding that mRNA vaccinations reduce the severity of COVID-19 and its long-term sequelae (PASC), instead suggesting they might trigger mechanisms that increase morbidity24.

Core Idea and Mechanisms: The central tenet of the Hybrid Harms Hypothesis is a two-step process: an initial exposure (mRNA vaccination) that establishes a vulnerable, primed state, followed by a secondary exposure (SARS-CoV-2 infection) that elicits an exaggerated and harmful response, exceeding what either exposure alone might cause1.... This process involves a convergence of "spike protein harms," leading to pronounced immune dysregulation and inflammatory cascades that can contribute to systemic issues, including cardiovascular, hematological, and neurological complications1.... The hypothesis emphasizes that these adverse effects are often misattributed solely to the viral infection due to temporal biases and systemic issues in data collection1....

Key Distinguishing Features of the Hybrid Harms Hypothesis: The hypothesis is characterized by five fundamental features14...:

• Three-pronged toxic payload: COVID-19 mRNA products deliver a "three-pronged toxic payload" comprising the spike protein, lipid nanoparticles (LNPs), and process-related DNA impurities14....

    ◦ Spike Protein: The spike protein, whether from the vaccine or the virus, has inherent toxic and pathogenic potential, causing "spikeopathy" through mechanisms like oxidative stress, inflammation, thrombogenesis (blood clotting), and damage to endothelial cells by downregulating ACE26.... It can also trigger neuroinflammatory and neurotoxic effects by crossing the blood-brain barrier23.... Frameshifting events during translation of the modified mRNA can lead to the production of aberrant proteins forming toxic prion-like fibrils, with a reported surge in rare prion diseases post-injection23....

    ◦ Lipid Nanoparticles (LNPs): The LNP delivery system is intrinsically immunotoxic and can contribute to prolonged inflammation by activating pro-inflammatory and pro-apoptotic pathways, including the NLRP3 inflammasome and Toll-like receptors (TLRs)18.... Pre-existing inflammation (e.g., from chronic diseases like obesity or diabetes) can amplify these inflammatory impacts18....

    ◦ Process-related DNA Impurities: The production process can introduce plasmid-sourced DNA fragments (e.g., SV40 fragments) that may exceed acceptable regulatory limits, raising concerns about potential integration into the human genome, disruption of immune function, and triggering autoimmune conditions or oncogenesis18.... A Florida study suggested a higher risk of mortality for Pfizer vaccine recipients compared to Moderna, which might be linked to higher DNA contamination in Pfizer's product3233.

• Whole-body biodistribution: Both the mRNA encoding the spike protein and the protein itself can distribute throughout the entire body, including distant tissues and organs like the heart, liver, spleen, ovaries, and nervous system, and can cross barriers like the blood-brain barrier and blood-placenta barrier11.... This systemic distribution explains the link to inflammatory organ damage25....

• Multiple mRNA injections with cumulative adverse effects: Repeated mRNA vaccinations are theorized to lead to increased and potentially cumulative toxic impacts and disruption of immune system functioning37.... This concept is sometimes referred to as the "Triple-Hit Hypothesis" when a coronavirus infection is also involved37.... Successive doses can perpetuate immune dysregulation, including T-cell exhaustion and a shift towards IgG4 antibody production, which may favor immune tolerance over viral elimination, potentially weakening antiviral defenses and increasing susceptibility to infections and certain cancers or autoimmune diseases41....

• Prolonged exposure to the mRNA product’s payload: The spike protein and mRNA from vaccines do not decay immediately as initially assumed; evidence indicates they can persist for 4-8 months, up to 17 months in cerebral arteries, and even for 23.6 months (nearly two years) in circulation in some individuals. One case report cited suggests detectable Pfizer vaccine-generated mRNA was found in the blood 3.2 years after injection39.... This prolonged presence creates a "window of vulnerability" (WOV) of at least 2-3 years, during which subsequent coronavirus infections can amplify adverse effects linked to the vaccine-induced spike protein17....

• Interaction with SARS-CoV-2 or Omicron variants: The hypothesis suggests that an infection occurring before or many months after vaccination can interact with the persistent vaccine-induced spike protein, leading to disease symptoms that are often misattributed solely to the viral infection based on timing7....

Proposed Mechanisms and Pathological Outcomes ("Hybrid Harms"): The Hybrid Harms Hypothesis posits that both vaccine and infection contribute to the total toxic burden of spike protein, either additively or synergistically20.... These "hybrid harms" manifest as:

• Immune System Overactivation & Hyperinflammation: Both COVID-19 mRNA vaccinations and SARS-CoV-2 infections trigger immune hyperactivation, leading to systemic inflammation, cytokine storms, and tissue damage8.... The hypothesis questions how many severe ICU cases were exacerbated by recent vaccinations6465.

• Autoimmunity and Chronic Inflammation: Anti-spike antibodies from vaccination/infection may cross-react with human tissues through molecular mimicry, triggering autoimmune conditions like vasculitis, thrombocytopenia, rheumatoid arthritis, lupus erythematosus, and autoimmune hepatitis46.... Prolonged spike protein exposure can cause chronic immune dysregulation, T-cell exhaustion, and aberrant antibody responses (e.g., IgG4 class switch), exacerbating inflammatory pathology45.... This shift in immunity may increase susceptibility to infections and cancers47.... The hypothesis also links hybrid exposure to increased risks for mast cell activation syndrome71.

• Cardiovascular and Hematological Issues: Spike protein toxicity and immune dysregulation cause cardiovascular adverse events (e.g., myocarditis, thrombosis, arrhythmias), sometimes leading to sudden collapse63.... The same coagulopathies seen in severe COVID-19 are mirrored by thrombotic complications from mRNA vaccinations63.... The hypothesis suggests that subclinical myocarditis caused by vaccine-derived spike protein can be exacerbated by later infection-induced spike protein, triggering hyperimmune responses and transforming it into fulminant myocarditis, arrhythmias, or heart failure50.... Repeated doses increase the risk of myocarditis, particularly in young males, showing a dose-response relationship51....

• PASC-like Syndromes (Post-COVID Vaccination Syndrome - PCVS): The hypothesis proposes that many cases of PASC (Post-Acute Sequelae of COVID-19, or "Long COVID") are subsumed by "Post-COVID Vaccination Syndrome" (PCVS) due to the overlapping clinical features and shared spike protein pathogenesis40.... Vaccinated individuals with long COVID symptoms have shown significantly higher spike antibody levels compared to unvaccinated recovered individuals, implying a greater or more persistent spike protein burden71.... The vaccines themselves might exacerbate or precipitate PASC-like symptoms due to the prolonged presence of vaccine-induced spike protein9091.

Misattribution of Causality and Epidemiological Implications: The Hybrid Harms Hypothesis highlights that severe adverse events post-vaccination are often misattributed to infections due to temporal bias, especially because infections typically occur in the "window of vulnerability" established by vaccination7.... This "case-counting window bias" can artificially inflate vaccine efficacy and safety estimates by misclassifying individuals experiencing adverse events shortly after vaccination as "unvaccinated"96.... The hypothesis suggests that much of the morbidity and mortality attributed to COVID-19 in heavily vaccinated populations in 2022-2023 was likely due to the long-term persistence of vaccine-induced spike protein and other vaccine components, creating a false appearance of viral causation2.... Epidemiological data from the Omicron era, showing paradoxical spikes in all-cause mortality in highly vaccinated countries despite Omicron's mild pathogenicity, are presented as supporting the hybrid harms phenomenon79....

Distinction from "Hybrid Immunity": While "hybrid immunity" refers to the enhanced immune protection from prior SARS-CoV-2 infection followed by mRNA vaccination, the Hybrid Harms Hypothesis focuses on the potential adverse interactions109110. Studies supporting the benefits of hybrid immunity are often short-term and suffer from temporal bias, with protection against Omicron reinfection declining rapidly111.... The hypothesis raises concerns that the theoretical "enhanced" immune response from hybrid immunity may be counterbalanced by the risk of excessive antibody production, innate immune suppression, and serious adverse events, including vaccine-associated enhanced disease (VAED) or pathogenic priming46.... High antibody levels may paradoxically inhibit macrophages, potentially explaining why hybrid immunity could translate into more serious adverse events114117.

In essence, the Hybrid Harms Hypothesis suggests that the prolonged presence of vaccine-induced spike protein creates a chronic toxic environment that interacts synergistically with subsequent infections, leading to amplified harms that are often misattributed solely to the viral infection10.... It calls for a re-evaluation of risk-benefit analyses and public health strategies, especially for low-risk groups121.

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Vaccine effectiveness.

The topic of vaccine effectiveness, particularly concerning COVID-19 mRNA vaccines, is a complex and debated subject within the provided sources. While initially lauded for high efficacy, the sources present arguments and data suggesting a more nuanced and, in some cases, concerning picture regarding sustained protection and potential adverse outcomes1....

Here's a discussion on vaccine effectiveness based on the provided materials:

1. Initial Efficacy and Safety Claims

• Vaccines manufactured by Pfizer-BioNTech and Moderna were the first two COVID-19 vaccines to receive emergency use authorization in the United States56.

• Preliminary data demonstrated efficacy rates greater than 95% after a second dose against the virus5.... These initial findings were widely considered a sign of hope amidst the pandemic69.

• Initial data also suggested marked safety, with only 21 cases of anaphylaxis reported out of over 1.8 million doses administered5. While rates of anaphylaxis with mRNA vaccines were noted as relatively low (4.7 cases per million doses), they were still believed to be tenfold higher than prior vaccines6.

• The overwhelming morbidity and mortality of COVID-19 made the rapid development and distribution of these vaccines a significant success of modern science10. Unvaccinated individuals reportedly faced a 13.9 times higher risk of infection and a 53.2 times higher risk of COVID-19-associated death compared to fully vaccinated (including boosters) individuals between October and November 202110.

2. Waning Immunity and Breakthrough Infections (BTIs)

• Despite initial high efficacy, sources indicate that humoral immune protection from mRNA vaccines is short-lived24.

• Neutralizing antibody titers decline rapidly within 2-6 months after the second mRNA dose, with the sharpest declines seen in elderly and vulnerable populations2....

• Protection against symptomatic Omicron infection was observed to drop to about 10-20% by 6 months following the second dose of COVID-19 mRNA products1314. For example, vaccine effectiveness for two BNT162b2 doses against Omicron fell from 65.5% (2-4 weeks post-second dose) to 15.4% (at ~4 months) and further to 8.8% (after 6 months)13....

• This rapid decline in immunological protection is linked to an increased risk of "breakthrough infections" (BTIs), which are post-vaccination infections or reinfections by variants like Delta and Omicron, even in "fully vaccinated" individuals16.... A more accurate term for BTIs might be "vaccine failure"16....

• Surveys showed a significant percentage of vaccinated participants contracting COVID-19 after full vaccination, with infections occurring after the first (46%), second (41.2%), and third (12.8%) doses in some populations1920.

• Data from the UK and US suggest that some BTIs can lead to severe morbidity and potential lethality, with a significant percentage of Delta variant deaths in June 2021 occurring in fully vaccinated individuals (29% in UK, rising to 43% by June 25th)21.... These BTI death counts are likely underestimated due to systemic biases in data collection and reporting, influenced by financial incentives and political pressures to promote vaccine efficacy23....

3. Negative Efficacy

• Later studies suggested that repeated or successive doses of modified mRNA products could lead to "negative efficacy," where vaccinated individuals become more likely to contract the targeted disease (COVID-19) than unvaccinated individuals, indicating an elevated disease risk23....

• A large-scale retrospective cohort study at the Cleveland Clinic (n=51,017) indicated that while mRNA vaccinations initially reduced infection risk, this protection diminished over time, and the risk of infection actually rose with successive doses (e.g., 107% higher risk after one dose, up to 253% higher after more than three doses compared to unvaccinated individuals)27....

• Similar findings of increased infection rates post-vaccination, especially after six months or additional doses, were observed in studies from Japan, Qatar, the UK, and Iceland29....

• An Israeli study of 32,000 COVID-19 vaccinees found a 27-fold higher risk of contracting symptomatic COVID-19 compared to non-vaccinated individuals in the same healthcare system29....

• Data from the Vaccine Adverse Event Reporting System (VAERS) showed a dose-dependent rise in breakthrough infections, with a 30% increase after the fourth dose compared to 16% after the third29....

• An ecological study across 145 countries suggested a causal link between vaccination programs and significantly increased global COVID-19 cases (up to 291%) and deaths (up to 205.25%), with these increases correlating positively with the number of vaccine doses administered35....

• Time-series charts using Johns Hopkins data for highly vaccinated countries (e.g., Sweden, Denmark, Norway, Finland, South Korea, Australia, Hong Kong, Singapore) showed major surges in COVID-19 cases and deaths becoming apparent after these places reached high levels of vaccine coverage (75% or more)58.... This leads to the argument that unexpected mortality rates in 2022-2023 in highly vaccinated populations cannot be solely attributed to the milder Omicron variant, but rather to an interaction between widespread infections and widespread injections22....

4. Illusions of Protection Against Severe Disease

• Claims that mRNA products reduce severe COVID-19 disease, hospitalizations, and death are vigorously challenged in some sources, which point to significant methodological flaws in studies supporting these claims11....

• These flaws include inconsistent follow-up periods, uneven exclusion criteria, varying COVID-19 testing rates, selection biases, and selective result reporting56....

• A critical flaw is the "case-counting window bias," where the observation period for counting adverse events (AEs) is started too late (typically 1-3 weeks after the second dose)50.... This practice misclassifies individuals experiencing serious AEs shortly after vaccination as "unvaccinated," artificially inflating vaccine efficacy estimates and potentially making an ineffective vaccine appear moderately effective (50-65% effective)48....

• This misclassification also occurs by incorrectly categorizing vaccinated people as "unvaccinated" if they have not yet reached "immunologic maturity," are only partially vaccinated, or were vaccinated too long ago to be considered "up-to-date"8485. This practice reinforces the "safe and effective" narrative and distorts risk-benefit analyses85....

• Some studies indicate negative efficacy in terms of increasing post-injection hospitalizations, morbidity, and mortality15.... The Israeli study (mentioned above) found an 8-fold higher likelihood of hospitalization among vaccinated individuals compared to unvaccinated within the same healthcare system48.... Mortality rates after developing severe COVID-19 disease were also higher following additional doses of mRNA products in hospitalized recipients15....

5. Hybrid Immunity vs. Hybrid Harms

• Hybrid immunity, defined as synergistic immune protection from prior SARS-CoV-2 infection followed by COVID-19 mRNA vaccination, has been shown to confer enhanced immunological responses88.... This can result in a more robust and diverse antibody repertoire, with elevated neutralizing antibody titers and broader epitope recognition9294.

• However, sources highlight that most studies on hybrid immunity benefits were short-term, and protection against Omicron reinfection, even with booster doses, declined significantly (from 80.6% to 36.9% within 16 weeks)88....

• The "Hybrid Harms Hypothesis" challenges the notion of solely enhanced protection, proposing that the prolonged presence of vaccine-induced spike protein (lasting 2-3 years, potentially up to 3.2 years for mRNA itself) creates a "window of vulnerability"101.... During this period, subsequent coronavirus infections may amplify adverse events linked to the ongoing presence of vaccine-induced spike protein41....

• This hypothesis suggests that the morbidity and mortality attributed to COVID-19 in extensively vaccinated populations (2022-2023) were plausibly due to a combination of mass vaccination and coronavirus infections, given the long-term background persistence of spike protein and other vaccine-associated components1....

• The hypothesis posits that both the vaccine and the virus contribute to a total toxic burden of spike protein, either additively or synergistically, leading to "spikeopathy" (toxic effects of spike protein) and chronic issues like myocarditis, blood clotting disorders, and "long COVID" symptoms (PASC)108....

• The overproduction of non-neutralizing antibodies and potential for vaccine-associated enhanced disease (VAED) or pathogenic priming are also concerns with hybrid immunity, although VAED has mainly been observed in animal models32....

In conclusion, while initial data highlighted high efficacy for COVID-19 mRNA vaccines, subsequent analyses and the "Hybrid Harms Hypothesis" presented in the sources propose that the long-term effectiveness is compromised by waning immunity, breakthrough infections, and potentially "negative efficacy" where vaccinated individuals might paradoxically face increased risk of infection and severe outcomes due to chronic immune dysregulation and the prolonged presence of vaccine-induced spike protein3.... This challenges the traditional dichotomy between vaccine and viral effects, suggesting a complex interaction that amplifies adverse events1134.

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Pharmacovigilance database.

Pharmacovigilance databases are crucial systems used to monitor adverse reactions to medical products, including vaccines, after they have been authorized for public use1.... These systems aim to collect and analyze reports of adverse events to assess safety, guide further evaluations, and inform vaccine recommendations and regulatory actions34.

Here's a detailed discussion of pharmacovigilance databases based on the provided sources:

1. Purpose and Function

• Post-Licensure Safety Monitoring: Pharmacovigilance systems, like the Vaccine Adverse Event Reporting System (VAERS) in the U.S. and EudraVigilance in the European Economic Area (EEA), conduct post-licensure monitoring of vaccine safety1.... This means that after a vaccine is approved, these systems continue to track safety by collecting and analyzing spontaneous reports of adverse events that occur in individuals following vaccination3.

• Signal Detection and Hypothesis Generation: VAERS is primarily designed as a safety signal detection and hypothesis-generating system. It helps identify potential safety concerns that warrant further investigation, but generally, VAERS data alone cannot determine if a vaccine caused an adverse event3.

• Manufacturer Reporting: Health Canada, for example, requires vaccine manufacturers to submit detailed individual adverse reaction reports, as well as monthly safety reports summarizing everything observed globally5. This information is then reviewed to determine if there's a relationship between an event and the vaccine6.

• Public and Healthcare Professional Reporting: Anyone, including healthcare professionals and the general public, is encouraged to report any clinically significant adverse events to systems like VAERS, even if they are unsure if the vaccine caused the event78. In Canada, public reports go through local public health systems and are then provided to the Public Health Agency of Canada8.

2. Key Databases Mentioned

• VAERS (United States): A spontaneous or passive reporting system managed by the CDC and FDA. It is frequently cited in the sources for data on allergic reactions and other adverse events related to COVID-19 mRNA vaccines1....

• EudraVigilance (European Economic Area): Collects allergic reaction data following COVID-19 vaccination in Europe1....

• Lareb (The Netherlands Pharmacovigilance Centre): An example of a national pharmacovigilance center that receives spontaneous reports of suspected allergic reactions, including anaphylaxis and other hypersensitivity events, following COVID-19 vaccines19....

• World Health Organization International Pharmacovigilance Database (VigiBase): A large-scale international database used to investigate the global burden of vaccine-associated anaphylaxis and related vaccines224.

3. Data and Findings Related to COVID-19 Vaccines

• Anaphylaxis Reports:

    ◦ Initial reports in December 2020 estimated anaphylaxis rates for Pfizer-BioNTech vaccine at 11.1 per million doses, decreasing to 4.7 per million by January 202117. Moderna's vaccine was reported at 2.5 cases per million doses17.

    ◦ Overall incidence across all COVID-19 vaccine types was 7.91 per million in 2021, most recently reported as 5 cases per million doses17.

    ◦ A global analysis of the WHO International Pharmacovigilance Database identified 31,676 reports of vaccine-associated anaphylaxis out of over 131 million total reports between 1967 and 202324.

    ◦ COVID-19 mRNA vaccines were associated with 1.89 anaphylactic reports per million doses, while inactivated whole-virus COVID-19 vaccines had a rate of 2.21 per million24.

    ◦ Adenovirus-vectored vaccines (e.g., Janssen, Oxford/AstraZeneca) had higher reported anaphylactic reaction rates compared to mRNA-based vaccines in both EudraVigilance and VAERS12.

    ◦ Anaphylaxis fatality rates were extremely rare and two to sixfold higher for vectored than mRNA vaccines in both databases1825. The Ad5-vectored COVID-19 vaccine anaphylaxis reports had the highest fatality rate (15.0%)24.

    ◦ Anaphylaxis is rare, occurring in about 1-3 cases per million doses for most vaccines, and these are acute, treatable events26.... It occurs almost exclusively in people with pre-existing allergies to specific components like polyethylene glycol (PEG)27....

• Waning Immunity and Negative Efficacy (Challenging Claims):

    ◦ VAERS data from November 2024 showed a dose-dependent rise in breakthrough infections, with a 30% increase after the fourth dose compared to 16% after the third, which some sources interpret as declining vaccine efficacy with additional doses3233.

    ◦ An Israeli study of 32,000 COVID-19 vaccinees found a 27-fold higher risk of contracting symptomatic COVID-19 compared to non-vaccinated individuals in the same healthcare system, and an 8-fold higher likelihood of hospitalization33....

4. Limitations and Challenges of Pharmacovigilance Data

• Passive Surveillance Limitations: VAERS, being a passive surveillance system, has inherent limitations3. Data must be interpreted with caution as it cannot generally determine cause and effect, and data interpreted alone or out of context can lead to erroneous conclusions3.

• Underreporting: A potential limitation is the likely underreporting of allergic reactions, including anaphylaxis36. However, for COVID-19 vaccines, this might be less pronounced due to intense scrutiny from regulators, healthcare professionals, and the public36. Many serious adverse events (AEs) like ischemic stroke, myocardial infarction, and pulmonary embolism, which are common, may be less likely to be attributed to vaccines by clinicians, leading to underreporting37.... This "concealment within routine disease statistics" skews risk-benefit assessments3839.

• Misclassification Issues:

    ◦ Case-counting window bias: Studies may start counting AEs too late (e.g., 1-3 weeks after the second dose), misclassifying individuals experiencing serious AEs shortly after vaccination as "unvaccinated," thereby artificially inflating vaccine efficacy and safety estimates35....

    ◦ Inconsistent Definitions: Inconsistencies in classifying "fully vaccinated" status (e.g., excluding individuals within 14 days of their second dose or those with waning immunity) contribute to underreporting of vaccine-related morbidity and mortality47.

    ◦ Temporal Bias: Clinicians may attribute severe AEs (e.g., myocarditis) solely to the most recent event, such as a coronavirus infection, overlooking prior mRNA vaccination as a predisposing factor due to prolonged spike protein persistence39....

• Reporting Errors: Passive reporting systems can involve possible reporting errors, such as duplicate or incomplete records36. The terminology used for anaphylaxis post-vaccination may also introduce inaccurate mechanistic explanations36.

5. Critical Interpretations and "Hybrid Harms Hypothesis" Some sources argue that these systemic biases and misclassification issues have significantly distorted the assessment of COVID-19 mRNA vaccine efficacy and safety, particularly in observational studies45.... The "Hybrid Harms Hypothesis" proposes that many morbidity and mortality events attributed to COVID-19 in extensively vaccinated populations in 2022-2023 were likely due to the long-term persistence of vaccine-derived spike protein and other vaccine-associated components, interacting with and amplifying subsequent Omicron infections52.... These interactions are often misattributed solely to the viral infection due to temporal biases and systemic data collection issues39....

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Spike protein toxicity.

The spike protein is a critical component of the SARS-CoV-2 viral envelope, facilitating its entry into host cells and initiating infection1. It is also the primary target of COVID-19 mRNA vaccinations, which induce its expression to elicit an immune response1. However, the provided sources extensively discuss the toxic and pathogenic potential of the spike protein itself, regardless of whether it originates from the COVID-19 mRNA vaccination or from a coronavirus infection, a phenomenon referred to as "spikeopathy"1....

Here's a detailed discussion of spike protein toxicity:

1. Intrinsic Pathogenic Potential ("Spikeopathy") The spike protein is described as inherently non-benign, capable of causing a wide range of harms to the human body1.... Its pathophysiological effects, or "spikeopathy," arise from mechanisms that lead to:

• Oxidative stress1....

• Inflammation and hyperinflammation, including cytokine storms1....

• Thrombogenesis (blood clotting) and endothelial cell damage1.... It damages endothelial cells by downregulating ACE2, thereby inhibiting mitochondrial function1....

• Neuroinflammatory and neurotoxic effects4.... It can trigger a pro-inflammatory response in brain endothelial cells, potentially altering the blood-brain barrier, and can cross this barrier7....

• Prion-related dysregulation: Frameshifting events due to mistranslation of pseudouridinated mRNA can result in the production of aberrant proteins capable of forming toxic prion-like fibrils in neurons, potentially causing and/or accelerating neurodegenerative disorders14.... A surge in rare prion diseases has been documented since 2021, with initial symptoms appearing, on average, within 11.38 days post-injection14....

• Inflammatory organ damage in various systems, including the heart, liver, spleen, ovaries, and nervous system14....

2. Prolonged Persistence of Spike Protein A critical aspect highlighted in the sources is the prolonged presence and cumulative antigenic load of spike protein in the body, which challenges initial assumptions of rapid clearance2....

• While initially assumed to clear within days or weeks (e.g., 1-2 weeks), evidence suggests it can persist much longer29....

• Studies show vaccine-derived spike protein present on exosomes circulating for over 4 months4....

• It has been detected in circulation for 6-8 months (187-245 days) in some individuals31....

• In one Japanese study, spike protein was found in cerebral arteries up to 17 months following COVID-19 mRNA vaccination31....

• Circulating spike protein was elevated in individuals with substantial immune dysfunction after injections, persisting for 23.6 months (709 days)31....

• Most strikingly, one case report cited by the authors suggests detectable Pfizer vaccine-generated mRNA was found in the blood 3.2 years after injection29....

• The best estimates for extended spike production post-vaccination are in the range of 24 to 38 months, suggesting no inherent "off switch" for spike protein generation by transfected cells46....

• This prolonged generation and cumulative antigenic load can lead to ongoing systemic inflammation, immunological dysfunction, and various immune-related disorders4....

3. Systemic Biodistribution of Vaccine Payload The mRNA and the spike protein, along with other vaccine components, do not remain localized at the injection site but distribute throughout the entire body14....

• Early rodent biodistribution studies showed lipid nanoparticles delivering synthetic, modified mRNA to all organs, including the blood-brain barrier and blood-placenta barrier14....

• Notable accumulation was observed in the spleen, liver, ovaries, adrenal glands, brain, eyes, heart, testes, uterus, pituitary gland, spinal cord, and bone marrow27....

• This systemic biodistribution explains the widespread inflammatory organ damage observed14....

4. Role in the "Hybrid Harms Hypothesis" The persistent presence of vaccine-induced spike protein is central to the "Hybrid Harms Hypothesis"2....

• It posits that coronavirus infections are often superimposed on a pre-existing milieu of toxic spike protein (from vaccination), inflammatory lipid nanoparticles, and residual process-related DNA impurities3....

• This prolonged presence creates a "window of vulnerability" (WOV) potentially lasting 2-3 years, during which subsequent coronavirus infections can amplify adverse effects linked to the ongoing presence of vaccine-induced spike protein3....

• The hypothesis suggests that both COVID-19 mRNA vaccinations and coronavirus infections contribute to the total toxic burden of spike protein, either additively or synergistically73.... This convergence leads to pronounced immune dysregulation and inflammatory cascades, which may account for unexpected surges in morbidity and all-cause mortality, particularly in highly vaccinated populations during the Omicron era (2022-2023)73....

5. Specific Adverse Events Linked to Spike Protein Toxicity

• Myocarditis and Cardiovascular Conditions: The spike protein is strongly linked to inflammation of the heart muscle (myocarditis) and other cardiac complications14....

    ◦ Evidence suggests a stronger link between COVID-19 mRNA vaccines and severe cardiac complications compared to SARS-CoV-2 infections alone92....

    ◦ Autopsy studies have identified vaccine-derived mRNA and spike protein in cardiac tissue post-vaccination, and in vitro studies show direct cardiotoxic effects of mRNA vaccines on heart cells, which have not been observed with the virus itself92....

    ◦ The hypothesis suggests that subclinical myocarditis induced by the mRNA vaccine may be exacerbated by a subsequent infection12.... Persistent vaccine-derived spike protein in cardiac tissues, combined with infection-induced spike protein, can trigger hyperimmune responses and cardiomyocyte damage, potentially transforming subclinical myocarditis into fulminant myocarditis, leading to arrhythmias and heart failure12....

    ◦ Repeated doses increase the risk of myocarditis, with a dose-response relationship observed94.... Case reports illustrate severe myocarditis developing after Omicron infection in individuals vaccinated months prior, arguing for misattribution where the vaccine predisposed the individual to the severe outcome105....

• Blood Clotting Disorders (Thrombotic Events): The spike protein, whether from the virus or vaccine, is a common denominator in clotting disorders and serious thrombotic complications14....

    ◦ It can interact with ACE2 receptors and promote a hypercoagulable state through cytokine storms and upregulation of procoagulant factors111....

    ◦ Vaccine-induced immune thrombotic thrombocytopenia (VITT), involving autoantibodies and transient spike protein-mediated endothelial activation, also promotes thrombosis111....

    ◦ The same coagulopathies seen in severe COVID-19 are mirrored by serious thrombotic complications from mRNA vaccinations, including myocardial infarction, disseminated intravascular coagulation, and venous thromboembolism94....

• Post-Acute Sequelae of COVID-19 (PASC) / Post-COVID-19 Vaccine Syndrome (PCVS): The spike protein is implicated in the pathogenesis of both PASC and PCVS10....

    ◦ Studies show that vaccinated individuals with "long COVID" symptoms exhibited spike antibody levels approximately seven times higher than unvaccinated individuals who recovered from infection, even without a recent infection in the vaccinated group32.... This implies a potentially higher or more persistent spike protein burden in vaccinated individuals experiencing long-term symptoms32....

    ◦ A retrospective analysis found that 70% of PASC cases occurred in individuals who had completed a full course of COVID-19 mRNA vaccinations, suggesting the injections may exacerbate or precipitate PASC symptomatology32....

6. Immunological Dysregulation due to Spike Protein Prolonged spike protein exposure and repeated mRNA vaccinations are linked to various forms of immune dysregulation10....

• T-cell exhaustion: Key immune cells can become "worn out" or dysfunctional32....

• IgG4 class switch: Multiple mRNA vaccine doses can lead to an antibody class-switch to IgG44.... This IgG4 switch may promote immune tolerance rather than viral elimination, potentially increasing susceptibility to infections, cancers, and autoimmune diseases4.... This appears almost exclusively in individuals who received multiple COVID-19 mRNA vaccinations or were infected after vaccination, unlike conventional vaccines141....

• Autoimmunity: Both SARS-CoV-2 infections and mRNA vaccinations may promote autoimmune reactions, likely through molecular mimicry between the spike protein and human proteins4.... The homologous peptides in the translated spike protein from mRNA injections are 100% matched to many human proteins, leading to extensive cross-reactivity that can trigger or exacerbate autoimmune conditions10....

In summary, the sources present the spike protein, whether from infection or vaccination, as a key driver of various pathologies. Its prolonged persistence, systemic distribution, and ability to induce chronic immune dysregulation contribute significantly to the "Hybrid Harms Hypothesis," which suggests that the combination of mRNA vaccination and subsequent SARS-CoV-2 infection can amplify severe adverse outcomes often mistakenly attributed solely to the virus3....

keep_pinSave to note

copy_all

thumb_up

thumb_down

Discuss Individual Autonomy.

Individual autonomy is a fundamental ethical principle that grants individuals the right to make decisions about their own body and health12. This right is rooted in respect for human dignity and the concept of informed consent1. In most democracies, individuals generally have the legal right to refuse medical interventions, including vaccines34.

However, the sources and our conversation extensively highlight that autonomy is not absolute and exists within a broader societal context, necessitating a balance with collective welfare and other ethical principles25.

Here's a detailed discussion of individual autonomy in the context of our conversation:

• Balancing Individual Rights with Societal Responsibilities:

    ◦ Ethical Principles: While autonomy upholds individual choice, public health ethics also emphasize principles like non-maleficence (the duty to avoid harming others) and beneficence (the duty to act for the benefit of others)25. These principles often come into conflict when individual choices, such as vaccine refusal, can potentially impact the health and well-being of the community2....

    ◦ Justice: The principle of justice also plays a role, as individuals who refuse vaccination might "free-ride" on the herd immunity created by others, thereby shifting risks to society6....

    ◦ Interconnectedness: The argument is made that no individual exists in a vacuum; personal health choices can ripple through social, economic, and biological networks, affecting vulnerable populations like the immunocompromised or infants who cannot be vaccinated2....

• Legal Frameworks and Mandates:

    ◦ Governments may impose vaccine mandates to protect public health, and such measures have been upheld as constitutional by courts (e.g., Jacobson v. Massachusetts, 1905)3.... These mandates are considered legally and ethically distinct from coercing participation in unproven experiments because vaccines are approved, evidence-based interventions1517.

    ◦ International human rights law balances individual autonomy with communal welfare, requiring that public health measures limiting individual rights be necessary, proportionate, and non-discriminatory16.

• Consequences and Ethical Implications of Refusal:

    ◦ Societal Harm: Refusal to vaccinate can increase the likelihood of contracting and spreading contagious diseases, burdening healthcare systems and potentially prolonging epidemics1118. This is seen as violating the ethical duty to avoid harming others67.

    ◦ Penalties: Depending on jurisdiction and context, refusing vaccination might result in denied employment, education, or travel privileges14.

    ◦ Misinformation: If a decision to refuse a vaccine is based on false or inaccurate information, it undermines the concept of informed consent, making the ethical stance problematic4.... Ethical refusal requires an accurate understanding of risks and benefits20.

• The "Genius" Hypothetical and Expert Responsibility:

    ◦ Even in the extreme hypothetical of a universally recognized genius or a domain-specific expert, individual autonomy does not automatically override collective welfare or empirical evidence21....

    ◦ Such an individual's refusal, even if personally justified by their unique insights, could still inadvertently cause societal harm by influencing others or reducing overall herd immunity23....

    ◦ For an expert-genius, there's a heightened ethical responsibility for transparency and accountability; if their stance contradicts scientific consensus, they are expected to publish rigorous, reproducible evidence and take steps to minimize any public harm29....

• Rare Ethical Justification:

    ◦ Only in an "extraordinarily rare and highly specific scenario"—where a domain expert/genius refuses vaccination based on rigorous, peer-validated evidence that genuinely exposes a new, legitimate risk, and they take stringent measures to minimize harm to others (e.g., through isolation)—could their decision be considered ethically justifiable32.... This is an exception and does not apply to general vaccine refusal35.

In summary, while individual autonomy is a cornerstone of medical ethics, its exercise in public health contexts is subject to ethical scrutiny based on its potential impact on others and society at large3637. Ethical judgment, even from a "genius," must align with empirical evidence and the collective good to be truly sound2538.

keep_pinSave to note

copy_all

thumb_up

thumb_down

21 s